,Region,Sub-region,Country/Territory,Total,Male,Female,Year,Age,Source,Method,Drug,Low,High,ISO3
0,Africa,East Africa,Kenya,1.2,2.1,0.3,2016,15-64,ARQ,HHS,Cannabis,,,KEN
1,Africa,East Africa,Kenya,2.1,,,2007,15-65,Govt,HHS,Cannabis,0.3,4,KEN
2,Africa,East Africa,Kenya,7.1,,,2004,15-64,"ARQ, NGO, Council of Europe ","SS, A ",Cannabis,,,KEN
3,Africa,East Africa,Madagascar,9.1,,,2004,15-64,ARQ,"SS, A",Cannabis,,,MDG
4,Africa,East Africa,Mauritius,1.08,,,2009,15-54,Government source,,Cannabis,,,MUS
5,Africa,East Africa,Mauritius,3.9,,,2004,15-54,ARQ ,,Cannabis,,,MUS
6,Africa,North Africa,Algeria,0.52,1.06,0.03,2010,12+,ARQ,HHS,Cannabis,,,DZA
7,Africa,North Africa,Egypt,5.31,,,2016,15-64,MedSPAD/UNODC estimate ,SS,Cannabis,,,EGY
8,Africa,North Africa,Egypt,6.24,,,2006,15-64,Govt; Academic Research,"HHS, SS",Cannabis,2.9,9.58,EGY
9,Africa,North Africa,Morocco,10.47,,,2017,15-64,MedSPAD/UNODC estimate ,SS,Cannabis,,,MAR
10,Africa,North Africa,Morocco,4.22,,,2004,15-64,ARQ,HHS ,Cannabis,,,MAR
11,Africa,North Africa,Tunisia,5.35,,,2017,15-64,MedSPAD/UNODC estimate ,SS,Cannabis,,,TUN
12,Africa,North Africa,Tunisia,2.6,,,2013,15-64,ARQ,HHS,Cannabis,,,TUN
13,Africa,Southern Africa,South Africa,3.65,,,2011,15-64,ARQ,SS,Cannabis,2.88,4.42,ZAF
14,Africa,Southern Africa,South Africa,4.26,,,2008,15-64,ARQ ,HHS ,Cannabis,3.52,6.18,ZAF
15,Africa,Southern Africa,Zambia,9.5,,,2004,15-64,Govt; Academic Research,SS,Cannabis,4,15.6,ZMB
16,Africa,Southern Africa,Zambia,17.7,,,2003,,UNODC Estimate ,,Cannabis,,,ZMB
17,Africa,West and Central Africa,Burkina Faso,2.9,,,2006,15-64,UNODC Estimate,,Cannabis,,,BFA
18,Africa,West and Central Africa,Cabo Verde,2.4,,,2012,15-64,UNODC/Govt.,HHS,Cannabis,,,CPV
19,Africa,West and Central Africa,Cabo Verde,8.1,,,2004,15-64,UNODC Estimate,,Cannabis,,,CPV
20,Africa,West and Central Africa,Côte d'Ivoire,3.24,,,2017,15-64,Government/UNODC Estimate,SS,Cannabis,1.99,4.3,CIV
21,Africa,West and Central Africa,Liberia,7.52,,,2017,15-64,WHO GSHS/UNODC Estimate,SS,Cannabis,,,LBR
22,Africa,West and Central Africa,Liberia,3.18,,,2008,15-64,UNODC Estimate,,Cannabis,1.53,4.83,LBR
23,Africa,West and Central Africa,Nigeria ,10.76,18.8,2.6,2017,15-64,Government/UNODC,HHS/I,Cannabis,10.26,11.26,NGA
24,Africa,West and Central Africa,Nigeria,14.3,,,2008,15-64,ARQ,HHS,Cannabis,11.76,16.84,NGA
25,Africa,West and Central Africa,Sierra Leone,6.48,,,2017,15-64,WHO GSHS/UNODC Estimate,SS,Cannabis,,,SLE
26,Africa,West and Central Africa,Sierra Leone,5.42,,,2010,15-64,UNODC Estimate,,Cannabis,3.52,7.32,SLE
27,Africa,West and Central Africa,Togo,1,,,2009,15-64,UNODC Estimate,SS,Cannabis,0.2,3.1,TGO
28,Africa,West and Central Africa,Togo,2.73,,,2006,15-64,UNODC Estimate ,SS ,Cannabis,,,TGO
29,Americas,Caribbean,Bahamas,3.1,5,1,2017,12-65,ARQ,HHS,Cannabis,,,BHS
30,Americas,Caribbean,Bahamas,5.54,,,2008,15-64,ARQ,SS,Cannabis,3.2,7.89,BHS
31,Americas,Caribbean,Bahamas,4.7,,,2003,15-64,UNODC Estimate ,SS ,Cannabis,,,BHS
32,Americas,Caribbean,Barbados,8.3,,,2006,15-64,CICAD,HHS,Cannabis,,,BRB
33,Americas,Caribbean,Dominican Republic,0.68,1.4,0.22,2010,12-65,CICAD,HHS,Cannabis,,,DOM
34,Americas,Caribbean,Dominican Republic,0.31,,,2008,15-64,ARQ,SS,Cannabis,0.25,1.41,DOM
35,Americas,Caribbean,Haiti,2.5,2.3,2.7,2018,15-64,ARQ,HHS,Cannabis,,,HTI
36,Americas,Caribbean,Haiti,1.51,,,2010,15-64,UNODC Estimate,SS,Cannabis,0.26,2.75,HTI
37,Americas,Caribbean,Haiti,1.41,,,2005,15-64,UNODC Estimate,SS,Cannabis,0.43,2.15,HTI
38,Americas,Caribbean,Jamaica,18,28.5,7.8,2016,12-65,Government source,HHS,Cannabis,,,JAM
39,Americas,Caribbean,Jamaica,7.21,,,2010,15-64,UNODC Estimate,SS,Cannabis,4.25,10.17,JAM
40,Americas,Caribbean,Jamaica,9.86,,,2006,15-64,Government source,SS,Cannabis,7.52,12.2,JAM
41,Americas,Caribbean,Jamaica,10.7,,,2001,12-55,UNODC Estimate ,,Cannabis,,,JAM
42,Americas,Caribbean,Puerto Rico,4.88,,,2005,15-64,Government source,SS,Cannabis,3.1,6.65,PRI
43,Americas,Caribbean,Saint Lucia,8.87,,,2010,15-64,UNODC Estimate,SS,Cannabis,5.64,12.1,LCA
44,Americas,Caribbean,Saint Lucia,9,,,2006,15-64,UNODC Estimate,SS,Cannabis,,,LCA
45,Americas,Caribbean,Trinidad and Tobago,4.788,,,2017,15-64,WHO GSHS/UNODC Estimate,SS,Cannabis,1.396,8.179,TTO
46,Americas,Caribbean,Trinidad and Tobago,4.03,,,2010,15-64,UNODC Estimate,SS,Cannabis,1.55,6.52,TTO
47,Americas,Caribbean,Trinidad and Tobago,4.66,,,2006,15-64,Government source,SS,Cannabis,2.91,6.42,TTO
48,Americas,Caribbean,Trinidad and Tobago,3.7,,,2002,,UNODC Estimate ,,Cannabis,,,TTO
49,Americas,Central America,Belize,8.45,,,2005,12-65,CICAD,HHS,Cannabis,,,BLZ
50,Americas,Central America,Costa Rica,5.18,7.84,2.49,2015,15-64,ARQ,HHS,Cannabis,,,CRI
51,Americas,Central America,Costa Rica,2.76,4.4,1.07,2010,15-64,ARQ,HHS,Cannabis,,,CRI
52,Americas,Central America,Costa Rica,1.02,,,2006,12-70,ARQ ,HHS ,Cannabis,,,CRI
53,Americas,Central America,El Salvador,2.03,3.93,0.62,2014,12-65,Government source,HHS,Cannabis,1.12,3.67,SLV
54,Americas,Central America,El Salvador,0.39,,,2005,12-65,CICAD,HHS,Cannabis,0.35,0.43,SLV
55,Americas,Central America,Guatemala,3.48,,,2014,15-64,Government source/UNODC Estimate,SS,Cannabis,0.438,6.521,GTM
56,Americas,Central America,Guatemala,4.8,,,2005,12-65,UNODC Estimate,"HHS, SS",Cannabis,,,GTM
57,Americas,Central America,Honduras,0.83,,,2005,12-65,UNODC Estimate,SS,Cannabis,0.41,1.59,HND
58,Americas,Central America,Honduras,1.5,,,2004,15-64,UNODC Estimate ,SS ,Cannabis,,,HND
59,Americas,Central America,Nicaragua,1.07,,,2006,12-65,UNODC Estimate,HHS,Cannabis,1.06,1.07,NIC
60,Americas,Central America,Nicaragua,2.2,,,2002,12-65,UNODC Estimate,HHS ,Cannabis,,,NIC
61,Americas,Central America,Panama,0.77,1.52,0.14,2015,12-65,ARQ,HHS,Cannabis,,,PAN
62,Americas,Central America,Panama,3.55,,,2003,12-65,UNODC Estimate,HHS,Cannabis,3.4,3.7,PAN
63,Americas,North America,Bermuda,10.9,,,2009,16-65,Government source,HHS,Cannabis,10.7,11.2,BMU
64,Americas,North America,Canada,20.7,22.8,18.6,2019,15+,ARQ/Government source,HHS,Cannabis,19.4,22,CAN
65,Americas,North America,Canada,14.8,18.7,11.1,2017,15+,ARQ,HHS,Cannabis,,,CAN
66,Americas,North America,Canada,14.73,17.64,11.83,2015,15-64,ARQ,HHS,Cannabis,,,CAN
67,Americas,North America,Canada,12.7,16.4,9,2013,15-64,ARQ,HHS,Cannabis,,,CAN
68,Americas,North America,Canada,12.2,15.9,8.5,2012,15-64,ARQ,HHS,Cannabis,,,CAN
69,Americas,North America,Canada,10.9,,,2011,15-64,ARQ,HHS,Cannabis,,,CAN
70,Americas,North America,Canada,12.65,,,2010,15-64,ARQ ,HHS ,Cannabis,,,CAN
71,Americas,North America,Mexico,2.1,3.5,0.9,2016,12-65,ARQ/Government,HHS,Cannabis,1.9,2.3,MEX
72,Americas,North America,Mexico,1.2,2.2,0.3,2011,12-65,Government Source,HHS,Cannabis,0.96,1.46,MEX
73,Americas,North America,Mexico,1,,,2008,12-65,Government source,HHS,Cannabis,,,MEX
74,Americas,North America,United States of America,21.9,23.8,20.1,2020,15-64,ARQ,HHS,Cannabis,,,USA
75,Americas,North America,United States of America,19.4,22.2,16.8,2018,15-64,ARQ,HHS,Cannabis,,,USA
76,Americas,North America,United States of America,18.4,21.4,15.5,2017,15-64,ARQ,HHS,Cannabis,,,USA
77,Americas,North America,United States of America,17,19.9,14.1,2016,15-64,ARQ,HHS,Cannabis,,,USA
78,Americas,North America,United States of America,16.5,19.4,13.6,2015,15-64,ARQ,HHS,Cannabis,,,USA
79,Americas,North America,United States of America,16.2,19.9,12.7,2014,15-64,ARQ,HHS,Cannabis,,,USA
80,Americas,North America,United States of America,15.4,18.7,12.2,2013,15-64,ARQ,HHS,Cannabis,,,USA
81,Americas,North America,United States of America,14.8,,,2012,15-64,ARQ,HHS,Cannabis,,,USA
82,Americas,North America,United States of America,14,,,2011,15-64,ARQ,HHS,Cannabis,,,USA
83,Americas,North America,United States of America,14,,,2010,15-64,ARQ,HHS ,Cannabis,,,USA
84,Americas,South America,Argentina,8.13,11.1,5.46,2017,15-64,ARQ,HHS,Cannabis,,,ARG
85,Americas,South America,Argentina,3.2,4.7,1.7,2011,15-64,ARQ,HHS,Cannabis,,,ARG
86,Americas,South America,Argentina,3.7,,,2008,15-64,ARQ,HHS ,Cannabis,,,ARG
87,Americas,South America,Bolivia (Plurinational State of),2.19,3.29,1.24,2018,15-64,ARQ,HHS,Cannabis,,,BOL
88,Americas,South America,Bolivia (Plurinational State of),1.42,2.1100000000000003,0.8600000000000001,2014,12-65,ARQ/UNODC Estimate,HHS,Cannabis,1.27,1.57,BOL
89,Americas,South America,Bolivia (Plurinational State of),1.27,1.86,0.81,2013,12-65,ARQ,HHS,Cannabis,,,BOL
90,Americas,South America,Bolivia (Plurinational State of),4.5,8.9,1.1,2007,12-65,ARQ,HHS,Cannabis,,,BOL
91,Americas,South America,Brazil,2.81,5.1,0.66,2012,15-64,Government source,HHS,Cannabis,,,BRA
92,Americas,South America,Brazil,2.6,,,2005,12-65,Government source ,HHS,Cannabis,,,BRA
93,Americas,South America,Chile,12.05,17.05,7.17,2020,15-64,ARQ,HHS,Cannabis,,,CHL
94,Americas,South America,Chile,13.33,18.98,7.76,2018,15-64,ARQ,HHS,Cannabis,,,CHL
95,Americas,South America,Chile,15.1,19.11,11.07,2016,15-64,ARQ,HHS,Cannabis,,,CHL
96,Americas,South America,Chile,11.83,15.37,8.38,2014,15-64,ARQ,HHS,Cannabis,,,CHL
97,Americas,South America,Chile,7.47,10.52,4.52,2012,15-64,ARQ,HHS,Cannabis,,,CHL
98,Americas,South America,Chile,4.88,,,2010,15-64,ARQ,,Cannabis,,,CHL
99,Americas,South America,Chile,6.7,,,2008,15-64,ARQ ,HHS ,Cannabis,,,CHL
100,Americas,South America,Colombia,2.68,4.21,1.26,2019,12-65,Government source,HHS,Cannabis,2.46,2.9,COL
101,Americas,South America,Colombia,3.27,5.36,1.3,2013,12-65,ARQ,HHS,Cannabis,2.94,3.6,COL
102,Americas,South America,Colombia,2.27,3.79,0.93,2008,12-65,ARQ,,Cannabis,1.93,2.61,COL
103,Americas,South America,Colombia,1.9,,,2003,18-65 ,ARQ ,,Cannabis,,,COL
104,Americas,South America,Ecuador,0.67,0.84,0.53,2013,12-65,ARQ,HHS,Cannabis,,,ECU
105,Americas,South America,Ecuador,0.7,,,2007,12-65,ARQ,HHS,Cannabis,,,ECU
106,Americas,South America,Guyana,4.6,,,2016,12-65,Government source,HHS,Cannabis,,,GUY
107,Americas,South America,Guyana,4.04,,,2010,15-64,UNODC Estimate,SS,Cannabis,1.56,6.53,GUY
108,Americas,South America,Guyana,3.5,,,2008,15-64,UNODC Estimate,,Cannabis,0.97,5.95,GUY
109,Americas,South America,Guyana,2.6,,,2002,,UNODC Estimate ,,Cannabis,,,GUY
110,Americas,South America,Paraguay,1.6,,,2005,12-65,UNODC Estimate,,Cannabis,,,PRY
111,Americas,South America,Peru,1.624,,,2017,15-64,Government source/UNODC Estimate,SS,Cannabis,1.241,2.006,PER
112,Americas,South America,Peru,1.03,1.98,0.22,2010,12-65,ARQ,HHS,Cannabis,,,PER
113,Americas,South America,Peru,0.7,,,2006,15-64,Government source,HHS,Cannabis,,,PER
114,Americas,South America,Suriname,3.4,6.6,0.4,2013,12-65,ARQ,HHS,Cannabis,,,SUR
115,Americas,South America,Suriname,4.25,,,2007,12-65,Government source,HHS,Cannabis,3.8,4.7,SUR
116,Americas,South America,Suriname,2,,,2002,15-64,UNODC Estimate ,,Cannabis,,,SUR
117,Americas,South America,Uruguay,14.6,17.8,11.5,2018,15-65,ARQ,HHS,Cannabis,,,URY
118,Americas,South America,Uruguay,9.3,12.5,6.4,2014,15-65,ARQ,HHS,Cannabis,,,URY
119,Americas,South America,Uruguay,8.3,11.5,5.4,2011,15-64,ARQ,HHS,Cannabis,,,URY
120,Americas,South America,Uruguay,5.6,,,2006,15-64,ARQ ,HHS ,Cannabis,,,URY
121,Americas,South America,Venezuela (Bolivarian Republic of),1.56,,,2011,12-65,Government source,HHS,Cannabis,,,VEN
122,Americas,South America,Venezuela (Bolivarian Republic of),0.85,,,2005,15-64,Government source ,HHS ,Cannabis,,,VEN
123,Asia,Central Asia and Transcaucasia,Armenia,3.5,,,2003,15-64,UNODC Estimate,,Cannabis,,,ARM
124,Asia,Central Asia and Transcaucasia,Azerbaijan,3.5,,,2004,15-65,UNODC Estimate,,Cannabis,,,AZE
125,Asia,Central Asia and Transcaucasia,Georgia,3.4,6.6,0.5,2015,18-64,ARQ,HHS,Cannabis,,,GEO
126,Asia,Central Asia and Transcaucasia,Georgia,2.7,,,2009,15-64,Government source/ NGO/Academic research,SS,Cannabis,1.2,4.3,GEO
127,Asia,Central Asia and Transcaucasia,Georgia,1.1,,,2005,15-64,ARQ ,SS ,Cannabis,,,GEO
128,Asia,Central Asia and Transcaucasia,Kazakhstan,2.4,,,2012,15-64,ARQ,SS,Cannabis,0.6,4.3,KAZ
129,Asia,Central Asia and Transcaucasia,Kazakhstan,4.2,,,2003,15-64,INCSR,,Cannabis,,,KAZ
130,Asia,Central Asia and Transcaucasia,Uzbekistan,4.2,,,2003,15-64,UNODC Estimate,,Cannabis,,,UZB
131,Asia,East and South-East Asia,Cambodia,3.5,,,2003,15-64,UNODC Estimate,,Cannabis,,,KHM
132,Asia,East and South-East Asia,"China, Taiwan Province of China",0.3,,,2005,12-64,AMCEWG,,Cannabis,,,TWN
133,Asia,East and South-East Asia,Indonesia,1.44,,,2019,15-64,ARQ/UNODC Estimate,HHS,Cannabis,1.41,1.46,IDN
134,Asia,East and South-East Asia,Indonesia,0.91,,,2015,10-59,Government source,HHS,Cannabis,,,IDN
135,Asia,East and South-East Asia,Indonesia,0.18,0.33,0.04,2015,10-60,ARQ,HHS,Cannabis,,,IDN
136,Asia,East and South-East Asia,Indonesia,0.5,,,2010,10-60,ARQ,HHS,Cannabis,,,IDN
137,Asia,East and South-East Asia,Indonesia,0.44,,,2008,10-59,ARQ ,HHS ,Cannabis,,,IDN
138,Asia,East and South-East Asia,Japan,0.1,,,2019,15-64,ARQ,HHS,Cannabis,,,JPN
139,Asia,East and South-East Asia,Japan,0.03,,,2017,15-64,ARQ,HHS,Cannabis,,,JPN
140,Asia,East and South-East Asia,Japan,0.3,,,2011,15-64,UNODC Estimate,HHS,Cannabis,,,JPN
141,Asia,East and South-East Asia,Lao People's Democratic Republic,0.88,,,2008,15-64,UNODC report,SS,Cannabis,0.69,1.07,LAO
142,Asia,East and South-East Asia,Malaysia,1.6,,,2003,15-64,UNODC Estimate,,Cannabis,,,MYS
143,Asia,East and South-East Asia,Myanmar,0.94,,,2005,15-64,UNODC Estimate,,Cannabis,,,MMR
144,Asia,East and South-East Asia,Philippines,1.64,,,2016,10-69,ARQ,HHS,Cannabis,,,PHL
145,Asia,East and South-East Asia,Philippines,0.61,,,2012,10-69,ARQ,HHS,Cannabis,,,PHL
146,Asia,East and South-East Asia,Philippines,0.74,,,2008,10-64,ARQ,HHS,Cannabis,,,PHL
147,Asia,East and South-East Asia,Republic of Korea,0.29,,,2004,15-64,ARQ,HHS,Cannabis,0.07,0.55,PRK
148,Asia,East and South-East Asia,Thailand,1.33,1.81,0.861,2019,12-65,Government source,HHS,Cannabis,,,THA
149,Asia,East and South-East Asia,Thailand,1.2,,,2007,12-65,ARQ,HHS,Cannabis,,,THA
150,Asia,Near and Middle East/South-West Asia,Afghanistan,3.8,6.1,1.5,2015,15+,INL,HHS,Cannabis,,,AFG
151,Asia,Near and Middle East/South-West Asia,Afghanistan,4.28,8.1,0.2,2009,15-64,UNODC/ Govt. Source,HHS,Cannabis,3.37,5.18,AFG
152,Asia,Near and Middle East/South-West Asia,Afghanistan,3.59,,,2005,15-64,UNODC Study (ICMP) ,,Cannabis,,,AFG
153,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.58,,,2015,15-64,Government source/UNODC Estimate,HHS,Cannabis,,,IRN
154,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.61,,,2013,18+,Academic/UNODC Estimate,NSUM,Cannabis,0.54,0.7,IRN
155,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.17,,,2011,15-64,Government source,,Cannabis,,,IRN
156,Asia,Near and Middle East/South-West Asia,Israel,14,15.3,12.3,2020,18-86,ARQ,HHS,Cannabis,,,ISR
157,Asia,Near and Middle East/South-West Asia,Israel,27,32.2,21.8,2016,18-65,ARQ,HHS,Cannabis,,,ISR
158,Asia,Near and Middle East/South-West Asia,Israel,8.88,12.3,5.5,2009,18-40,ARQ,HHS,Cannabis,8.9,8.9,ISR
159,Asia,Near and Middle East/South-West Asia,Israel,8.5,,,2005,18-40,ARQ ,,Cannabis,,,ISR
160,Asia,Near and Middle East/South-West Asia,Kuwait,3.1,,,2005,15-64,UNODC Estimate,,Cannabis,,,KWT
161,Asia,Near and Middle East/South-West Asia,Lebanon,2,,,2009,15-64,Government source/MEDSPAD,SS,Cannabis,0.5,3.5,LBN
162,Asia,Near and Middle East/South-West Asia,Lebanon,6.4,,,2001,15-64,ARQ ,,Cannabis,,,LBN
163,Asia,Near and Middle East/South-West Asia,Pakistan,3.6,6.7,0.2,2012,15-64,Government/UNODC,,Cannabis,3.1,4,PAK
164,Asia,Near and Middle East/South-West Asia,Pakistan,3.9,,,2000,15-64,INCSR ,,Cannabis,,,PAK
165,Asia,Near and Middle East/South-West Asia,Saudi Arabia,0.3,,,2006,15-64,Government source/ NGO/Academic research,R,Cannabis,,,SAU
166,Asia,Near and Middle East/South-West Asia,United Arab Emirates,5.35,,,2006,15-64,UNODC Estimate,,Cannabis,,,ARE
167,Asia,South Asia,Bangladesh,3.3,,,2004,15-54,Academic research,HHS,Cannabis,,,BGD
168,Asia,South Asia,Bhutan,4.2,,,2009,15-64,UNODC Estimate,,Cannabis,1.8,6.5,BTN
169,Asia,South Asia,India,2.83,5.05,0.6,2018,10-75,Government source,HHS,Cannabis,,,IND
170,Asia,South Asia,Maldives,2.55,,,2012,15-64,Government source,,Cannabis,,,MDV
171,Asia,South Asia,Nepal,0.709,,,2019,15-50,Government source/UNODC Estimate,HHS,Cannabis,,,NPL
172,Asia,South Asia,Sri Lanka,1.9,,,2018,14+,Government source,HHS,Cannabis,,,LKA
173,Asia,South Asia,Sri Lanka,1.42,,,2016,15-64,Government source,I,Cannabis,1.26,1.58,LKA
174,Asia,South Asia,Sri Lanka,1.31,,,2012,15-64,ARQ,HHS,Cannabis,,,LKA
175,Asia,South Asia,Sri Lanka,1.43,,,2010,15-64,UNODC Estimate,,Cannabis,1.43,1.43,LKA
176,Europe,Eastern Europe,Belarus,1.07,,,2007,15-64,ESPAD,SS,Cannabis,0.9,1.3,BLR
177,Europe,Eastern Europe,Republic of Moldova,0.7,,,2010,15-64,Government source,HHS,Cannabis,,,MDA
178,Europe,Eastern Europe,Republic of Moldova,0.9,,,2008,15-64,Government source ,HHS ,Cannabis,,,MDA
179,Europe,Eastern Europe,Russian Federation,3.49,,,2007,15-64,ESPAD/UNODC Estimate,SS,Cannabis,3.46,3.51,RUS
180,Europe,Eastern Europe,Ukraine,2.13,,,2015,15-64,ESPAD/UNODC Estimate,SS,Cannabis,1.29,2.98,UKR
181,Europe,Eastern Europe,Ukraine,2.9,,,2011,15-64,UNODC Estimate,SS,Cannabis,1.2,4.6,UKR
182,Europe,Eastern Europe,Ukraine,2.5,,,2007,15-64,ESPAD ,SS ,Cannabis,2.4,2.59,UKR
183,Europe,South-Eastern Europe,Albania,5.6,,,2014,15-64,,HHS,Cannabis,,,ALB
184,Europe,South-Eastern Europe,Albania,5.6,10.2,1,2014,15-64,ARQ,HHS,Cannabis,,,ALB
185,Europe,South-Eastern Europe,Albania,1.8,,,2006,15-64,Government source,SS,Cannabis,,,ALB
186,Europe,South-Eastern Europe,Bosnia and Herzegovina,1.6,,,2011,15-64,ESPAD,SS,Cannabis,0.32,2.89,BIH
187,Europe,South-Eastern Europe,Bosnia and Herzegovina,2.8,,,2007,15-64,ESPAD ,SS ,Cannabis,2.75,4.63,BIH
188,Europe,South-Eastern Europe,Bulgaria,2.4,2.6,2.2,2020,15-64,ARQ,HHS,Cannabis,,,BGR
189,Europe,South-Eastern Europe,Bulgaria,4.2,5.9,2.3,2016,15-64,ARQ,HHS,Cannabis,,,BGR
190,Europe,South-Eastern Europe,Bulgaria,3.5,5.1,1.9,2012,15-64,ARQ,HHS,Cannabis,,,BGR
191,Europe,South-Eastern Europe,Bulgaria,2.5,,,2008,15-64,ARQ,HHS,Cannabis,,,BGR
192,Europe,South-Eastern Europe,Bulgaria,2.2,,,2007,15-64,ARQ ,HHS ,Cannabis,,,BGR
193,Europe,South-Eastern Europe,Croatia,10.2,14.2,6.2,2019,15-64,ARQ,HHS,Cannabis,,,HRV
194,Europe,South-Eastern Europe,Croatia,7.9,11.5,4.3,2015,15-64,ARQ,HHS,Cannabis,,,HRV
195,Europe,South-Eastern Europe,Croatia,5,,,2012,15-64,EMCDDA,HHS,Cannabis,,,HRV
196,Europe,South-Eastern Europe,Croatia,5.18,,,2007,15-64,ESPAD ,SS ,Cannabis,5.1,5.3,HRV
197,Europe,South-Eastern Europe,Kosovo under UNSCR 1244,1.3,,,2019,15-64,ESPAD/UNODC Estimate,SS,Cannabis,,,XKX
198,Europe,South-Eastern Europe,Montenegro,4.6,4.9,4.3,2017,15-64,ARQ,HHS,Cannabis,,,MNE
199,Europe,South-Eastern Europe,Montenegro,1.82,,,2015,15-64,ESPAD/UNODC Estimate,SS,Cannabis,1.1,2.54,MNE
200,Europe,South-Eastern Europe,Montenegro,1.9,,,2011,15-64,ESPAD,SS,Cannabis,0.43,3.3,MNE
201,Europe,South-Eastern Europe,Montenegro,0.23,,,2008,15-64,ESPAD ,SS ,Cannabis,,,MNE
202,Europe,South-Eastern Europe,North Macedonia,6.6,8.3,4,2017,15-64,ARQ,HHS,Cannabis,,,MKD
203,Europe,South-Eastern Europe,North Macedonia,1.13,,,2015,15-64,ESPAD/UNODC Estimate,SS,Cannabis,0.68,1.58,MKD
204,Europe,South-Eastern Europe,North Macedonia,0.63,,,2008,15-64,ESPAD,SS,Cannabis,0.46,2.38,MKD
205,Europe,South-Eastern Europe,Romania,3.5,4.8,2.1,2019,15-64,ARQ,HHS,Cannabis,,,ROU
206,Europe,South-Eastern Europe,Romania,3.2,4.3,2,2016,15-64,ARQ,HHS,Cannabis,,,ROU
207,Europe,South-Eastern Europe,Romania,2,2.3,1.8,2013,15-64,ARQ,HHS,Cannabis,,,ROU
208,Europe,South-Eastern Europe,Romania,0.3,,,2010,15-64,ARQ,HHS,Cannabis,,,ROU
209,Europe,South-Eastern Europe,Romania,0.4,,,2007,15-64,ARQ ,HHS ,Cannabis,,,ROU
210,Europe,South-Eastern Europe,Serbia,2,2.8,1.2,2018,15-64,ARQ,HHS,Cannabis,,,SRB
211,Europe,South-Eastern Europe,Serbia,1.6,2.5,0.6,2014,18-64,Government source,HHS,Cannabis,,,SRB
212,Europe,South-Eastern Europe,Serbia,4.07,,,2006,15-64,Government source,HHS,Cannabis,2.75,5.39,SRB
213,Europe,South-Eastern Europe,Türkiye,1.11,2.22,0.09,2018,15-64,ARQ,HHS,Cannabis,,,TUR
214,Europe,South-Eastern Europe,Türkiye,1.11,2.22,0.09,2017,15-64,EMCDDA,HHS,Cannabis,,,TUR
215,Europe,South-Eastern Europe,Türkiye,0.3,0.5,0.1,2011,15-64,EMCDDA,HHS,Cannabis,,,TUR
216,Europe,South-Eastern Europe,Türkiye,1.9,,,2003,15-64,UNODC Estimate,,Cannabis,,,TUR
217,Europe,Western and Central Europe,Austria,6.3,,,2020,15-64,Government source,HHS,Cannabis,5.62,7.04,AUT
218,Europe,Western and Central Europe,Austria,6.4,7.2,5.6,2015,15-64,Government source,HHS,Cannabis,5.5,7.2,AUT
219,Europe,Western and Central Europe,Austria,3.5,,,2008,15-64,ARQ,HHS,Cannabis,,,AUT
220,Europe,Western and Central Europe,Austria,7.5,,,2004,15-64,EMCDDA ,HHS ,Cannabis,,,AUT
221,Europe,Western and Central Europe,Belgium,7,10.4,3.7,2018,15-64,ARQ,HHS,Cannabis,,,BEL
222,Europe,Western and Central Europe,Belgium,4.6,6.3,2.9,2013,15-64,ARQ,HHS,Cannabis,,,BEL
223,Europe,Western and Central Europe,Belgium,5.1,7.2,3.2,2008,15-64,ARQ,HHS,Cannabis,,,BEL
224,Europe,Western and Central Europe,Belgium,5,6.9,3.2,2004,15-64,EMCDDA/Government source,HHS ,Cannabis,,,BEL
225,Europe,Western and Central Europe,Cyprus,4,6.4,1.7,2019,15-64,ARQ,HHS,Cannabis,,,CYP
226,Europe,Western and Central Europe,Cyprus,2.2,3.5,0.9,2016,15-64,ARQ,HHS,Cannabis,,,CYP
227,Europe,Western and Central Europe,Cyprus,2.2,3.5,1,2012,15-64,ARQ,HHS,Cannabis,,,CYP
228,Europe,Western and Central Europe,Cyprus,4.4,7.3,1.5,2009,15-64,ARQ,HHS,Cannabis,,,CYP
229,Europe,Western and Central Europe,Cyprus,2.1,3.7,0.6,2006,15-65,ARQ ,,Cannabis,,,CYP
230,Europe,Western and Central Europe,Czechia,9.4,14.6,4.2,2019,15-64,ARQ,HHS,Cannabis,,,CZE
231,Europe,Western and Central Europe,Czechia,7.9,10,5.8,2018,15-64,ARQ,HHS,Cannabis,,,CZE
232,Europe,Western and Central Europe,Czechia,8.9,11.9,5.9,2017,15-64,EMCDDA,HHS,Cannabis,,,CZE
233,Europe,Western and Central Europe,Czechia,9.5,14.2,5,2016,15-64,ARQ,HHS,Cannabis,,,CZE
234,Europe,Western and Central Europe,Czechia,9.4,13.4,5.3,2015,15-64,ARQ,HHS,Cannabis,,,CZE
235,Europe,Western and Central Europe,Czechia,11.4,15.4,7.3,2014,15-64,ARQ,HHS,Cannabis,,,CZE
236,Europe,Western and Central Europe,Czechia,8.9,13.2,5.3,2013,15-64,ARQ,HHS,Cannabis,,,CZE
237,Europe,Western and Central Europe,Czechia,9.2,13.1,5.3,2012,15-64,ARQ,HHS,Cannabis,,,CZE
238,Europe,Western and Central Europe,Czechia,9.7,,,2010,15-64,ARQ,HHS,Cannabis,,,CZE
239,Europe,Western and Central Europe,Czechia,15.2,,,2008,15-64,Government source ,HHS ,Cannabis,,,CZE
240,Europe,Western and Central Europe,Denmark,6.4,8.7,4.6,2017,16-64,ARQ,HHS,Cannabis,,,DNK
241,Europe,Western and Central Europe,Denmark,6.9,9.2,5.1,2013,16-64,ARQ,HHS,Cannabis,,,DNK
242,Europe,Western and Central Europe,Denmark,5.4,,,2010,16-64,ARQ,HHS,Cannabis,,,DNK
243,Europe,Western and Central Europe,Denmark,5.5,,,2008,16-64,ARQ ,HHS ,Cannabis,,,DNK
244,Europe,Western and Central Europe,Estonia,6.59,9.2,4.81,2018,16-64,ARQ,HHS,Cannabis,,,EST
245,Europe,Western and Central Europe,Estonia,6,8.3,3.8,2008,15-64,ARQ,HHS,Cannabis,,,EST
246,Europe,Western and Central Europe,Estonia,4.6,,,2003,15-64,ARQ ,HHS ,Cannabis,,,EST
247,Europe,Western and Central Europe,Finland,8.2,11.2,5.2,2018,15-64,ARQ,HHS,Cannabis,,,FIN
248,Europe,Western and Central Europe,Finland,6.8,9.2,4.3,2014,15-64,ARQ,HHS,Cannabis,,,FIN
249,Europe,Western and Central Europe,Finland,4.6,5.8,3.3,2010,15-64,ARQ,HHS,Cannabis,,,FIN
250,Europe,Western and Central Europe,Finland,3.6,,,2006,15-64,ARQ ,HHS ,Cannabis,,,FIN
251,Europe,Western and Central Europe,France,11,15.1,7.1,2017,18-64,EMCDDA,HHS,Cannabis,,,FRA
252,Europe,Western and Central Europe,France,11.1,15.2,7.1,2016,18-64,EMCDDA,HHS,Cannabis,,,FRA
253,Europe,Western and Central Europe,France,11.1,15,7.4,2014,15-64,ARQ,HHS,Cannabis,,,FRA
254,Europe,Western and Central Europe,France,8.4,11.8,5.2,2010,15-64,ARQ,HHS,Cannabis,,,FRA
255,Europe,Western and Central Europe,France,8.6,,,2005,15-64,ARQ ,,Cannabis,,,FRA
256,Europe,Western and Central Europe,Germany,7.09,8.87,5.25,2018,18-64,ARQ,HHS,Cannabis,,,DEU
257,Europe,Western and Central Europe,Germany,6.1,7.4,4.9,2015,18-64,ARQ/Academic,HHS,Cannabis,5.6,6.7,DEU
258,Europe,Western and Central Europe,Germany,4.5,6,3,2012,18-64,ARQ,HHS,Cannabis,,,DEU
259,Europe,Western and Central Europe,Germany,4.8,6.4,3.1,2009,18-64,ARQ,HHS,Cannabis,,,DEU
260,Europe,Western and Central Europe,Germany,4.7,,,2007,18-64,Government source ,HHS ,Cannabis,,,DEU
261,Europe,Western and Central Europe,Greece,2.8,4.1,1.6,2015,18-64,ARQ,HHS,Cannabis,,,GRC
262,Europe,Western and Central Europe,Greece,1.7,2.5,0.9,2004,15-64,EMCDDA,,Cannabis,,,GRC
263,Europe,Western and Central Europe,Hungary,1.3,2,0.6,2019,18-64,ARQ,HHS,Cannabis,,,HUN
264,Europe,Western and Central Europe,Hungary,1.53,2.46,0.81,2015,18-64,ARQ,HHS,Cannabis,,,HUN
265,Europe,Western and Central Europe,Hungary,2.3,,,2007,18-64,ARQ,HHS,Cannabis,1.7,2.9,HUN
266,Europe,Western and Central Europe,Iceland,5.8,7.4,4.2,2017,18-64,ARQ,HHS,Cannabis,,,ISL
267,Europe,Western and Central Europe,Iceland,6.6,,,2012,18-67,ARQ/Government,HHS,Cannabis,,,ISL
268,Europe,Western and Central Europe,Iceland,3.4,,,2011,15-64,ESPAD,SS,Cannabis,1.67,5.16,ISL
269,Europe,Western and Central Europe,Iceland,3.37,,,2007,15-64,ESPAD ,SS ,Cannabis,3.21,3.53,ISL
270,Europe,Western and Central Europe,Ireland,7.1,9.9,4.4,2019,15-64,ARQ,HHS,Cannabis,,,IRL
271,Europe,Western and Central Europe,Ireland,7.7,11.2,4.3,2015,15-64,ARQ,HHS,Cannabis,,,IRL
272,Europe,Western and Central Europe,Ireland,6,9.1,2.9,2011,15-64,ARQ,HHS,Cannabis,,,IRL
273,Europe,Western and Central Europe,Ireland,6.3,,,2007,15-64,Government source ,HHS ,Cannabis,,,IRL
274,Europe,Western and Central Europe,Italy,10.21,12.6,7.83,2017,15-64,ARQ,HHS,Cannabis,,,ITA
275,Europe,Western and Central Europe,Italy,9.2,11.9,6.6,2013,15-64,ARQ,HHS,Cannabis,,,ITA
276,Europe,Western and Central Europe,Italy,4,5.19,3,2012,15-64,ARQ,HHS,Cannabis,,,ITA
277,Europe,Western and Central Europe,Italy,14.6,,,2008,15-64,Government source,HHS,Cannabis,,,ITA
278,Europe,Western and Central Europe,Italy,11.2,,,2005,15-65,EMCDDA ,HHS ,Cannabis,,,ITA
279,Europe,Western and Central Europe,Latvia,3.9,6.1,1.8,2020,15-64,ARQ,HHS,Cannabis,,,LVA
280,Europe,Western and Central Europe,Latvia,4.2,6.9,1.7,2015,15-64,ARQ,HHS,Cannabis,,,LVA
281,Europe,Western and Central Europe,Latvia,4,5.7,2.4,2011,15-64,ARQ,HHS,Cannabis,,,LVA
282,Europe,Western and Central Europe,Latvia,4.9,,,2007,15-64,ARQ ,,Cannabis,,,LVA
283,Europe,Western and Central Europe,Lithuania,2.7,4.6,1,2016,15-64,ARQ,HHS,Cannabis,,,LTU
284,Europe,Western and Central Europe,Lithuania,2.3,3.6,1,2012,15-64,ARQ,HHS,Cannabis,,,LTU
285,Europe,Western and Central Europe,Lithuania,5.6,,,2008,15-64,ARQ,HHS,Cannabis,,,LTU
286,Europe,Western and Central Europe,Lithuania,2.2,,,2004,15-64,ARQ ,,Cannabis,,,LTU
287,Europe,Western and Central Europe,Luxembourg,5.4,7,4,2019,15-64,ARQ,HHS,Cannabis,,,LUX
288,Europe,Western and Central Europe,Luxembourg,4.9,6.6,3.5,2014,15-64,ARQ/EMCDDA,HHS,Cannabis,,,LUX
289,Europe,Western and Central Europe,Luxembourg,5.2,,,2010,15-64,ARQ,SS,Cannabis,3.2,7.1,LUX
290,Europe,Western and Central Europe,Luxembourg,6.6,,,2006,15-64,ARQ,SS,Cannabis,4.5,8.66,LUX
291,Europe,Western and Central Europe,Luxembourg,7.6,,,2003,15-64,UNODC Estimate ,,Cannabis,,,LUX
292,Europe,Western and Central Europe,Malta,0.9,,,2013,15-64,ARQ,HHS,Cannabis,,,MLT
293,Europe,Western and Central Europe,Malta,3.1,,,2011,15-64,ESPAD,SS,Cannabis,1.39,4.82,MLT
294,Europe,Western and Central Europe,Malta,4.51,,,2007,15-64,ESPAD ,SS ,Cannabis,4.42,4.6,MLT
295,Europe,Western and Central Europe,Monaco,10.47,,,2017,18-64,ESPAD/UNODC Estimate,SS,Cannabis,,,MCO
296,Europe,Western and Central Europe,Netherlands,10.1,12.9,7.3,2020,15-64,ARQ,HHS,Cannabis,,,NLD
297,Europe,Western and Central Europe,Netherlands,9.3,12.1,6.4,2019,15-64,EMCDDA,HHS,Cannabis,,,NLD
298,Europe,Western and Central Europe,Netherlands,9.6,13.9,6.3,2018,15-64,EMCDDA,HHS,Cannabis,,,NLD
299,Europe,Western and Central Europe,Netherlands,9.2,12.3,6.2,2017,15-64,EMCDDA,HHS,Cannabis,8.5,9.9,NLD
300,Europe,Western and Central Europe,Netherlands,8.4,11,5.7,2016,15-64,EMCDDA,HHS,Cannabis,,,NLD
301,Europe,Western and Central Europe,Netherlands,8.7,11.6,5.7,2015,15-64,EMCDDA,HHS,Cannabis,,,NLD
302,Europe,Western and Central Europe,Netherlands,8,10.5,5.4,2014,15-64,ARQ,HHS,Cannabis,,,NLD
303,Europe,Western and Central Europe,Netherlands,7,,,2009,15-64,ARQ,,Cannabis,,,NLD
304,Europe,Western and Central Europe,Netherlands,5.4,,,2005,15-64,ARQ ,,Cannabis,,,NLD
305,Europe,Western and Central Europe,Norway,4.3,5.8,2.8,2020,16-64,ARQ,HHS,Cannabis,,,NOR
306,Europe,Western and Central Europe,Norway,5.1,7.1,3,2019,16-64,ARQ,HHS,Cannabis,,,NOR
307,Europe,Western and Central Europe,Norway,5.4,7,3.7,2018,16-64,ARQ,HHS,Cannabis,,,NOR
308,Europe,Western and Central Europe,Norway,5.3,7,3.4,2017,16-64,ARQ,HHS,Cannabis,,,NOR
309,Europe,Western and Central Europe,Norway,3.9,5.1,2.6,2016,16-64,ARQ,HHS,Cannabis,,,NOR
310,Europe,Western and Central Europe,Norway,4.2,5.5,2.9,2015,16-64,ARQ,HHS,Cannabis,,,NOR
311,Europe,Western and Central Europe,Norway,4.2,6,2.3,2014,16-64,ARQ,HHS,Cannabis,,,NOR
312,Europe,Western and Central Europe,Norway,5.1,7.2,2.8,2013,16-64,ARQ,HHS,Cannabis,,,NOR
313,Europe,Western and Central Europe,Norway,3.8,,,2009,15-64,ARQ,HHS,Cannabis,,,NOR
314,Europe,Western and Central Europe,Norway,4.6,,,2004,15-64,ARQ ,,Cannabis,,,NOR
315,Europe,Western and Central Europe,Poland,3.8,5,2.6,2019,15-64,ARQ,HHS,Cannabis,,,POL
316,Europe,Western and Central Europe,Poland,2.4,3.2,1.7,2016,15-64,ARQ,HHS,Cannabis,,,POL
317,Europe,Western and Central Europe,Poland,4.6,7.8,1.7,2014,15-64,ARQ,HHS,Cannabis,,,POL
318,Europe,Western and Central Europe,Poland,3.8,6,1.7,2012,15-64,ARQ,HHS,Cannabis,,,POL
319,Europe,Western and Central Europe,Poland,9.6,,,2010,15-64,ARQ,HHS,Cannabis,,,POL
320,Europe,Western and Central Europe,Poland,2.7,,,2006,15-64,ARQ ,HHS ,Cannabis,,,POL
321,Europe,Western and Central Europe,Portugal,5.1,7.3,3.1,2017,15-64,ARQ,HHS,Cannabis,,,PRT
322,Europe,Western and Central Europe,Portugal,2.7,4.1,1.3,2012,15-64,ARQ,HHS,Cannabis,,,PRT
323,Europe,Western and Central Europe,Portugal,3.6,,,2007,15-64,ARQ,HHS,Cannabis,,,PRT
324,Europe,Western and Central Europe,Slovakia,3.8,5.9,1.7,2019,15-64,ARQ,HHS,Cannabis,,,SVK
325,Europe,Western and Central Europe,Slovakia,4.3,7,1.7,2015,15-64,ARQ,HHS,Cannabis,,,SVK
326,Europe,Western and Central Europe,Slovakia,3.63,,,2010,15-64,EMCDDA,HHS,Cannabis,,,SVK
327,Europe,Western and Central Europe,Slovakia,6.9,,,2006,15-64,ARQ,HHS,Cannabis,,,SVK
328,Europe,Western and Central Europe,Slovenia,5.9,7.8,3.8,2018,15-64,EMCDDA,HHS,Cannabis,5.4,6.4,SVN
329,Europe,Western and Central Europe,Slovenia,4.4,5.9,2.8,2012,15-64,ARQ,HHS,Cannabis,,,SVN
330,Europe,Western and Central Europe,Slovenia,3.1,,,2007,15-64,EMCDDA,HHS,Cannabis,,,SVN
331,Europe,Western and Central Europe,Spain,10.5,14.6,6.3,2020,15-64,ARQ,HHS,Cannabis,,,ESP
332,Europe,Western and Central Europe,Spain,11,15.4,6.6,2017,15-64,EMCDDA,HHS,Cannabis,10.6,11.4,ESP
333,Europe,Western and Central Europe,Spain,9.5,13.3,5.6,2015,15-64,ARQ,HHS,Cannabis,,,ESP
334,Europe,Western and Central Europe,Spain,9.2,12.9,5.4,2013,15-64,ARQ,HHS,Cannabis,,,ESP
335,Europe,Western and Central Europe,Spain,9.6,13.6,5.5,2011,15-64,ARQ,HHS,Cannabis,,,ESP
336,Europe,Western and Central Europe,Spain,10.6,14.8,6.2,2009,15-64,ARQ ,HHS ,Cannabis,,,ESP
337,Europe,Western and Central Europe,Sweden,3.8,5,2.5,2020,16-64,ARQ,HHS,Cannabis,,,SWE
338,Europe,Western and Central Europe,Sweden,3.9,5.2,2.4,2018,16-64,ARQ,HHS,Cannabis,,,SWE
339,Europe,Western and Central Europe,Sweden,3.4,4.1,2.6,2016,16-64,ARQ,HHS,Cannabis,,,SWE
340,Europe,Western and Central Europe,Sweden,3.2,4.1,2.3,2015,16-64,ARQ,HHS,Cannabis,,,SWE
341,Europe,Western and Central Europe,Sweden,2.88,4.1,1.63,2014,15-64,ARQ,HHS,Cannabis,,,SWE
342,Europe,Western and Central Europe,Sweden,3.16,4.35,1.86,2013,17-64,ARQ,HHS,Cannabis,,,SWE
343,Europe,Western and Central Europe,Sweden,3,,,2012,16-64,ARQ,HHS,Cannabis,,,SWE
344,Europe,Western and Central Europe,Sweden,2.61,,,2011,16-64,ARQ,HHS,Cannabis,,,SWE
345,Europe,Western and Central Europe,Sweden,2.8,,,2010,16-64,ARQ ,HHS ,Cannabis,,,SWE
346,Europe,Western and Central Europe,Switzerland,9.09,,,2016,15-64,Government source,HHS,Cannabis,,,CHE
347,Europe,Western and Central Europe,Switzerland,8.09,,,2015,15-64,ARQ,HHS,Cannabis,,,CHE
348,Europe,Western and Central Europe,Switzerland,6.7,9.3,4.2,2014,15-64,ARQ,HHS,Cannabis,,,CHE
349,Europe,Western and Central Europe,Switzerland,5.7,7.8,3.7,2013,15-64,ARQ,HHS,Cannabis,,,CHE
350,Europe,Western and Central Europe,Switzerland,6.3,,,2012,15+,ARQ,HHS,Cannabis,,,CHE
351,Europe,Western and Central Europe,Switzerland,5.1,,,2011,15-64,ARQ,HHS,Cannabis,,,CHE
352,Europe,Western and Central Europe,Switzerland,3.4,,,2008,15-64,ARQ ,HHS ,Cannabis,,,CHE
353,Europe,Western and Central Europe,United Kingdom (England and Wales),7.15,9.07,5.26,2019,16-64,ARQ,HHS,Cannabis,,,GBR
354,Europe,Western and Central Europe,United Kingdom (England and Wales),7.6,10.28,5,2018,16-59,Government source,HHS,Cannabis,,,GBR
355,Europe,Western and Central Europe,United Kingdom (England and Wales),7.18,9.55,4.82,2017,16-59,Government source,HHS,Cannabis,,,GBR
356,Europe,Western and Central Europe,United Kingdom (England and Wales),6.6,8.99,4.23,2016,16-59,Government source,HHS,Cannabis,,,GBR
357,Europe,Western and Central Europe,United Kingdom (England and Wales),6.47,9.14,3.85,2015,16-59,Government source,HHS,Cannabis,,,GBR
358,Europe,Western and Central Europe,United Kingdom (England and Wales),6.69,9.43,4.02,2014,16-59,Government source,HHS,Cannabis,,,GBR
359,Europe,Western and Central Europe,United Kingdom (England and Wales),6.59,9.11,4.1,2013,16-59,Government source,HHS,Cannabis,,,GBR
360,Europe,Western and Central Europe,United Kingdom (England and Wales),6.29,8.51,4.08,2012,16-59,Government source,HHS,Cannabis,,,GBR
361,Europe,Western and Central Europe,United Kingdom (England and Wales),6.8,9.53,4.1,2011,16-59,Government source,HHS,Cannabis,,,GBR
362,Europe,Western and Central Europe,United Kingdom (England and Wales),6.7,9.15,4.29,2010,16-59,Government source ,HHS ,Cannabis,,,GBR
363,Europe,Western and Central Europe,United Kingdom (Northern Ireland),4.6,,,2014,15-64,Government source,HHS,Cannabis,,,GBR
364,Europe,Western and Central Europe,United Kingdom (Northern Ireland),5.1,,,2011,15-64,Government source,HHS,Cannabis,,,GBR
365,Europe,Western and Central Europe,United Kingdom (Northern Ireland),7.2,,,2006,15-64,Government source ,HHS ,Cannabis,,,GBR
366,Europe,Western and Central Europe,United Kingdom (Scotland),6.29,9,3.68,2014,16-64,Government source,HHS,Cannabis,,,GBR
367,Europe,Western and Central Europe,United Kingdom (Scotland),6.5,9.5,3.6,2013,16-64,Government source,HHS,Cannabis,,,GBR
368,Europe,Western and Central Europe,United Kingdom (Scotland),7,,,2011,16-64,Government source,HHS,Cannabis,,,GBR
369,Europe,Western and Central Europe,United Kingdom (Scotland),7.6,,,2010,16-64,Government source ,HHS ,Cannabis,,,GBR
370,Oceania,Australia and New Zealand,Australia,11.6,14.7,8.6,2019,14+,ARQ,HHS,Cannabis,,,AUS
371,Oceania,Australia and New Zealand,Australia,10.4,13.1,7.9,2016,14+,ARQ,HHS,Cannabis,,,AUS
372,Oceania,Australia and New Zealand,Australia,10.2,12.8,7.6,2013,14+,ARQ,HHS,Cannabis,,,AUS
373,Oceania,Australia and New Zealand,Australia,10.3,,,2010,14+,ARQ,HHS,Cannabis,,,AUS
374,Oceania,Australia and New Zealand,Australia,10.6,,,2007,15-64,Government source ,HHS ,Cannabis,,,AUS
375,Oceania,Australia and New Zealand,New Zealand,15,19,11,2020,18+,ARQ,HHS,Cannabis,,,NZL
376,Oceania,Australia and New Zealand,New Zealand,15,19.9,10.3,2019,15+,ARQ,HHS,Cannabis,,,NZL
377,Oceania,Australia and New Zealand,New Zealand,11.9,15.7,8.4,2018,15+,Government source,HHS,Cannabis,,,NZL
378,Oceania,Australia and New Zealand,New Zealand,14.03,18.55,9.61,2017,15-64,Government source,HHS,Cannabis,,,NZL
379,Oceania,Australia and New Zealand,New Zealand,13.73,17.9,9.66,2016,15-64,Government source,HHS,Cannabis,,,NZL
380,Oceania,Australia and New Zealand,New Zealand,11,14.3,7.9,2013,15+,Government source,HHS,Cannabis,10.3,11.7,NZL
381,Oceania,Australia and New Zealand,New Zealand,14.6,18.2,11.3,2008,16-64,Government source,HHS,Cannabis,13.4,15.7,NZL
382,Oceania,Australia and New Zealand,New Zealand,14.6,,,2007,16-64,Government source,HHS,Cannabis,,,NZL
383,Oceania,Australia and New Zealand,New Zealand,13.25,,,2006,15-64,ARQ ,HHS ,Cannabis,,,NZL
384,Oceania,Melanesia,Fiji,5.08,,,2004,15-64,Government source,SS,Cannabis,3.04,7.12,FJI
0,Africa,East Africa,Kenya,0.1,0.2,0,2016,15-64,ARQ,HHS,Cocaine,,,KEN
1,Africa,East Africa,Kenya,0.3,,,2007,15-65,Government source,HHS,Cocaine,0.2,0.4,KEN
2,Africa,North Africa,Algeria,0.01,0.02,,2010,12+,ARQ,HHS,Cocaine,,,DZA
3,Africa,North Africa,Egypt,0.35,,,2016,15-64,MedSPAD/UNODC Estimate,SS,Cocaine,,,EGY
4,Africa,North Africa,Egypt,0.02,,,2006,15-64,Government source; Academic Research,"HHS, SS",Cocaine,,,EGY
5,Africa,North Africa,Morocco,0.43,,,2017,15-64,MedSPAD/UNODC Estimate,SS,Cocaine,0.33,0.52,MAR
6,Africa,North Africa,Morocco,0.05,,,2004,15-64,ARQ,,Cocaine,,,MAR
7,Africa,North Africa,Tunisia,0.1,,,2017,15-64,MedSPAD/UNODC Estimate,SS,Cocaine,,,TUN
8,Africa,Southern Africa,South Africa,1.02,,,2011,15-64,ARQ,SS,Cocaine,0.29,1.1,ZAF
9,Africa,Southern Africa,South Africa,0.78,,,2008,15-64,ARQ ,HHS ,Cocaine,0.64,1.17,ZAF
10,Africa,West and Central Africa,Cabo Verde,0.2,,,2012,15-64,UNODC/Government source,HHS,Cocaine,,,CPV
11,Africa,West and Central Africa,Cabo Verde,0.23,,,2004,15-64,UNODC Estimate,,Cocaine,,,CPV
12,Africa,West and Central Africa,Côte d'Ivoire,0.59,,,2017,15-64,Government source/UNODC Estimate,SS,Cocaine,0.49,0.78,CIV
13,Africa,West and Central Africa,Nigeria,0.09,,,2017,15-64,Government source/UNODC,HHS/I,Cocaine,0,0.24,NGA
14,Africa,West and Central Africa,Nigeria,0.7,,,2008,15-64,ARQ,HHS,Cocaine,0.28,1.11,NGA
15,Americas,Caribbean,Bahamas,0.05,0.1,0,2017,12-65,Government source,HHS,Cocaine,0.02,0.1,BHS
16,Americas,Caribbean,Barbados,0.4,,,2006,15-64,CICAD,HHS,Cocaine,,,BRB
17,Americas,Caribbean,Dominican Republic,0.32,,,2010,12-65,CICAD,HHS,Cocaine,0.28,0.35,DOM
18,Americas,Caribbean,Dominican Republic,0.3,,,2008,15-64,ARQ,SS,Cocaine,0.13,0.57,DOM
19,Americas,Caribbean,Haiti,0.2,0.3,0.1,2018,15-64,ARQ,HHS,Cocaine,,,HTI
20,Americas,Caribbean,Haiti,0.88,,,2010,15-64,UNODC Estimate,SS,Cocaine,0.34,1.42,HTI
21,Americas,Caribbean,Haiti,0.9,,,2005,15-64,UNODC Estimate,,Cocaine,,,HTI
22,Americas,Caribbean,Jamaica,0.98,,,2010,15-64,UNODC Estimate,SS,Cocaine,0.39,1.56,JAM
23,Americas,Caribbean,Jamaica,1.1,,,2006,15-64,UNODC Estimate,SS,Cocaine,,,JAM
24,Americas,Caribbean,Puerto Rico,0.83,,,2005,15-64,Government source,SS,Cocaine,0.34,1.39,PRI
25,Americas,Caribbean,Saint Lucia,0.6,,,2010,15-64,UNODC Estimate,SS,Cocaine,0.19,1.02,LCA
26,Americas,Caribbean,Saint Lucia,1,,,2002,15-64,UNODC Estimate,,Cocaine,,,LCA
27,Americas,Caribbean,Trinidad and Tobago,0.48,,,2010,15-64,UNODC Estimate,SS,Cocaine,0.11,0.84,TTO
28,Americas,Central America,Belize,0.85,,,2005,12-65,UNODC Estimate,HHS,Cocaine,,,BLZ
29,Americas,Central America,Costa Rica,1.23,1.95,0.49,2015,12-70,ARQ,HHS,Cocaine,,,CRI
30,Americas,Central America,Costa Rica,1.33,2.16,0.5,2015,15-64,ARQ,HHS,Cocaine,,,CRI
31,Americas,Central America,Costa Rica,1.06,1.73,0.38,2010,15-64,ARQ,HHS,Cocaine,,,CRI
32,Americas,Central America,Costa Rica,0.31,,,2006,12-70,ARQ ,HHS ,Cocaine,0.23,0.38,CRI
33,Americas,Central America,El Salvador,0.37,0.73,0.11,2014,12-65,UNODC Estimate/ Government source,HHS,Cocaine,0.27,0.47,SLV
34,Americas,Central America,El Salvador,0.41,,,2005,12-65,ARQ,HHS,Cocaine,,,SLV
35,Americas,Central America,Guatemala,1.247,,,2014,15-64,Government source/UNODC Estimate,SS,Cocaine,0.395,2.1,GTM
36,Americas,Central America,Guatemala,0.21,,,2005,15-64,ARQ,HHS,Cocaine,,,GTM
37,Americas,Central America,Honduras,0.87,,,2005,12-35,ARQ,,Cocaine,,,HND
38,Americas,Central America,Nicaragua,0.69,,,2006,12-65,UNODC Estimate,HHS,Cocaine,0.52,0.86,NIC
39,Americas,Central America,Panama,0.1,,,2015,12-65,ARQ/Government source,HHS,Cocaine,,,PAN
40,Americas,Central America,Panama,1.2,,,2003,12-65,Government source,HHS,Cocaine,,,PAN
41,Americas,North America,Bermuda,1.3,,,2009,16-65,Government source,HHS,Cocaine,1,1.6,BMU
42,Americas,North America,Canada,2,2.4,1.5,2019,15+,ARQ/Government source,HHS,Cocaine,1.4,2.5,CAN
43,Americas,North America,Canada,2.5,3.7,1.3,2017,15+,ARQ,HHS,Cocaine,,,CAN
44,Americas,North America,Canada,1.47,1.83,1.12,2015,15-64,ARQ,HHS,Cocaine,,,CAN
45,Americas,North America,Canada,1.1,1.6,0.6,2013,15-64,ARQ,HHS,Cocaine,,,CAN
46,Americas,North America,Canada,1.3,1.7,,2012,15-64,ARQ,HHS,Cocaine,,,CAN
47,Americas,North America,Canada,1.1,,,2011,15-64,ARQ,HHS,Cocaine,,,CAN
48,Americas,North America,Canada,0.82,,,2010,15-64,ARQ ,HHS ,Cocaine,,,CAN
49,Americas,North America,Mexico,0.8,1.4,0.2,2016,12-65,ARQ/Government source,HHS,Cocaine,0.63,0.97,MEX
50,Americas,North America,Mexico,0.5,0.9,0.1,2011,12-65,Government source (ENA),HHS,Cocaine,0.35,0.64,MEX
51,Americas,North America,Mexico,0.4,,,2008,12-65,Government source,HHS,Cocaine,,,MEX
52,Americas,North America,United States of America,2.4,3.1,1.7,2020,15-64,ARQ,HHS,Cocaine,,,USA
53,Americas,North America,United States of America,2.6,3.3,1.9,2018,15-64,ARQ,HHS,Cocaine,,,USA
54,Americas,North America,United States of America,2.7,3.7,1.8,2017,15-64,ARQ,HHS,Cocaine,,,USA
55,Americas,North America,United States of America,2.4,3.1,1.7,2016,15-64,ARQ,HHS,Cocaine,,,USA
56,Americas,North America,United States of America,2.3,3,1.6,2015,15-64,ARQ,HHS,Cocaine,,,USA
57,Americas,North America,United States of America,2.1,2.9,1.5,2014,15-64,ARQ,HHS,Cocaine,,,USA
58,Americas,North America,United States of America,2.15,3,1.4,2013,15-64,ARQ,HHS,Cocaine,,,USA
59,Americas,North America,United States of America,2.3,,,2012,15-64,ARQ,HHS,Cocaine,,,USA
60,Americas,North America,United States of America,1.9,,,2011,15-64,ARQ,HHS,Cocaine,,,USA
61,Americas,North America,United States of America,2.2,,,2010,15-64,ARQ,HHS,Cocaine,,,USA
62,Americas,South America,Argentina,1.67,,,2017,15-64,UNODC Estimate,HHS,Cocaine,1.6,1.75,ARG
63,Americas,South America,Argentina,0.73,1.26,0.11,2011,16-65,ARQ,HHS,Cocaine,,,ARG
64,Americas,South America,Argentina,1,,,2008,12-65,Government source ,HHS ,Cocaine,,,ARG
65,Americas,South America,Bolivia (Plurinational State of),0.74,1.1,0.43000000000000005,2018,15-64,ARQ/UNODC Estimate,HHS,Cocaine,0.62,0.85,BOL
66,Americas,South America,Bolivia (Plurinational State of),0.36,0.48,0.29500000000000004,2014,12-65,UNODC Estimate,HHS,Cocaine,0.33,0.39,BOL
67,Americas,South America,Bolivia (Plurinational State of),0.36,,,2013,12-65,UNODC Estimate,HHS,Cocaine,0.33,0.39,BOL
68,Americas,South America,Bolivia (Plurinational State of),0.6,0.6,0.5,2007,15-64,ARQ,HHS,Cocaine,,,BOL
69,Americas,South America,Brazil,2.18,3.73,0.74,2012,15-64,Government source,HHS,Cocaine,,,BRA
70,Americas,South America,Brazil,0.7,,,2005,12-65,Government source ,HHS,Cocaine,,,BRA
71,Americas,South America,Chile,0.76,1.37,0.17,2020,15-64,ARQ,HHS,Cocaine,,,CHL
72,Americas,South America,Chile,1.42,2.4,0.46,2018,15-64,ARQ,HHS,Cocaine,,,CHL
73,Americas,South America,Chile,1.38,2.21,0.55,2016,15-64,ARQ,HHS,Cocaine,,,CHL
74,Americas,South America,Chile,1.73,2.85,0.65,2014,15-64,ARQ,HHS,Cocaine,,,CHL
75,Americas,South America,Chile,1.21,1.92,0.51,2012,15-64,ARQ,HHS,Cocaine,,,CHL
76,Americas,South America,Chile,1.01,,,2010,15-64,ARQ,HHS,Cocaine,,,CHL
77,Americas,South America,Chile,2.4,,,2008,15-64,ARQ ,HHS ,Cocaine,,,CHL
78,Americas,South America,Colombia,0.62,0.97,0.2,2019,12-65,Government source/ARQ,HHS,Cocaine,0.57,0.6699999999999999,COL
79,Americas,South America,Colombia,0.7,1.23,0.2,2013,12-65,ARQ,HHS,Cocaine,0.55,0.84,COL
80,Americas,South America,Colombia,0.72,1.28,0.22,2008,12-65,ARQ,HHS,Cocaine,0.53,0.9,COL
81,Americas,South America,Colombia,0.8,,,2003,18-65,Government source ,,Cocaine,,,COL
82,Americas,South America,Ecuador,1.686,,,2017,12-65,Government source/UNODC Estimate,SS,Cocaine,0.018,3.354,ECU
83,Americas,South America,Ecuador,0.2,,,2007,12-65,ARQ,HHS,Cocaine,0.14,0.25,ECU
84,Americas,South America,Paraguay,0.25,,,2003,12-64,UNODC Estimate,HHS,Cocaine,0.2,0.3,PRY
85,Americas,South America,Peru,0.964,,,2017,15-64,Government source/UNODC Estimate,SS,Cocaine,0.175,1.752,PER
86,Americas,South America,Peru,0.7,,,2010,12-65,Government source,HHS,Cocaine,,,PER
87,Americas,South America,Peru,0.48,,,2006,15-64,ARQ ,HHS ,Cocaine,0.34,0.61,PER
88,Americas,South America,Suriname,0.25,,,2013,12-65,UNODC Estimate/ARQ,HHS,Cocaine,0.2,0.3,SUR
89,Americas,South America,Suriname,0.3,,,2007,12-65,Government source,HHS,Cocaine,,,SUR
90,Americas,South America,Suriname,0.5,,,2002,15-64,UNODC Estimate ,,Cocaine,,,SUR
91,Americas,South America,Uruguay,2.1,3.4,0.8,2018,15-65,ARQ,HHS,Cocaine,,,URY
92,Americas,South America,Uruguay,1.8,2.6,1,2014,15-65,ARQ,HHS,Cocaine,,,URY
93,Americas,South America,Uruguay,2.1,3.4,0.9,2011,15-65,ARQ,HHS,Cocaine,,,URY
94,Americas,South America,Uruguay,1.7,,,2006,15-64,ARQ ,HHS ,Cocaine,,,URY
95,Americas,South America,Venezuela (Bolivarian Republic of),0.64,,,2011,12-65,ARQ,HHS,Cocaine,,,VEN
96,Americas,South America,Venezuela (Bolivarian Republic of),0.63,,,2005,15-64,Government source ,HHS ,Cocaine,,,VEN
97,Asia,Central Asia and Transcaucasia,Armenia,0.1,,,2005,15-64,UNODC Estimate,HHS,Cocaine,,,ARM
98,Asia,Central Asia and Transcaucasia,Georgia,0,0,0,2015,18-64,ARQ,HHS,Cocaine,,,GEO
99,Asia,East and South-East Asia,"China, Taiwan Province of China",0.1,,,2005,15-64,AMCEWG,,Cocaine,,,TWN
100,Asia,East and South-East Asia,Indonesia,0.03,0.06,0,2019,15-64,ARQ,HHS,Cocaine,,,IDN
101,Asia,East and South-East Asia,Indonesia,0,0,0,2015,10-60,ARQ,HHS,Cocaine,,,IDN
102,Asia,East and South-East Asia,Indonesia,0.01,,,2010,10-60,ARQ,HHS,Cocaine,,,IDN
103,Asia,East and South-East Asia,Indonesia,0.02,,,2008,15-64,ARQ ,HHS ,Cocaine,,,IDN
104,Asia,East and South-East Asia,Japan,0.03,,,2019,15-64,ARQ,HHS,Cocaine,,,JPN
105,Asia,East and South-East Asia,Japan,0,,,2017,15-64,ARQ,HHS,Cocaine,,,JPN
106,Asia,East and South-East Asia,Philippines,0.07,,,2016,10-69,ARQ,HHS,Cocaine,,,PHL
107,Asia,East and South-East Asia,Philippines,0.04,,,2012,10-69,ARQ,HHS,Cocaine,,,PHL
108,Asia,East and South-East Asia,Philippines,0.03,,,2005,15-64,UNODC Estimate,HHS,Cocaine,,,PHL
109,Asia,East and South-East Asia,Republic of Korea,0.03,,,2004,15-64,ARQ,HHS,Cocaine,,,PRK
110,Asia,East and South-East Asia,Thailand,0.065,,,2019,12-65,Government source,HHS,Cocaine,,,THA
111,Asia,East and South-East Asia,Thailand,0.05,,,2007,15-64,ARQ,HHS,Cocaine,,,THA
112,Asia,Near and Middle East/South-West Asia,Afghanistan,0,,,2009,15-64,UNODC/ Government source,HHS,Cocaine,,,AFG
113,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.11,,,2011,15-64,Academic source,HHS,Cocaine,0,0.22,IRN
114,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.01,,,2008,15-64,Government source,I,Cocaine,0,0.01,IRN
115,Asia,Near and Middle East/South-West Asia,Israel,0.2,0,0.3,2020,18-86,ARQ,HHS,Cocaine,,,ISR
116,Asia,Near and Middle East/South-West Asia,Israel,0.6,,,2016,18-65,UNODC Estimate,HHS,Cocaine,0.5,0.7,ISR
117,Asia,Near and Middle East/South-West Asia,Israel,1.06,1.64,0.42,2009,18-40,ARQ,,Cocaine,0.94,1.19,ISR
118,Asia,Near and Middle East/South-West Asia,Kuwait,0.04,,,2005,15-64,UNODC Estimate,,Cocaine,,,KWT
119,Asia,Near and Middle East/South-West Asia,Pakistan,0.01,0.01,0,2012,15-64,Government/UNODC,,Cocaine,0,0.02,PAK
120,Asia,Near and Middle East/South-West Asia,Syrian Arab Republic,0,,,2005,15-64,UNODC Estimate,,Cocaine,,,SYR
121,Asia,South Asia,India,0.1,0.18,0.01,2018,10-75,Government source,HHS/I,Cocaine,,,IND
122,Asia,South Asia,Maldives,0.04,,,2012,15-64,Government source,HHS,Cocaine,,,MDV
123,Europe,Eastern Europe,Belarus,0.06,,,2007,15-64,ESPAD,SS,Cocaine,0.01,0.12,BLR
124,Europe,Eastern Europe,Republic of Moldova,0.04,,,2008,15-64,Government sources,HHS,Cocaine,0.02,0.06,MDA
125,Europe,Eastern Europe,Russian Federation,0.23,,,2007,15-64,ESPAD/UNODC Estimate,SS,Cocaine,0.16,0.29,RUS
126,Europe,Eastern Europe,Ukraine,0.32,,,2015,15-64,ESPAD/UNODC Estimate,,Cocaine,0.01,0.62,UKR
127,Europe,Eastern Europe,Ukraine,0.52,,,2011,15-64,ESPAD,SS,Cocaine,0.17,0.86,UKR
128,Europe,Eastern Europe,Ukraine,0.23,,,2007,15-64,ESPAD ,SS ,Cocaine,0.16,0.29,UKR
129,Europe,South-Eastern Europe,Albania,2.5,,,2014,15-64,Public health research,HHS,Cocaine,,,ALB
130,Europe,South-Eastern Europe,Albania,2.5,4.5,0.5,2014,15-64,ARQ,HHS,Cocaine,,,ALB
131,Europe,South-Eastern Europe,Albania,0.78,,,2006,15-64,Government sources,SS,Cocaine,0.01,1.62,ALB
132,Europe,South-Eastern Europe,Albania,0.08,,,2004,15-64,UNODC Estimate ,,Cocaine,,,ALB
133,Europe,South-Eastern Europe,Bosnia and Herzegovina,0.63,,,2008,15-64,ESPAD,SS,Cocaine,0.01,1.92,BIH
134,Europe,South-Eastern Europe,Bulgaria,0.6,0.7,0.5,2020,15-64,ARQ,HHS,Cocaine,,,BGR
135,Europe,South-Eastern Europe,Bulgaria,0.3,0.4,0.2,2016,15-64,ARQ,HHS,Cocaine,,,BGR
136,Europe,South-Eastern Europe,Bulgaria,0.2,0.2,0.1,2012,15-64,ARQ,HHS,Cocaine,,,BGR
137,Europe,South-Eastern Europe,Bulgaria,0.6,,,2007,15-64,ARQ,HHS,Cocaine,,,BGR
138,Europe,South-Eastern Europe,Bulgaria,0.3,,,2005,18-60,ARQ ,HHS ,Cocaine,,,BGR
139,Europe,South-Eastern Europe,Croatia,1.9,2.8,0.9,2019,15-64,ARQ,HHS,Cocaine,,,HRV
140,Europe,South-Eastern Europe,Croatia,0.8,1.2,0.4,2015,15-64,ARQ,HHS,Cocaine,,,HRV
141,Europe,South-Eastern Europe,Croatia,0.5,,,2012,15-64,EMCDDA,HHS,Cocaine,,,HRV
142,Europe,South-Eastern Europe,Croatia,0.88,,,2007,15-64,ESPAD ,SS ,Cocaine,0.87,0.89,HRV
143,Europe,South-Eastern Europe,Montenegro,1.8,2,1.5,2017,15-64,ARQ,HHS,Cocaine,,,MNE
144,Europe,South-Eastern Europe,Montenegro,0.62,,,2015,15-64,ESPAD/UNODC Estimate,SS,Cocaine,0.18,1.06,MNE
145,Europe,South-Eastern Europe,Montenegro,0.52,,,2011,15-64,ESPAD,SS,Cocaine,0.17,0.86,MNE
146,Europe,South-Eastern Europe,Montenegro,0.77,,,2008,15-64,ESPAD ,SS ,Cocaine,0.01,1.71,MNE
147,Europe,South-Eastern Europe,North Macedonia,0.81,1.2,0.4,2017,15-64,ARQ,HHS,Cocaine,,,MKD
148,Europe,South-Eastern Europe,North Macedonia,0.34,,,2015,15-64,ESPAD/UNODC Estimate,SS,Cocaine,0.03,0.65,MKD
149,Europe,South-Eastern Europe,North Macedonia,0.08,,,2007,15-64,INCSR,,Cocaine,,,MKD
150,Europe,South-Eastern Europe,Romania,0.5,0.6,0.4,2019,15-64,ARQ,HHS,Cocaine,,,ROU
151,Europe,South-Eastern Europe,Romania,0.2,0.2,0.2,2016,15-64,ARQ,HHS,Cocaine,,,ROU
152,Europe,South-Eastern Europe,Romania,0.2,0.2,0.2,2013,15-64,ARQ,HHS,Cocaine,,,ROU
153,Europe,South-Eastern Europe,Romania,0.1,,,2010,15-64,ARQ,HHS,Cocaine,,,ROU
154,Europe,South-Eastern Europe,Romania,0.04,,,2007,15-64,ARQ ,HHS ,Cocaine,,,ROU
155,Europe,South-Eastern Europe,Serbia,0.1,0.1,0.1,2018,15-64,ARQ ,HHS ,Cocaine,,,SRB
156,Europe,South-Eastern Europe,Serbia,0.1,0.2,0,2014,18-64,Government source,HHS,Cocaine,,,SRB
157,Europe,South-Eastern Europe,Serbia,0.54,,,2008,15-64,Government sources,HHS,Cocaine,0.14,1.18,SRB
158,Europe,South-Eastern Europe,Türkiye,0.05,0.11,,2018,15-64,ARQ,HHS,Cocaine,,,TUR
159,Europe,South-Eastern Europe,Türkiye,0.05,0.11,,2017,15-64,EMCDDA,HHS,Cocaine,,,TUR
160,Europe,South-Eastern Europe,Türkiye,0.04,,,2003,15-64,UNODC Estimate,,Cocaine,,,TUR
161,Europe,Western and Central Europe,Austria,2.42,,,2020,15-64,Government source,HHS,Cocaine,2.02,2.9,AUT
162,Europe,Western and Central Europe,Austria,0.4,0.4,0.3,2015,15-64,Government source,HHS,Cocaine,0.2,0.6,AUT
163,Europe,Western and Central Europe,Austria,0.9,,,2008,15-64,ARQ,HHS,Cocaine,,,AUT
164,Europe,Western and Central Europe,Austria,0.9,,,2004,15-64,EMCDDA ,HHS ,Cocaine,,,AUT
165,Europe,Western and Central Europe,Belgium,1.4,2.2,0.4,2018,15-64,ARQ,HHS,Cocaine,,,BEL
166,Europe,Western and Central Europe,Belgium,0.5,0.7,0.3,2013,15-64,ARQ,HHS,Cocaine,,,BEL
167,Europe,Western and Central Europe,Belgium,0.9,1.3,0.5,2008,15-64,ARQ,HHS,Cocaine,,,BEL
168,Europe,Western and Central Europe,Belgium,1.21,,,2007,15-64,ESPAD ,SS ,Cocaine,,,BEL
169,Europe,Western and Central Europe,Cyprus,0.5,0.9,0.1,2019,15-64,ARQ,HHS,Cocaine,,,CYP
170,Europe,Western and Central Europe,Cyprus,0.2,0.4,0,2016,15-64,ARQ,HHS,Cocaine,,,CYP
171,Europe,Western and Central Europe,Cyprus,0.3,0.4,0.2,2012,15-64,ARQ,HHS,Cocaine,,,CYP
172,Europe,Western and Central Europe,Cyprus,1.2,2,0.5,2009,15-64,ARQ,HHS,Cocaine,,,CYP
173,Europe,Western and Central Europe,Cyprus,0.6,1.1,0.1,2006,15-65,ARQ ,,Cocaine,,,CYP
174,Europe,Western and Central Europe,Czechia,0.5,0.2,0.7,2019,15-64,ARQ,HHS,Cocaine,,,CZE
175,Europe,Western and Central Europe,Czechia,0.1,0.1,0.1,2018,15-64,ARQ,HHS,Cocaine,,,CZE
176,Europe,Western and Central Europe,Czechia,0.1,0,0.2,2017,15-64,EMCDDA,HHS,Cocaine,,,CZE
177,Europe,Western and Central Europe,Czechia,0.3,0.4,0.2,2016,15-64,ARQ,HHS,Cocaine,,,CZE
178,Europe,Western and Central Europe,Czechia,0.1,0,0.2,2015,15-64,ARQ,HHS,Cocaine,,,CZE
179,Europe,Western and Central Europe,Czechia,0.2,0.5,0,2014,15-64,ARQ,HHS,Cocaine,,,CZE
180,Europe,Western and Central Europe,Czechia,0.1,0.2,0,2013,15-64,ARQ,HHS,Cocaine,,,CZE
181,Europe,Western and Central Europe,Czechia,0.4,0.8,0,2012,15-64,ARQ,HHS,Cocaine,,,CZE
182,Europe,Western and Central Europe,Czechia,0.4,,,2010,15-64,ARQ,HHS,Cocaine,,,CZE
183,Europe,Western and Central Europe,Czechia,0.7,,,2008,15-64,Government sources ,HHS ,Cocaine,,,CZE
184,Europe,Western and Central Europe,Denmark,1.6,2.6,0.7,2017,16-64,ARQ,HHS,Cocaine,,,DNK
185,Europe,Western and Central Europe,Denmark,0.9,1.5,0.5,2013,16-64,ARQ,HHS,Cocaine,,,DNK
186,Europe,Western and Central Europe,Denmark,0.9,,,2010,16-64,ARQ,HHS,Cocaine,,,DNK
187,Europe,Western and Central Europe,Denmark,1.4,,,2008,16-64,ARQ,HHS,Cocaine,,,DNK
188,Europe,Western and Central Europe,Estonia,1.03,1.32,0.83,2018,16-64,ARQ,HHS,Cocaine,,,EST
189,Europe,Western and Central Europe,Estonia,0.6,0.8,0.4,2008,15-64,ARQ,HHS,Cocaine,,,EST
190,Europe,Western and Central Europe,Estonia,0.6,,,2003,15-64,ARQ ,HHS ,Cocaine,,,EST
191,Europe,Western and Central Europe,Finland,0.9,1.4,0.5,2018,15-64,ARQ,HHS,Cocaine,,,FIN
192,Europe,Western and Central Europe,Finland,0.5,0.9,0.1,2014,15-64,ARQ,HHS,Cocaine,,,FIN
193,Europe,Western and Central Europe,Finland,0.2,0.3,0.1,2010,15-64,ARQ,HHS,Cocaine,,,FIN
194,Europe,Western and Central Europe,Finland,0.5,,,2006,15-64,ARQ,,Cocaine,,,FIN
195,Europe,Western and Central Europe,France,1.7000000000000002,2.45,0.95,2017,18-64,ARQ/UNODC estimate,HHS,Cocaine,1.6,1.8,FRA
196,Europe,Western and Central Europe,France,1.1,1.4,0.7,2014,15-64,ARQ,HHS,Cocaine,,,FRA
197,Europe,Western and Central Europe,France,0.88,0.88,0.88,2010,15-64,EMCDDA,HHS,Cocaine,,,FRA
198,Europe,Western and Central Europe,France,0.6,,,2005,15-64,ARQ ,,Cocaine,,,FRA
199,Europe,Western and Central Europe,Germany,1.12,1.41,0.82,2018,18-64,ARQ,HHS,Cocaine,,,DEU
200,Europe,Western and Central Europe,Germany,0.6,0.8,0.5,2015,18-64,ARQ/Academic,HHS,Cocaine,0.4,0.9,DEU
201,Europe,Western and Central Europe,Germany,0.8,1.3,0.3,2012,18-64,ARQ,HHS,Cocaine,,,DEU
202,Europe,Western and Central Europe,Germany,0.8,1.2,0.4,2009,18-64,ARQ,HHS,Cocaine,,,DEU
203,Europe,Western and Central Europe,Germany,0.7,,,2006,18-64,Government source ,HHS ,Cocaine,,,DEU
204,Europe,Western and Central Europe,Greece,0.4,0.5,0.3,2015,18-64,ARQ,HHS,Cocaine,,,GRC
205,Europe,Western and Central Europe,Greece,0.1,0.1,0.1,2004,15-64,EMCDDA,,Cocaine,,,GRC
206,Europe,Western and Central Europe,Hungary,0.3,0.5,0.3,2019,18-64,ARQ,HHS,Cocaine,,,HUN
207,Europe,Western and Central Europe,Hungary,0.31,0.5,0.14,2015,18-64,ARQ,HHS,Cocaine,,,HUN
208,Europe,Western and Central Europe,Hungary,0.2,,,2007,18-64,ARQ,HHS,Cocaine,0,0.4,HUN
209,Europe,Western and Central Europe,Iceland,1.06,,,2015,15-64,ESPAD/UNODC Estimate,SS,Cocaine,0.29,1.83,ISL
210,Europe,Western and Central Europe,Iceland,0.92,,,2011,15-64,ESPAD,SS,Cocaine,0.35,1.5,ISL
211,Europe,Western and Central Europe,Iceland,0.88,,,2007,15-64,ESPAD ,SS ,Cocaine,0.87,0.89,ISL
212,Europe,Western and Central Europe,Ireland,2.4,,,2019,15-64,ARQ/UNODC Estimate,HHS,Cocaine,2.3,2.5,IRL
213,Europe,Western and Central Europe,Ireland,1.5,2.6,0.5,2015,15-64,ARQ,HHS,Cocaine,,,IRL
214,Europe,Western and Central Europe,Ireland,1.5,2.3,0.7,2011,15-64,ARQ,HHS,Cocaine,,,IRL
215,Europe,Western and Central Europe,Ireland,1.7,,,2007,15-64,Government source ,HHS ,Cocaine,,,IRL
216,Europe,Western and Central Europe,Italy,1.21,1.46,0.95,2017,15-64,ARQ,HHS,Cocaine,,,ITA
217,Europe,Western and Central Europe,Italy,1.1,1.4,0.7,2013,15-64,ARQ,HHS,Cocaine,,,ITA
218,Europe,Western and Central Europe,Italy,0.6,1.01,0.25,2012,15-64,ARQ,HHS,Cocaine,,,ITA
219,Europe,Western and Central Europe,Italy,2.1,,,2008,15-64,EMCDDA,HHS,Cocaine,,,ITA
220,Europe,Western and Central Europe,Italy,2.1,,,2005,15-64,EMCDDA ,HHS ,Cocaine,,,ITA
221,Europe,Western and Central Europe,Latvia,1.3,1.7,0.9,2020,15-64,ARQ,HHS,Cocaine,,,LVA
222,Europe,Western and Central Europe,Latvia,0.5,0.8,0.3,2015,15-64,ARQ,HHS,Cocaine,,,LVA
223,Europe,Western and Central Europe,Latvia,0.2,0.4,0.1,2011,15-64,ARQ,HHS,Cocaine,,,LVA
224,Europe,Western and Central Europe,Latvia,0.5,,,2007,15-64,ARQ ,HHS ,Cocaine,,,LVA
225,Europe,Western and Central Europe,Lithuania,0.1,0.3,0.04,2016,15-64,ARQ,HHS,Cocaine,,,LTU
226,Europe,Western and Central Europe,Lithuania,0.2,0.3,0,2012,15-64,ARQ,HHS,Cocaine,,,LTU
227,Europe,Western and Central Europe,Lithuania,0.2,,,2008,15-64,ARQ,HHS,Cocaine,,,LTU
228,Europe,Western and Central Europe,Lithuania,0.3,,,2004,15-64,ARQ ,,Cocaine,,,LTU
229,Europe,Western and Central Europe,Luxembourg,0.5,0.7,0.3,2019,15-64,ARQ,HHS,Cocaine,,,LUX
230,Europe,Western and Central Europe,Luxembourg,0.4,,,2014,15-64,ARQ/Government source,HHS,Cocaine,,,LUX
231,Europe,Western and Central Europe,Luxembourg,1.04,,,2010,15-64,ARQ,SS,Cocaine,0.3,1.8,LUX
232,Europe,Western and Central Europe,Luxembourg,0.9,,,2003,15-64,UNODC Estimate,,Cocaine,,,LUX
233,Europe,Western and Central Europe,Malta,0.5,,,2013,15-64,ARQ,HHS,Cocaine,,,MLT
234,Europe,Western and Central Europe,Malta,1.78,,,2011,15-64,ESPAD,SS,Cocaine,0.69,2.86,MLT
235,Europe,Western and Central Europe,Malta,1.11,,,2007,18-65,ESPAD ,SS ,Cocaine,1.07,1.15,MLT
236,Europe,Western and Central Europe,Netherlands,2.1,2.5,1.7,2020,15-64,ARQ,HHS,Cocaine,,,NLD
237,Europe,Western and Central Europe,Netherlands,2.3,3.4,1.3,2019,15-64,EMCDDA,HHS,Cocaine,,,NLD
238,Europe,Western and Central Europe,Netherlands,2,2.7,1.3,2018,15-64,EMCDDA,HHS,Cocaine,,,NLD
239,Europe,Western and Central Europe,Netherlands,2.2,3,1.4,2017,15-64,EMCDDA,HHS,Cocaine,1.9,2.6,NLD
240,Europe,Western and Central Europe,Netherlands,2,3,1,2016,15-64,EMCDDA,HHS,Cocaine,,,NLD
241,Europe,Western and Central Europe,Netherlands,1.9,2.8,1,2015,15-64,EMCDDA,HHS,Cocaine,,,NLD
242,Europe,Western and Central Europe,Netherlands,1.6,2.2,1,2014,15-64,ARQ,HHS,Cocaine,,,NLD
243,Europe,Western and Central Europe,Netherlands,1.2,,,2009,15-64,ARQ,HHS,Cocaine,,,NLD
244,Europe,Western and Central Europe,Netherlands,0.6,,,2005,15-64,ARQ ,,Cocaine,,,NLD
245,Europe,Western and Central Europe,Norway,0.8,1.2,0.4,2020,16-64,ARQ,HHS,Cocaine,,,NOR
246,Europe,Western and Central Europe,Norway,1.2,1.6,0.8,2019,16-64,ARQ,HHS,Cocaine,,,NOR
247,Europe,Western and Central Europe,Norway,1.2,2.1,0.2,2018,16-64,ARQ,HHS,Cocaine,,,NOR
248,Europe,Western and Central Europe,Norway,1.1,1.4,0.7,2017,16-64,ARQ,HHS,Cocaine,,,NOR
249,Europe,Western and Central Europe,Norway,0.6,1,0.3,2016,16-64,ARQ,HHS,Cocaine,,,NOR
250,Europe,Western and Central Europe,Norway,1,1.7,0.3,2015,16-64,ARQ,HHS,Cocaine,,,NOR
251,Europe,Western and Central Europe,Norway,1,1.6,0.3,2014,16-64,ARQ,HHS,Cocaine,,,NOR
252,Europe,Western and Central Europe,Norway,0.9,1.6,0.2,2013,16-64,ARQ,HHS,Cocaine,,,NOR
253,Europe,Western and Central Europe,Norway,0.4,,,2009,15-64,ARQ,HHS,Cocaine,,,NOR
254,Europe,Western and Central Europe,Norway,0.8,,,2004,15-64,ARQ ,,Cocaine,,,NOR
255,Europe,Western and Central Europe,Poland,0.3,0.3,0.2,2019,15-64,ARQ,HHS,Cocaine,,,POL
256,Europe,Western and Central Europe,Poland,1.4,1.4,1.5,2016,15-64,ARQ,HHS,Cocaine,,,POL
257,Europe,Western and Central Europe,Poland,0.2,0.4,,2014,15-64,ARQ,HHS,Cocaine,,,POL
258,Europe,Western and Central Europe,Poland,0.2,0.3,,2012,15-64,ARQ,HHS,Cocaine,,,POL
259,Europe,Western and Central Europe,Poland,0.7,,,2010,15-64,ARQ,HHS,Cocaine,,,POL
260,Europe,Western and Central Europe,Poland,0.2,,,2006,16-64,ARQ ,,Cocaine,,,POL
261,Europe,Western and Central Europe,Portugal,0.2,0.3,0.1,2017,15-64,ARQ,HHS,Cocaine,,,PRT
262,Europe,Western and Central Europe,Portugal,0.2,0.3,0.1,2012,15-64,ARQ,HHS,Cocaine,,,PRT
263,Europe,Western and Central Europe,Portugal,0.6,,,2007,15-64,ARQ,HHS,Cocaine,,,PRT
264,Europe,Western and Central Europe,Slovakia,0.1,0.3,,2019,15-64,ARQ,HHS,Cocaine,,,SVK
265,Europe,Western and Central Europe,Slovakia,0.1,0.3,0,2015,15-64,ARQ,HHS,Cocaine,,,SVK
266,Europe,Western and Central Europe,Slovakia,0.2,,,2010,15-64,EMCDDA,HHS,Cocaine,,,SVK
267,Europe,Western and Central Europe,Slovakia,0.6,,,2006,15-64,ARQ,HHS,Cocaine,,,SVK
268,Europe,Western and Central Europe,Slovenia,0.8,1,0.5,2018,15-64,EMCDDA,HHS,Cocaine,0.6,1,SVN
269,Europe,Western and Central Europe,Slovenia,0.5,0.7,0.3,2012,15-64,ARQ,HHS,Cocaine,,,SVN
270,Europe,Western and Central Europe,Slovenia,0.6,,,2008,15-64,ARQ,HHS,Cocaine,,,SVN
271,Europe,Western and Central Europe,Slovenia,0.88,,,2007,15-64,ESPAD ,SS ,Cocaine,,,SVN
272,Europe,Western and Central Europe,Spain,2.5,4.1,1,2020,15-64,ARQ,HHS,Cocaine,,,ESP
273,Europe,Western and Central Europe,Spain,2.2,3.4,1,2017,15-64,EMCDDA,HHS,Cocaine,2,2.4,ESP
274,Europe,Western and Central Europe,Spain,2,3.1,0.9,2015,15-64,ARQ,HHS,Cocaine,,,ESP
275,Europe,Western and Central Europe,Spain,2.2,3.3,1,2013,15-64,ARQ,HHS,Cocaine,,,ESP
276,Europe,Western and Central Europe,Spain,2.3,3.6,0.9,2011,15-64,ARQ,HHS,Cocaine,,,ESP
277,Europe,Western and Central Europe,Spain,2.7,4.2,1,2009,15-64,ARQ ,HHS ,Cocaine,,,ESP
278,Europe,Western and Central Europe,Sweden,1.2,,,2017,17-64,ARQ,HHS,Cocaine,,,SWE
279,Europe,Western and Central Europe,Sweden,0.6,0.8,0.4,2013,15-64,EMCDDA,HHS,Cocaine,,,SWE
280,Europe,Western and Central Europe,Sweden,0.5,,,2008,15-64,ARQ,HHS,Cocaine,,,SWE
281,Europe,Western and Central Europe,Switzerland,0.81,,,2016,15-64,Government source,HHS,Cocaine,,,CHE
282,Europe,Western and Central Europe,Switzerland,0.66,,,2015,15-64,ARQ,HHS,Cocaine,,,CHE
283,Europe,Western and Central Europe,Switzerland,0.5,0.7,0.3,2014,15-64,ARQ,HHS,Cocaine,,,CHE
284,Europe,Western and Central Europe,Switzerland,0.5,0.5,0.4,2013,15-64,ARQ,HHS,Cocaine,,,CHE
285,Europe,Western and Central Europe,Switzerland,0.4,,,2012,15+,ARQ,HHS,Cocaine,,,CHE
286,Europe,Western and Central Europe,Switzerland,0.5,,,2011,15-64,ARQ,HHS,Cocaine,,,CHE
287,Europe,Western and Central Europe,Switzerland,0.2,,,2007,15-64,ARQ ,HHS ,Cocaine,,,CHE
288,Europe,Western and Central Europe,United Kingdom (England and Wales),2.4,3.17,1.64,2019,16-64,ARQ,HHS,Cocaine,,,GBR
289,Europe,Western and Central Europe,United Kingdom (England and Wales),2.92,4.1,1.76,2018,16-59,Government source,HHS,Cocaine,,,GBR
290,Europe,Western and Central Europe,United Kingdom (England and Wales),2.67,3.76,1.59,2017,16-59,Government source,HHS,Cocaine,,,GBR
291,Europe,Western and Central Europe,United Kingdom (England and Wales),2.32,3.34,1.31,2016,16-59,Government source,HHS,Cocaine,,,GBR
292,Europe,Western and Central Europe,United Kingdom (England and Wales),2.25,3.33,1.18,2015,16-59,Government source,HHS,Cocaine,,,GBR
293,Europe,Western and Central Europe,United Kingdom (England and Wales),2.4,3.5,1.3,2014,16-59,Government source,HHS,Cocaine,,,GBR
294,Europe,Western and Central Europe,United Kingdom (England and Wales),2.4,3.3,1.4,2013,16-59,Government source,HHS,Cocaine,,,GBR
295,Europe,Western and Central Europe,United Kingdom (England and Wales),2,2.8,1.1,2012,16-59,Government source,HHS,Cocaine,,,GBR
296,Europe,Western and Central Europe,United Kingdom (England and Wales),2.2,,,2011,16-59,Government source,HHS,Cocaine,,,GBR
297,Europe,Western and Central Europe,United Kingdom (England and Wales),2.2,,,2010,16-59,Government source ,HHS ,Cocaine,,,GBR
298,Europe,Western and Central Europe,United Kingdom (Northern Ireland),1.8,,,2014,15-64,Government source,HHS,Cocaine,,,GBR
299,Europe,Western and Central Europe,United Kingdom (Northern Ireland),1.5,,,2011,15-64,Government source,HHS,Cocaine,,,GBR
300,Europe,Western and Central Europe,United Kingdom (Northern Ireland),1.9,,,2006,15-64,Government source ,HHS ,Cocaine,,,GBR
301,Europe,Western and Central Europe,United Kingdom (Scotland),2.34,3.82,0.9,2014,16-64,Government source,HHS,Cocaine,,,GBR
302,Europe,Western and Central Europe,United Kingdom (Scotland),2.2,3.3,1.1,2012,16-64,Government source,HHS,Cocaine,,,GBR
303,Europe,Western and Central Europe,United Kingdom (Scotland),2.4,,,2011,16-64,Government source,HHS,Cocaine,,,GBR
304,Europe,Western and Central Europe,United Kingdom (Scotland),2.7,,,2010,16-64,Government source ,HHS ,Cocaine,,,GBR
305,Oceania,Australia and New Zealand,Australia,4.2,5.5,3,2019,14+,ARQ,HHS,Cocaine,,,AUS
306,Oceania,Australia and New Zealand,Australia,2.5,3.1,2,2016,14+,ARQ,HHS,Cocaine,,,AUS
307,Oceania,Australia and New Zealand,Australia,2.1,2.9,1.4,2013,14+,ARQ,HHS,Cocaine,,,AUS
308,Oceania,Australia and New Zealand,Australia,2.1,,,2010,14+,ARQ,HHS,Cocaine,,,AUS
309,Oceania,Australia and New Zealand,Australia,1.9,,,2007,15-64,Government source ,HHS ,Cocaine,,,AUS
310,Oceania,Australia and New Zealand,New Zealand,0.6,0.9,0.3,2008,16-64,Government source,HHS,Cocaine,0.3,0.8,NZL
311,Oceania,Australia and New Zealand,New Zealand,0.76,,,2006,15-64,ARQ ,HHS ,Cocaine,,,NZL
0,Africa,North Africa,Algeria,0.03,0.06,0.01,2010,12+,ARQ,HHS ,Amphetamines,,,DZA
1,Africa,North Africa,Egypt,0.48,,,2006,15-64,Govt; Academic Research,"HHS, SS",Amphetamines,0.43,0.52,EGY
2,Africa,Southern Africa,South Africa,1.02,,,2008,15-64,ARQ,HHS,Amphetamines,0.75,1.37,ZAF
3,Africa,Southern Africa,Zambia,0.1,,,2003,15-64,UNODC Estimate,,Amphetamines,,,ZMB
4,Africa,West and Central Africa,Côte d'Ivoire,0.61,,,2017,15-64,UNODC Estimate,SS,Amphetamines,0.31,0.9,CIV
5,Africa,West and Central Africa,Nigeria,0.09,,,2017,15-64,Government/UNODC,HHS/I,Amphetamines,0,1,NGA
6,Africa,West and Central Africa,Nigeria,1.4,,,2008,15-64,ARQ,HHS,Amphetamines,0.71,2.01,NGA
7,Africa,West and Central Africa,Nigeria,1.05,,,1999,,UNODC Estimate ,,Amphetamines,,,NGA
8,Americas,Caribbean,Bahamas,0.43,,,2008,15-64,ARQ,SS,Amphetamines,0.13,1.06,BHS
9,Americas,Caribbean,Bahamas,0.29,,,2003,15-64,UNODC Estimate ,,Amphetamines,,,BHS
10,Americas,Caribbean,Barbados,0.2,,,2006,12-65,CICAD,HHS,Amphetamines,,,BRB
11,Americas,Caribbean,Dominican Republic,0.95,,,2008,15-64,ARQ,SS,Amphetamines,0.04,2.59,DOM
12,Americas,Caribbean,Dominican Republic,1.1,,,2003,15-64,UNODC Estimate ,,Amphetamines,,,DOM
13,Americas,Caribbean,Grenada,0.7,,,2005,15-64,ARQ,,Amphetamines,,,GRD
14,Americas,Caribbean,Haiti,6.1,6.7,5.7,2018,15-64,ARQ,HHS,Amphetamines,,,HTI
15,Americas,Caribbean,Jamaica,0.81,,,2010,15-64,ARQ,SS,Amphetamines,0.13,1.5,JAM
16,Americas,Caribbean,Jamaica,1.14,,,2006,15-64,Government source ,SS ,Amphetamines,0.39,1.91,JAM
17,Americas,Caribbean,Puerto Rico,0.43,,,2005,15-64,Government source,SS,Amphetamines,0.13,1.06,PRI
18,Americas,Caribbean,Trinidad and Tobago,0.7,,,2006,15-64,UNODC Estimate,SS,Amphetamines,0.23,1.38,TTO
19,Americas,Caribbean,Trinidad and Tobago,0.78,,,2002,15-64,UNODC Estimate ,,Amphetamines,,,TTO
20,Americas,Central America,Belize,1.35,,,2005,12-65,CICAD,HHS,Amphetamines,,,BLZ
21,Americas,Central America,Costa Rica,0,0,0,2015,12-70,ARQ,HHS,Amphetamines,,,CRI
22,Americas,Central America,El Salvador,0.38,0.54,0.23,2014,12-65,Government Source,HHS,Amphetamines,0.24,0.54,SLV
23,Americas,Central America,Guatemala,0.91,,,2005,15-64,UNODC Estimate,,Amphetamines,,,GTM
24,Americas,Central America,Honduras,0.84,,,2005,15-64,UNODC Estimate,,Amphetamines,,,HND
25,Americas,Central America,Nicaragua,0.76,,,2003,15-64,UNODC Estimate,,Amphetamines,,,NIC
26,Americas,Central America,Panama,1.2,,,2003,12-65,CICAD,HHS,Amphetamines,,,PAN
27,Americas,North America,Bermuda,0.1,,,2009,16-65,Government source,HHS,Amphetamines,0,0.1,BMU
28,Americas,North America,Canada,0.5,0.8,0.1,2019,15+,ARQ/Government source,HHS,Amphetamines,0.2,0.7,CAN
29,Americas,North America,Canada,0.4,,0.08,2017,15+,ARQ,HHS,Amphetamines,,,CAN
30,Americas,North America,Canada,0.25,,,2015,15-64,ARQ,HHS,Amphetamines,,,CAN
31,Americas,North America,Canada,0.2,0.2,0.2,2013,15-64,ARQ,HHS,Amphetamines,,,CAN
32,Americas,North America,Canada,1.6,2.1,1.1,2012,15-64,ARQ,HHS,Amphetamines,,,CAN
33,Americas,North America,Canada,1.2,1.5,0.9,2011,15-64,ARQ,HHS,Amphetamines,,,CAN
34,Americas,North America,Canada,0.5,,,2010,15-64,ARQ ,HHS ,Amphetamines,,,CAN
35,Americas,North America,Mexico,0.3,,,2016,12-65,ARQ/UNODC Estimate,HHS,Amphetamines,0.2,0.4,MEX
36,Americas,North America,Mexico,0.12,0.2,0.1,2011,12-65,Government Source,HHS,Amphetamines,0.04,0.19,MEX
37,Americas,North America,Mexico,0.02,,,2008,12-65,Government source,HHS,Amphetamines,,,MEX
38,Americas,North America,United States of America,5.6499999999999995,5.85,5.55,2020,15-64,ARQ/UNODC Estimates,HHS,Amphetamines,5.1,6.199999999999999,USA
39,Americas,North America,United States of America,3.3,3.6,2.8,2018,15-64,ARQ,HHS,Amphetamines,,,USA
40,Americas,North America,United States of America,3.1,,,2017,15-64,UNODC Estimate/ARQ,HHS,Amphetamines,2.7,3.5,USA
41,Americas,North America,United States of America,2.95,,,2016,15-64,UNODC Estimate,HHS,Amphetamines,2.6,3.3,USA
42,Americas,North America,United States of America,2.9,,,2015,15-64,UNODC Estimate,HHS,Amphetamines,2.5,3.3,USA
43,Americas,North America,United States of America,1.7,,,2014,15-64,Government,,Amphetamines,,,USA
44,Americas,North America,United States of America,1.9,2.2,1.7,2013,15-64,ARQ,HHS,Amphetamines,,,USA
45,Americas,North America,United States of America,1.9,,,2012,15-64,ARQ,HHS,Amphetamines,1.6,2.2,USA
46,Americas,North America,United States of America,1.55,,,2011,15-64,ARQ,HHS,Amphetamines,1.3,1.8,USA
47,Americas,North America,United States of America,1.8,,,2010,15-64,ARQ ,HHS,Amphetamines,,,USA
48,Americas,South America,Bolivia (Plurinational State of),0.1,0.4,0,2014,12-65,ARQ,HHS,Amphetamines,,,BOL
49,Americas,South America,Bolivia (Plurinational State of),0.5,0.5,0.4,2007,12-65,ARQ,HHS,Amphetamines,,,BOL
50,Americas,South America,Brazil,1.23,0.78,1.64,2012,15-64,Government source,HHS,Amphetamines,,,BRA
51,Americas,South America,Chile,0.18,0.1,,2020,15-64,ARQ,HHS,Amphetamines,,,CHL
52,Americas,South America,Chile,0.08,0.14,0.03,2018,15-64,ARQ,HHS,Amphetamines,,,CHL
53,Americas,South America,Chile,0.18,0.25,0.11,2016,15-64,ARQ,HHS,Amphetamines,,,CHL
54,Americas,South America,Chile,0.06,0.06,0.06,2014,15-64,ARQ,HHS,Amphetamines,,,CHL
55,Americas,South America,Chile,0.08,0.14,0.03,2012,15-64,ARQ,HHS,Amphetamines,,,CHL
56,Americas,South America,Chile,0.27,,,2010,15-64,ARQ,HHS,Amphetamines,0.17,0.37,CHL
57,Americas,South America,Chile,0.4,,,2008,15-64,ARQ ,HHS ,Amphetamines,,,CHL
58,Americas,South America,Colombia,0.06,,,2008,12-65,ARQ,HHS,Amphetamines,,,COL
59,Americas,South America,Ecuador,0.2,,,2007,15-64,ARQ,HHS,Amphetamines,,,ECU
60,Americas,South America,Ecuador,0.21,,,2005,15-64,UNODC Estimate ,SS,Amphetamines,,,ECU
61,Americas,South America,Paraguay,0.51,,,2005,15-64,UNODC Estimate,SS,Amphetamines,,,PRY
62,Americas,South America,Peru,0.2,,,2006,12-64,ARQ,HHS,Amphetamines,,,PER
63,Americas,South America,Suriname,0.5,,,2007,12-65,CICAD,HHS,Amphetamines,,,SUR
64,Americas,South America,Suriname,0.6,,,2002,15-64,UNODC Estimate ,,Amphetamines,,,SUR
65,Americas,South America,Uruguay,0.3,0.3,0.2,2018,15-64,ARQ,HHS,Amphetamines,,,URY
66,Americas,South America,Uruguay,0.1,,,2018,15-65,Government sources,HHS,Amphetamines,,,URY
67,Americas,South America,Uruguay,0.04,,,2014,15-65,ARQ,HHS,Amphetamines,,,URY
68,Americas,South America,Uruguay,0.01,,,2011,15-65,ARQ,HHS,Amphetamines,,,URY
69,Americas,South America,Uruguay,0.3,,,2006,15-64,ARQ ,HHS ,Amphetamines,,,URY
70,Americas,South America,Venezuela (Bolivarian Republic of),0.095,,,2011,15-65,Government source/UNODC Estimate,HHS,Amphetamines,0.07,0.12,VEN
71,Americas,South America,Venezuela (Bolivarian Republic of),0.6,,,2002,15-64,UNODC Estimate ,,Amphetamines,,,VEN
72,Asia,Central Asia and Transcaucasia,Armenia,0.04,,,2005,15-64,UNODC Estimate,HHS,Amphetamines,,,ARM
73,Asia,Central Asia and Transcaucasia,Georgia,0,0,0,2015,18-64,ARQ,HHS,Amphetamines,,,GEO
74,Asia,Central Asia and Transcaucasia,Georgia,0.56,,,2009,15-64,Government source/ NGO/Academic research,SS,Amphetamines,0.1,1.06,GEO
75,Asia,East and South-East Asia,Brunei Darussalam,0.25,,,2006,15-64,UNODC Estimate,,Amphetamines,,,BRN
76,Asia,East and South-East Asia,Cambodia,0.6,,,2004,15-64,UNODC Estimate,,Amphetamines,,,KHM
77,Asia,East and South-East Asia,China,0.57,,,2018,15-64,Academic research,HHS,Amphetamines,,,CHN
78,Asia,East and South-East Asia,"China, Taiwan Province of China",0.6,,,2005,12-64,AMCEWG,,Amphetamines,,,TWN
79,Asia,East and South-East Asia,Indonesia,0.6,,,2019,15-64,ARQ/UNODC Estimate,HHS,Amphetamines,0.6,0.6,IDN
80,Asia,East and South-East Asia,Indonesia,0.52,,,2017,10-59,UNODC Estimate,HHS,Amphetamines,0.45,0.5800000000000001,IDN
81,Asia,East and South-East Asia,Indonesia,0.09,0.2,0,2015,10-60,ARQ,HHS,Amphetamines,,,IDN
82,Asia,East and South-East Asia,Indonesia,0.18,,,2010,10-60,ARQ,HHS,Amphetamines,,,IDN
83,Asia,East and South-East Asia,Indonesia,0.16,,,2008,10-59,ARQ ,HHS ,Amphetamines,,,IDN
84,Asia,East and South-East Asia,Japan,0.04,,,2019,15-64,ARQ,HHS,Amphetamines,,,JPN
85,Asia,East and South-East Asia,Japan,0.3,,,2011,15-64,UNODC Estimate,HHS,Amphetamines,0.03,0.4,JPN
86,Asia,East and South-East Asia,Japan,0.2,,,2009,15-64,UNODC Estimate ,HHS ,Amphetamines,0.18,0.22,JPN
87,Asia,East and South-East Asia,Lao People's Democratic Republic,1.39,,,2008,15-64,Academic research,SS,Amphetamines,1.07,1.71,LAO
88,Asia,East and South-East Asia,Malaysia,0.55,,,2005,15-64,UNODC Estimate,,Amphetamines,,,MYS
89,Asia,East and South-East Asia,Myanmar,0.22,,,2005,15-64,UNODC Estimate,,Amphetamines,,,MMR
90,Asia,East and South-East Asia,Philippines,1.1,,,2016,10-69,ARQ,HHS,Amphetamines,,,PHL
91,Asia,East and South-East Asia,Philippines,0.74,,,2012,10-69,ARQ,HHS,Amphetamines,,,PHL
92,Asia,East and South-East Asia,Philippines,2.13,,,2008,15-64,Government source,HHS,Amphetamines,1.91,2.35,PHL
93,Asia,East and South-East Asia,Republic of Korea,0.12,,,2004,15-64,ARQ,HHS,Amphetamines,0.08,0.16,PRK
94,Asia,East and South-East Asia,Thailand,1.67,,,2019,12-65,Government source/UNODC Estimate,HHS,Amphetamines,1.3,2.04,THA
95,Asia,East and South-East Asia,Thailand,1.4,,,2007,12-65,ARQ,HHS,Amphetamines,,,THA
96,Asia,East and South-East Asia,Viet Nam,0.22,,,2003,15-64,UNODC Estimate,,Amphetamines,,,VNM
97,Asia,Near and Middle East/South-West Asia,Afghanistan,0,,,2009,15-64,UNODC/Government Source,HHS,Amphetamines,,,AFG
98,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.4,,,2015,15-64,Government source/UNODC Estimate,HHS,Amphetamines,,,IRN
99,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.77,,,2013,18+,Academic/UNODC Estimate,NSUM,Amphetamines,0.68,0.88,IRN
100,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.7,,,2011,15-64,Government source,,Amphetamines,,,IRN
101,Asia,Near and Middle East/South-West Asia,Israel,0.7,1.3,0.1,2016,18-65,ARQ,HHS,Amphetamines,,,ISR
102,Asia,Near and Middle East/South-West Asia,Israel,1.01,1.63,0.31,2009,18-40,ARQ,HHS,Amphetamines,,,ISR
103,Asia,Near and Middle East/South-West Asia,Israel,0.4,,,2005,18-40,ARQ ,,Amphetamines,,,ISR
104,Asia,Near and Middle East/South-West Asia,Kuwait,0.27,,,2005,15-64,UNODC Estimate,,Amphetamines,,,KWT
105,Asia,Near and Middle East/South-West Asia,Pakistan,0.08,0.1,0.14,2012,15-64,Government source/UNODC,HHS/I,Amphetamines,0.04,0.2,PAK
106,Asia,Near and Middle East/South-West Asia,Saudi Arabia,0.4,,,2006,15-64,UNODC Estimate,,Amphetamines,,,SAU
107,Asia,South Asia,India,0.18,,,2018,10-75,Government source,HHS/I,Amphetamines,,,IND
108,Asia,South Asia,Maldives,0.1,,,2012,15-64,Government source,HHS,Amphetamines,,,MDV
109,Europe,Eastern Europe,Belarus,0.35,,,2006,15-64,UNODC Estimate,,Amphetamines,,,BLR
110,Europe,Eastern Europe,Republic of Moldova,0.03,,,2008,15-64,Government source,HHS,Amphetamines,0.03,0.04,MDA
111,Europe,Eastern Europe,Russian Federation,0.39,,,2007,15-64,ESPAD/UNODC Estimate,SS,Amphetamines,0.22,0.56,RUS
112,Europe,Eastern Europe,Ukraine,0.3,,,2015,15-64,ESPAD/UNODC Estimate,SS,Amphetamines,0.13,0.48,UKR
113,Europe,Eastern Europe,Ukraine,0.72,,,2011,15-64,ARQ,SS,Amphetamines,0.19,1.25,UKR
114,Europe,Eastern Europe,Ukraine,0.39,,,2007,15-64,ESPAD ,SS ,Amphetamines,0.22,0.56,UKR
115,Europe,South-Eastern Europe,Albania,0.1,,,2014,15-64,Public health research,HHS,Amphetamines,,,ALB
116,Europe,South-Eastern Europe,Albania,0.1,0.4,0,2014,15-64,ARQ,HHS,Amphetamines,,,ALB
117,Europe,South-Eastern Europe,Albania,0.02,,,2004,15-64,ARQ,,Amphetamines,,,ALB
118,Europe,South-Eastern Europe,Bosnia and Herzegovina,0.5,,,2011,15-64,ARQ,SS,Amphetamines,0.09,0.91,BIH
119,Europe,South-Eastern Europe,Bosnia and Herzegovina,1.04,,,2008,15-64,ESPAD ,SS ,Amphetamines,0.37,1.71,BIH
120,Europe,South-Eastern Europe,Bulgaria,0.7,0.8,0.6,2020,15-64,ARQ,HHS,Amphetamines,,,BGR
121,Europe,South-Eastern Europe,Bulgaria,0.8,1,0.55,2016,15-64,UNODC Estimate,HHS,Amphetamines,0.7,0.9,BGR
122,Europe,South-Eastern Europe,Bulgaria,0.65,0.85,0.4,2012,15-64,ARQ,HHS,Amphetamines,0.6,0.7,BGR
123,Europe,South-Eastern Europe,Bulgaria,0.95,,,2008,15-64,ARQ,HHS,Amphetamines,0.9,1,BGR
124,Europe,South-Eastern Europe,Bulgaria,0.5,,,2007,15-64,ARQ ,"HHS, c ",Amphetamines,,,BGR
125,Europe,South-Eastern Europe,Croatia,1.8,2.6,1,2019,15-64,ARQ,HHS,Amphetamines,,,HRV
126,Europe,South-Eastern Europe,Croatia,1,1.6,0.4,2015,15-64,ARQ,HHS,Amphetamines,,,HRV
127,Europe,South-Eastern Europe,Croatia,0.8,,,2012,15-64,EMCDDA,HHS,Amphetamines,,,HRV
128,Europe,South-Eastern Europe,Croatia,0.7,,,2007,15-64,ESPAD ,SS ,Amphetamines,0.58,0.83,HRV
129,Europe,South-Eastern Europe,Montenegro,0.1,0.2,0.1,2017,15-64,ARQ,HHS,Amphetamines,,,MNE
130,Europe,South-Eastern Europe,Montenegro,0.66,,,2015,15-64,ESPAD/UNODC Estimate,SS,Amphetamines,0.28,1.04,MNE
131,Europe,South-Eastern Europe,Montenegro,0.72,,,2011,15-64,ESPAD,SS,Amphetamines,0.19,1.25,MNE
132,Europe,South-Eastern Europe,Montenegro,0.45,,,2007,15-64,ESPAD ,SS ,Amphetamines,0.07,0.93,MNE
133,Europe,South-Eastern Europe,North Macedonia,0.06,0.08,0.04,2017,15-64,ARQ,HHS,Amphetamines,,,MKD
134,Europe,South-Eastern Europe,North Macedonia,0.33,,,2015,15-64,ESPAD/UNODC Estimate,SS,Amphetamines,0.14,0.53,MKD
135,Europe,South-Eastern Europe,Romania,0.1,0.1,0,2016,15-64,ARQ,HHS,Amphetamines,,,ROU
136,Europe,South-Eastern Europe,Romania,0.1,0.1,0.1,2013,15-64,ARQ,HHS,Amphetamines,,,ROU
137,Europe,South-Eastern Europe,Romania,0.03,,,2010,15-64,EMCDDA,HHS,Amphetamines,,,ROU
138,Europe,South-Eastern Europe,Romania,0.1,,,2004,15-64,UNODC Estimate ,,Amphetamines,,,ROU
139,Europe,South-Eastern Europe,Serbia,0.2,0.2,0.2,2018,15-64,ARQ,HHS,Amphetamines,,,SRB
140,Europe,South-Eastern Europe,Serbia,0.1,0.2,0.1,2014,18-64,Government sources,HHS,Amphetamines,,,SRB
141,Europe,South-Eastern Europe,Serbia,0.24,,,2006,15-64,Government sources,HHS,Amphetamines,0.12,0.47,SRB
142,Europe,South-Eastern Europe,Türkiye,0.02,0.04,0.01,2018,15-64,ARQ,HHS,Amphetamines,,,TUR
143,Europe,South-Eastern Europe,Türkiye,,0.1,,2011,15-64,EMCDDA,HHS,Amphetamines,,,TUR
144,Europe,South-Eastern Europe,Türkiye,0.2,,,2003,15-64,UNODC Estimate,,Amphetamines,,,TUR
145,Europe,Western and Central Europe,Austria,2.31,,,2020,15-64,Government source/UNODC estimate,HHS,Amphetamines,1.81,2.82,AUT
146,Europe,Western and Central Europe,Austria,0.4,0.5,0.4,2015,15-64,Government source,HHS,Amphetamines,0.2,0.6,AUT
147,Europe,Western and Central Europe,Austria,0.5,,,2008,15-64,Government source,HHS,Amphetamines,,,AUT
148,Europe,Western and Central Europe,Austria,0.8,,,2004,15-64,EMCDDA ,HHS ,Amphetamines,,,AUT
149,Europe,Western and Central Europe,Belgium,0.65,,,2018,15-64,ARQ/UNODC Estimate,HHS,Amphetamines,0.5,0.8,BEL
150,Europe,Western and Central Europe,Belgium,0.2,0.3,0.1,2013,15-64,EMCDDA,HHS,Amphetamines,,,BEL
151,Europe,Western and Central Europe,Belgium,0.9,1.4,0.4,2008,15-64,ARQ,HHS,Amphetamines,,,BEL
152,Europe,Western and Central Europe,Belgium,0.85,,,2007,15-64,ESPAD ,SS ,Amphetamines,,,BEL
153,Europe,Western and Central Europe,Cyprus,0.1,0.2,0,2019,15-64,ARQ,HHS,Amphetamines,,,CYP
154,Europe,Western and Central Europe,Cyprus,0.1,0.1,0.1,2016,15-64,ARQ,HHS,Amphetamines,,,CYP
155,Europe,Western and Central Europe,Cyprus,0.3,0.5,0.1,2012,15-64,ARQ,HHS,Amphetamines,,,CYP
156,Europe,Western and Central Europe,Cyprus,0.3,0.4,0.2,2009,15-64,ARQ,HHS,Amphetamines,,,CYP
157,Europe,Western and Central Europe,Cyprus,0.4,0.6,0.1,2006,15-64,ARQ ,,Amphetamines,,,CYP
158,Europe,Western and Central Europe,Czechia,0.5,0.5,0.5,2019,15-64,ARQ,HHS,Amphetamines,,,CZE
159,Europe,Western and Central Europe,Czechia,0.3,0.1,0.5,2018,15-64,ARQ,HHS,Amphetamines,,,CZE
160,Europe,Western and Central Europe,Czechia,0.8,0.6,1,2016,15-64,ARQ,HHS,Amphetamines,,,CZE
161,Europe,Western and Central Europe,Czechia,0.8,0.7,1,2015,15-64,ARQ,HHS,Amphetamines,,,CZE
162,Europe,Western and Central Europe,Czechia,0.8,1.4,0.2,2014,15-64,ARQ,HHS,Amphetamines,,,CZE
163,Europe,Western and Central Europe,Czechia,0.2,,,2013,15-64,ARQ,HHS,Amphetamines,0.2,0.2,CZE
164,Europe,Western and Central Europe,Czechia,0.5,0.7,0.3,2012,15-64,ARQ,HHS,Amphetamines,,,CZE
165,Europe,Western and Central Europe,Czechia,0.9,,,2010,15-64,Government source,HHS,Amphetamines,,,CZE
166,Europe,Western and Central Europe,Czechia,1.7,,,2008,15-64,Government source ,HHS ,Amphetamines,,,CZE
167,Europe,Western and Central Europe,Denmark,0.7,1.1,0.4,2017,16-64,ARQ,HHS,Amphetamines,,,DNK
168,Europe,Western and Central Europe,Denmark,0.6,1,0.3,2013,16-64,ARQ,HHS,Amphetamines,,,DNK
169,Europe,Western and Central Europe,Denmark,0.7,,,2010,16-64,ARQ,HHS,Amphetamines,,,DNK
170,Europe,Western and Central Europe,Denmark,1.2,,,2008,16-64,ARQ ,HHS ,Amphetamines,,,DNK
171,Europe,Western and Central Europe,Estonia,0.94,1.65,0.45,2018,16-64,ARQ,HHS,Amphetamines,,,EST
172,Europe,Western and Central Europe,Estonia,1,1.3,0.8,2008,15-64,ARQ,HHS,Amphetamines,,,EST
173,Europe,Western and Central Europe,Estonia,1.3,,,2003,15-64,ARQ ,HHS ,Amphetamines,,,EST
174,Europe,Western and Central Europe,Finland,1.7,2.5,0.9,2018,15-64,ARQ,HHS,Amphetamines,,,FIN
175,Europe,Western and Central Europe,Finland,1.1,1.6,0.6,2014,15-64,ARQ,HHS,Amphetamines,,,FIN
176,Europe,Western and Central Europe,Finland,0.8,1.2,0.4,2010,15-64,ARQ,HHS,Amphetamines,,,FIN
177,Europe,Western and Central Europe,Finland,0.6,,,2006,15-64,ARQ ,,Amphetamines,,,FIN
178,Europe,Western and Central Europe,France,0.3,0.5,0.1,2017,18-64,EMCDDA,HHS,Amphetamines,,,FRA
179,Europe,Western and Central Europe,France,0.3,0.4,0.2,2014,15-64,ARQ,HHS,Amphetamines,,,FRA
180,Europe,Western and Central Europe,France,0.2,0.3,0.1,2010,15-64,ARQ,,Amphetamines,,,FRA
181,Europe,Western and Central Europe,France,0.2,,,2005,15-64,ARQ ,,Amphetamines,,,FRA
182,Europe,Western and Central Europe,Germany,1.2,1.5,0.9,2018,18-64,ARQ/Academic source,HHS,Amphetamines,0.9,1.6,DEU
183,Europe,Western and Central Europe,Germany,1.1,1.3,0.8,2015,18-64,ARQ/Academic source,HHS,Amphetamines,0.8,1.4,DEU
184,Europe,Western and Central Europe,Germany,0.9,1.4,0.4,2012,18-64,ARQ,HHS,Amphetamines,,,DEU
185,Europe,Western and Central Europe,Germany,0.8,1.1,0.5,2009,18-64,ARQ,HHS,Amphetamines,,,DEU
186,Europe,Western and Central Europe,Germany,0.5,,,2006,18-64,Government source ,HHS ,Amphetamines,,,DEU
187,Europe,Western and Central Europe,Greece,0,0.1,0,2004,15-64,EMCDDA,,Amphetamines,,,GRC
188,Europe,Western and Central Europe,Hungary,0.4,0.5,0.3,2019,18-64,ARQ,HHS,Amphetamines,,,HUN
189,Europe,Western and Central Europe,Hungary,0.45,0.82,0.13,2015,18-64,ARQ,HHS,Amphetamines,,,HUN
190,Europe,Western and Central Europe,Hungary,0.5,,,2007,18-64,ARQ,HHS,Amphetamines,0.2,0.8,HUN
191,Europe,Western and Central Europe,Iceland,1.4,1.8,1,2017,18-64,ARQ,HHS,Amphetamines,,,ISL
192,Europe,Western and Central Europe,Iceland,0.78,,,2015,15-64,ESPAD/UNODC Estimate,SS,Amphetamines,0.21,1.34,ISL
193,Europe,Western and Central Europe,Iceland,0.93,,,2011,15-64,ESPAD,SS,Amphetamines,0.29,1.57,ISL
194,Europe,Western and Central Europe,Iceland,0.74,,,2003,15-64,ESPAD ,SS ,Amphetamines,0.58,0.89,ISL
195,Europe,Western and Central Europe,Ireland,1,1.5,0.5,2019,15-64,ARQ,HHS,Amphetamines,,,IRL
196,Europe,Western and Central Europe,Ireland,0.3,0.5,0.1,2015,15-64,ARQ,HHS,Amphetamines,,,IRL
197,Europe,Western and Central Europe,Ireland,0.4,0.4,0.4,2011,15-64,ARQ,HHS,Amphetamines,,,IRL
198,Europe,Western and Central Europe,Ireland,0.4,,,2007,15-64,Government source ,HHS ,Amphetamines,,,IRL
199,Europe,Western and Central Europe,Italy,0.6,0.8,0.4,2017,15-64,ARQ,HHS,Amphetamines,,,ITA
200,Europe,Western and Central Europe,Italy,0.2,0.3,0.1,2013,15-64,ARQ,HHS,Amphetamines,,,ITA
201,Europe,Western and Central Europe,Italy,0.09,0.09,0.09,2012,15-64,ARQ,HHS,Amphetamines,,,ITA
202,Europe,Western and Central Europe,Italy,0.4,,,2008,15-64,EMCDDA,HHS,Amphetamines,,,ITA
203,Europe,Western and Central Europe,Italy,0.4,,,2005,15-64,EMCDDA ,HHS ,Amphetamines,,,ITA
204,Europe,Western and Central Europe,Latvia,0.6,0.8,0.4,2020,15-64,ARQ,HHS,Amphetamines,,,LVA
205,Europe,Western and Central Europe,Latvia,0.3,0.5,0.2,2015,15-64,ARQ,HHS,Amphetamines,,,LVA
206,Europe,Western and Central Europe,Latvia,0.3,0.5,0.1,2011,15-64,ARQ,HHS,Amphetamines,,,LVA
207,Europe,Western and Central Europe,Latvia,0.9,,,2007,15-64,ARQ ,,Amphetamines,,,LVA
208,Europe,Western and Central Europe,Lithuania,0.3,0.6,0.04,2016,15-64,ARQ,HHS,Amphetamines,,,LTU
209,Europe,Western and Central Europe,Lithuania,0.2,0.5,0,2012,15-64,ARQ,HHS,Amphetamines,,,LTU
210,Europe,Western and Central Europe,Lithuania,0.7,,,2008,15-64,ARQ,HHS,Amphetamines,,,LTU
211,Europe,Western and Central Europe,Lithuania,0.3,,,2004,15-64,ARQ ,HHS ,Amphetamines,,,LTU
212,Europe,Western and Central Europe,Luxembourg,0.15,,,2019,15-64,ARQ/UNODC Estimate,HHS,Amphetamines,0.1,0.2,LUX
213,Europe,Western and Central Europe,Luxembourg,0.06,,,2014,15-64,ARQ/Government source,HHS,Amphetamines,,,LUX
214,Europe,Western and Central Europe,Luxembourg,0.73,,,2010,15-64,ARQ,SS,Amphetamines,0.21,1.25,LUX
215,Europe,Western and Central Europe,Luxembourg,0.98,,,2006,15-64,ARQ,SS,Amphetamines,0.35,1.61,LUX
216,Europe,Western and Central Europe,Luxembourg,0.4,,,1999,15-64,UNODC Estimate ,,Amphetamines,,,LUX
217,Europe,Western and Central Europe,Malta,0,,,2013,15-64,ARQ,HHS,Amphetamines,,,MLT
218,Europe,Western and Central Europe,Malta,0.93,,,2011,15-64,ESPAD,SS,Amphetamines,0.29,1.57,MLT
219,Europe,Western and Central Europe,Malta,0.88,,,2007,15-64,ESPAD ,SS ,Amphetamines,0.59,1.16,MLT
220,Europe,Western and Central Europe,Netherlands,1.6,1.8,1.4,2020,15-64,ARQ,HHS,Amphetamines,,,NLD
221,Europe,Western and Central Europe,Netherlands,2.1,2.8,1.4,2019,15-64,EMCDDA,HHS,Amphetamines,,,NLD
222,Europe,Western and Central Europe,Netherlands,1.4,1.8,0.9,2018,15-64,EMCDDA,HHS,Amphetamines,,,NLD
223,Europe,Western and Central Europe,Netherlands,1.8,2.3,1.2,2017,15-64,EMCDDA,HHS,Amphetamines,1.4,2.1,NLD
224,Europe,Western and Central Europe,Netherlands,1.7,2.4,0.9,2016,15-64,EMCDDA,HHS,Amphetamines,,,NLD
225,Europe,Western and Central Europe,Netherlands,1.6,2,1.1,2015,15-64,EMCDDA,HHS,Amphetamines,,,NLD
226,Europe,Western and Central Europe,Netherlands,1.3,,,2014,16-64,ARQ,HHS,Amphetamines,,,NLD
227,Europe,Western and Central Europe,Netherlands,0.4,,,2009,15-64,ARQ,HHS,Amphetamines,,,NLD
228,Europe,Western and Central Europe,Netherlands,0.3,,,2005,15-64,ARQ ,HHS ,Amphetamines,,,NLD
229,Europe,Western and Central Europe,Norway,0.6,0.9,0.4,2020,16-64,ARQ,HHS,Amphetamines,,,NOR
230,Europe,Western and Central Europe,Norway,0.3,0.5,0.1,2019,16-64,ARQ,HHS,Amphetamines,,,NOR
231,Europe,Western and Central Europe,Norway,0.7,1.1,0.1,2018,16-64,ARQ,HHS,Amphetamines,,,NOR
232,Europe,Western and Central Europe,Norway,0.6,0.8,0.4,2017,16-64,ARQ,HHS,Amphetamines,,,NOR
233,Europe,Western and Central Europe,Norway,0.3,0.3,0.4,2016,16-64,ARQ,HHS,Amphetamines,,,NOR
234,Europe,Western and Central Europe,Norway,0.2,0.3,0,2015,16-64,ARQ,HHS,Amphetamines,,,NOR
235,Europe,Western and Central Europe,Norway,0.6,0.9,0.2,2014,16-64,ARQ,HHS,Amphetamines,,,NOR
236,Europe,Western and Central Europe,Norway,0.6,1.2,0.1,2013,16-64,ARQ,HHS,Amphetamines,,,NOR
237,Europe,Western and Central Europe,Norway,0.7,,,2009,15-64,ARQ,HHS,Amphetamines,,,NOR
238,Europe,Western and Central Europe,Norway,1.1,,,2004,15-64,ARQ ,HHS ,Amphetamines,,,NOR
239,Europe,Western and Central Europe,Poland,0.8,0.9,0.7,2019,15-64,ARQ,HHS,Amphetamines,,,POL
240,Europe,Western and Central Europe,Poland,1.7,1.8,1.5,2016,15-64,ARQ,HHS,Amphetamines,,,POL
241,Europe,Western and Central Europe,Poland,0.2,0.3,,2014,15-64,ARQ,HHS,Amphetamines,,,POL
242,Europe,Western and Central Europe,Poland,0.6,0.8,0.3,2012,15-64,ARQ,HHS,Amphetamines,,,POL
243,Europe,Western and Central Europe,Poland,1.9,,,2010,15-64,ARQ,HHS,Amphetamines,,,POL
244,Europe,Western and Central Europe,Poland,0.7,,,2006,15-64,ARQ ,HHS ,Amphetamines,,,POL
245,Europe,Western and Central Europe,Portugal,0.01,0.01,0,2017,15-64,ARQ,HHS,Amphetamines,,,PRT
246,Europe,Western and Central Europe,Portugal,0.05,0.1,0,2012,15-64,ARQ,HHS,Amphetamines,,,PRT
247,Europe,Western and Central Europe,Portugal,0.2,,,2007,15-64,ARQ,HHS,Amphetamines,,,PRT
248,Europe,Western and Central Europe,Slovakia,0.45,,,2019,15-64,ARQ/UNODC Estimate,HHS,Amphetamines,0.4,0.5,SVK
249,Europe,Western and Central Europe,Slovakia,0.4,0.7,0.1,2015,15-64,ARQ,HHS,Amphetamines,,,SVK
250,Europe,Western and Central Europe,Slovakia,0.12,,,2010,15-64,EMCDDA,HHS,Amphetamines,,,SVK
251,Europe,Western and Central Europe,Slovakia,0.3,,,2006,15-64,EMCDDA,HHS,Amphetamines,,,SVK
252,Europe,Western and Central Europe,Slovakia,0.2,,,2004,15-64,ARQ ,HHS ,Amphetamines,,,SVK
253,Europe,Western and Central Europe,Slovenia,0.4,0.5,0.2,2018,15-64,EMCDDA,HHS,Amphetamines,0.3,0.6,SVN
254,Europe,Western and Central Europe,Slovenia,0.3,0.5,0.1,2012,15-64,ARQ,HHS,Amphetamines,,,SVN
255,Europe,Western and Central Europe,Slovenia,0.72,,,2011,15-64,ESPAD,SS,Amphetamines,0.19,1.25,SVN
256,Europe,Western and Central Europe,Slovenia,0.51,,,2007,15-64,ESPAD ,SS ,Amphetamines,0.45,0.57,SVN
257,Europe,Western and Central Europe,Spain,0.8,1.1,0.5,2020,15-64,ARQ,HHS,Amphetamines,,,ESP
258,Europe,Western and Central Europe,Spain,0.5,0.8,0.2,2017,15-64,EMCDDA,HHS,Amphetamines,0.4,0.6,ESP
259,Europe,Western and Central Europe,Spain,0.58,0.86,0.31,2015,15-64,Government source/UNODC Estimate,HHS,Amphetamines,,,ESP
260,Europe,Western and Central Europe,Spain,0.6,0.8,0.4,2013,15-64,ARQ,HHS,Amphetamines,,,ESP
261,Europe,Western and Central Europe,Spain,0.6,0.9,0.3,2011,15-64,ARQ,HHS,Amphetamines,,,ESP
262,Europe,Western and Central Europe,Spain,0.6,,,2009,15-64,ARQ ,HHS ,Amphetamines,,,ESP
263,Europe,Western and Central Europe,Sweden,0.7,,,2017,17-64,ARQ,HHS,Amphetamines,,,SWE
264,Europe,Western and Central Europe,Sweden,0.72,0.96,0.47,2013,17-64,ARQ,HHS,Amphetamines,,,SWE
265,Europe,Western and Central Europe,Sweden,0.8,,,2008,15-64,ARQ,HHS,Amphetamines,,,SWE
266,Europe,Western and Central Europe,Sweden,0.39,,,2007,15-64,ESPAD ,SS ,Amphetamines,,,SWE
267,Europe,Western and Central Europe,Switzerland,0.32,,,2016,15-64,UNODC Estimate,HHS,Amphetamines,0.3,0.34,CHE
268,Europe,Western and Central Europe,Switzerland,0.43,,,2015,15-64,UNODC Estimate,HHS,Amphetamines,0.36,0.5,CHE
269,Europe,Western and Central Europe,Switzerland,0.27,0.29,0.26,2013,15-64,ARQ,HHS,Amphetamines,,,CHE
270,Europe,Western and Central Europe,Switzerland,0.08,,,2012,15+,ARQ,HHS,Amphetamines,0.08,0.09,CHE
271,Europe,Western and Central Europe,Switzerland,0.63,,,2007,15-64,ESPAD,SS,Amphetamines,0.57,0.69,CHE
272,Europe,Western and Central Europe,United Kingdom (England and Wales),0.32,0.38,0.26,2019,16-64,ARQ,HHS,Amphetamines,,,GBR
273,Europe,Western and Central Europe,United Kingdom (England and Wales),0.57,0.76,0.39,2018,16-59,Government source,HHS,Amphetamines,,,GBR
274,Europe,Western and Central Europe,United Kingdom (England and Wales),0.52,0.69,0.34,2017,16-59,Government source,HHS,Amphetamines,,,GBR
275,Europe,Western and Central Europe,United Kingdom (England and Wales),0.46,0.59,0.34,2016,16-59,Government source,HHS,Amphetamines,,,GBR
276,Europe,Western and Central Europe,United Kingdom (England and Wales),0.61,0.82,0.4,2015,16-59,Government source,HHS,Amphetamines,,,GBR
277,Europe,Western and Central Europe,United Kingdom (England and Wales),0.6,0.8,0.4,2014,16-59,ARQ,HHS,Amphetamines,,,GBR
278,Europe,Western and Central Europe,United Kingdom (England and Wales),0.8,1.1,0.5,2013,16-59,ARQ,HHS,Amphetamines,,,GBR
279,Europe,Western and Central Europe,United Kingdom (England and Wales),0.7,0.9,0.4,2012,16-59,Government source,HHS,Amphetamines,,,GBR
280,Europe,Western and Central Europe,United Kingdom (England and Wales),0.8,,,2011,16-59,Government source,HHS,Amphetamines,,,GBR
281,Europe,Western and Central Europe,United Kingdom (England and Wales),1.1,,,2010,16-59,Government source ,HHS ,Amphetamines,,,GBR
282,Europe,Western and Central Europe,United Kingdom (Northern Ireland),0.5,,,2014,15-64,Government source,HHS,Amphetamines,,,GBR
283,Europe,Western and Central Europe,United Kingdom (Northern Ireland),1.1,,,2011,15-64,Government source,HHS,Amphetamines,,,GBR
284,Europe,Western and Central Europe,United Kingdom (Northern Ireland),1,,,2006,15-64,Government source ,HHS ,Amphetamines,,,GBR
285,Europe,Western and Central Europe,United Kingdom (Scotland),0.82,1.37,0.29,2014,16-64,Government source,HHS,Amphetamines,,,GBR
286,Europe,Western and Central Europe,United Kingdom (Scotland),0.9,1.4,0.3,2013,16-64,Government source,HHS,Amphetamines,,,GBR
287,Europe,Western and Central Europe,United Kingdom (Scotland),1.2,,,2011,16-64,Government source,HHS,Amphetamines,,,GBR
288,Europe,Western and Central Europe,United Kingdom (Scotland),1.2,,,2010,16-64,Government source ,HHS ,Amphetamines,,,GBR
289,Oceania,Australia and New Zealand,Australia,1.3,1.8,0.8,2019,14+,ARQ,HHS,Amphetamines,,,AUS
290,Oceania,Australia and New Zealand,Australia,1.4,1.8,1,2016,14+,ARQ,HHS,Amphetamines,,,AUS
291,Oceania,Australia and New Zealand,Australia,2.1,2.7,1.5,2013,14+,Government source,HHS,Amphetamines,,,AUS
292,Oceania,Australia and New Zealand,Australia,2.1,,,2010,14+,ARQ,HHS,Amphetamines,,,AUS
293,Oceania,Australia and New Zealand,Australia,2.7,,,2007,15-64,Government source ,HHS ,Amphetamines,,,AUS
294,Oceania,Australia and New Zealand,New Zealand,1,2,1,2020,18+,ARQ,HHS,Amphetamines,,,NZL
295,Oceania,Australia and New Zealand,New Zealand,0.8,1.1,0.5,2018,16-64,ARQ ,HHS ,Amphetamines,,,NZL
296,Oceania,Australia and New Zealand,New Zealand,1,1.5,0.6,2017,16-64,Government source,HHS,Amphetamines,,,NZL
297,Oceania,Australia and New Zealand,New Zealand,1.1,,,2016,16-64,ARQ,HHS,Amphetamines,,,NZL
298,Oceania,Australia and New Zealand,New Zealand,1.1,1.5,0.7,2014,15-64,Government source,HHS,Amphetamines,0.8,1.4,NZL
299,Oceania,Australia and New Zealand,New Zealand,2.1,,,2007,16-64,Government source,HHS,Amphetamines,,,NZL
300,Oceania,Australia and New Zealand,New Zealand,2.3,,,2006,15-64,ARQ ,HHS ,Amphetamines,,,NZL
0,Africa,East Africa,Kenya,0.25,,,2007,15-65,Government source,HHS,Ecstasy,0.2,0.3,KEN
1,Africa,North Africa,Algeria,0.02,0.02,0.01,2010,12+,ARQ,HHS,Ecstasy,,,DZA
2,Africa,Southern Africa,South Africa,0.31,,,2011,15-64,ARQ,SS,Ecstasy,0.24,0.38,ZAF
3,Africa,Southern Africa,South Africa,0.4,,,2004,15-64,UNODC Estimate ,,Ecstasy,,,ZAF
4,Africa,Southern Africa,Zambia,0.3,,,2003,15-64,UNODC Estimate,,Ecstasy,,,ZMB
5,Africa,West and Central Africa,Cabo Verde,0.06,,,2004,15-64,UNODC Estimate,,Ecstasy,,,CPV
6,Africa,West and Central Africa,Nigeria,0.34,,,2017,15-64,Government/UNODC,HHS/I,Ecstasy,0,1.25,NGA
7,Americas,Caribbean,Bahamas,0.11,,,2008,15-64,Government source,SS,Ecstasy,0.04,0.6,BHS
8,Americas,Caribbean,Bahamas,0.14,,,2003,15-64,UNODC Estimate ,,Ecstasy,,,BHS
9,Americas,Caribbean,Barbados,0.3,,,2006,12-65,CICAD,HHS,Ecstasy,,,BRB
10,Americas,Caribbean,Dominican Republic,0.23,,,2010,12-65,CICAD,HHS,Ecstasy,,,DOM
11,Americas,Caribbean,Dominican Republic,0.05,,,2008,15-64,Government source,SS,Ecstasy,0.02,0.52,DOM
12,Americas,Caribbean,Dominican Republic,0.16,,,2000,15-64,UNODC Estimate ,,Ecstasy,,,DOM
13,Americas,Caribbean,Haiti,0.24,,,2010,15-64,UNODC Estimate,SS,Ecstasy,0.06,0.41,HTI
14,Americas,Caribbean,Haiti,0.56,,,2005,15-64,UNODC Estimate,SS,Ecstasy,0.11,1.17,HTI
15,Americas,Caribbean,Jamaica,0.23,,,2010,15-64,UNODC Estimate,SS,Ecstasy,0.06,0.4,JAM
16,Americas,Caribbean,Puerto Rico,0.42,,,2005,15-64,Government source,SS,Ecstasy,0.09,0.99,PRI
17,Americas,Caribbean,Saint Lucia,0.17,,,2010,15-64,UNODC Estimate,SS,Ecstasy,0.03,0.3,LCA
18,Americas,Caribbean,Trinidad and Tobago,0.14,,,2010,15-64,UNODC Estimate,SS,Ecstasy,0.02,0.26,TTO
19,Americas,Caribbean,Trinidad and Tobago,0.13,,,2006,15-64,UNODC Estimate,SS,Ecstasy,0.04,0.62,TTO
20,Americas,Caribbean,Trinidad and Tobago,0.11,,,2005,15-64,UNODC Estimate ,,Ecstasy,,,TTO
21,Americas,Central America,Belize,0.5,,,2005,12-65,Government source,HHS,Ecstasy,,,BLZ
22,Americas,Central America,Costa Rica,0.42,0.57,0.27,2015,12-70,ARQ,HHS,Ecstasy,,,CRI
23,Americas,Central America,Costa Rica,0.46,0.63,0.29,2015,15-64,ARQ,HHS,Ecstasy,,,CRI
24,Americas,Central America,Costa Rica,0.2,0.32,0.07,2010,15-64,ARQ,HHS,Ecstasy,,,CRI
25,Americas,Central America,Costa Rica,0.15,,,2006,12-70,ARQ,SS,Ecstasy,0.11,0.38,CRI
26,Americas,Central America,El Salvador,0.02,0.04,0,2014,12-65,Government source,HHS,Ecstasy,,,SLV
27,Americas,Central America,El Salvador,0.02,,,2005,15-64,UNODC Estimate,HHS,Ecstasy,0,0.03,SLV
28,Americas,Central America,Guatemala,0.08,,,2005,15-64,UNODC Estimate,,Ecstasy,,,GTM
29,Americas,Central America,Honduras,0.08,,,2005,15-64,UNODC Estimate,,Ecstasy,,,HND
30,Americas,Central America,Nicaragua,0.01,,,2006,12-65,UNODC Estimate,"HHS, c",Ecstasy,0,0.02,NIC
31,Americas,Central America,Panama,0.04,,,2015,12-65,ARQ,HHS,Ecstasy,,,PAN
32,Americas,Central America,Panama,0.4,,,2003,15-64,UNODC Estimate,,Ecstasy,,,PAN
33,Americas,North America,Canada,1.1,1.3,1,2019,15+,ARQ/Government source,HHS,Ecstasy,0.7,1.6,CAN
34,Americas,North America,Canada,0.9,1.2,0.6,2017,15+,ARQ,HHS,Ecstasy,,,CAN
35,Americas,North America,Canada,0.91,1.17,0.64,2015,15-64,ARQ,HHS,Ecstasy,,,CAN
36,Americas,North America,Canada,0.5,0.8,0.2,2013,15-64,ARQ,HHS,Ecstasy,,,CAN
37,Americas,North America,Canada,0.8,,,2012,15-64,ARQ,HHS,Ecstasy,,,CAN
38,Americas,North America,Canada,0.8,,,2011,15-64,ARQ,HHS,Ecstasy,,,CAN
39,Americas,North America,Canada,0.88,,,2010,15-64,ARQ ,HHS ,Ecstasy,,,CAN
40,Americas,North America,Mexico,0.1,,,2011,12-65,Government source,HHS,Ecstasy,,,MEX
41,Americas,North America,United States of America,1.2,1.3,1.1,2020,15-64,ARQ,HHS,Ecstasy,,,USA
42,Americas,North America,United States of America,1.2,1.4,1,2018,15-64,ARQ,HHS,Ecstasy,,,USA
43,Americas,North America,United States of America,1.2,1.4,0.9,2017,15-64,ARQ,HHS,Ecstasy,,,USA
44,Americas,North America,United States of America,1.2,1.4,0.9,2016,15-64,ARQ,HHS,Ecstasy,,,USA
45,Americas,North America,United States of America,1.2,1.6,0.9,2015,15-64,ARQ,HHS,Ecstasy,,,USA
46,Americas,North America,United States of America,1.1,1.4,0.9,2014,15-64,ARQ,HHS,Ecstasy,,,USA
47,Americas,North America,United States of America,1.2,1.5,1,2013,15-64,ARQ,HHS,Ecstasy,,,USA
48,Americas,North America,United States of America,1.2,,,2012,15-64,ARQ,HHS,Ecstasy,,,USA
49,Americas,North America,United States of America,1.2,,,2011,15-64,ARQ,HHS,Ecstasy,,,USA
50,Americas,North America,United States of America,1.3,,,2010,15-64,ARQ,HHS,Ecstasy,,,USA
51,Americas,South America,Argentina,0.33,0.46,0.22,2017,15-64,ARQ,HHS,Ecstasy,,,ARG
52,Americas,South America,Argentina,0.1,0.1,0.1,2011,16-65,ARQ,HHS,Ecstasy,,,ARG
53,Americas,South America,Argentina,0.2,,,2008,12-65,Government source ,HHS,Ecstasy,,,ARG
54,Americas,South America,Bolivia (Plurinational State of),0.06,0.05,0.07,2018,15-64,ARQ,HHS,Ecstasy,,,BOL
55,Americas,South America,Bolivia (Plurinational State of),0.01,0.02,0,2014,12-65,ARQ,HHS,Ecstasy,,,BOL
56,Americas,South America,Bolivia (Plurinational State of),0.01,0.02,0,2013,12-65,ARQ,HHS,Ecstasy,,,BOL
57,Americas,South America,Bolivia (Plurinational State of),0.1,0,0.1,2007,12-65,ARQ,HHS,Ecstasy,,,BOL
58,Americas,South America,Brazil,0.25,0.16,0.34,2012,15-64,Government source,HHS,Ecstasy,,,BRA
59,Americas,South America,Brazil,0.2,,,2005,15-64,UNODC Estimate ,,Ecstasy,,,BRA
60,Americas,South America,Chile,0.3,0.54,0.08,2020,15-64,ARQ,HHS,Ecstasy,,,CHL
61,Americas,South America,Chile,0.27,0.36,0.17,2018,15-64,ARQ,HHS,Ecstasy,,,CHL
62,Americas,South America,Chile,0.06,0.09,0.03,2016,15-64,ARQ,HHS,Ecstasy,,,CHL
63,Americas,South America,Chile,0.08,0.1,0.05,2014,15-64,ARQ,HHS,Ecstasy,,,CHL
64,Americas,South America,Chile,0.05,0.1,0,2012,15-64,ARQ,HHS,Ecstasy,,,CHL
65,Americas,South America,Chile,0.01,,,2010,15-64,ARQ,HHS,Ecstasy,,,CHL
66,Americas,South America,Chile,0.1,,,2008,15-64,ARQ ,HHS ,Ecstasy,,,CHL
67,Americas,South America,Colombia,0.16,0.22,0.1,2019,12-65,Government source,HHS,Ecstasy,0.11,0.21,COL
68,Americas,South America,Colombia,0.19,0.29,0.1,2013,12-65,ARQ,HHS,Ecstasy,0.09,0.29,COL
69,Americas,South America,Colombia,0.28,0.41,0.17,2008,12-65,ARQ,HHS,Ecstasy,0.17,0.39,COL
70,Americas,South America,Ecuador,0.01,0.01,0,2013,12-65,ARQ,HHS,Ecstasy,,,ECU
71,Americas,South America,Ecuador,0.2,,,2005,15-64,UNODC Estimate ,,Ecstasy,,,ECU
72,Americas,South America,Guyana,0.28,,,2010,15-64,UNODC Estimate,SS,Ecstasy,0.08,0.48,GUY
73,Americas,South America,Guyana,0.13,,,2002,15-64,UNODC Estimate,,Ecstasy,,,GUY
74,Americas,South America,Paraguay,0.09,,,2005,15-64,UNODC Estimate,,Ecstasy,,,PRY
75,Americas,South America,Peru,0.301,,,2017,12-65,Government source/UNODC Estimates,SS,Ecstasy,0.027,0.575,PER
76,Americas,South America,Peru,0.04,,,2010,12-65,Government source,HHS,Ecstasy,,,PER
77,Americas,South America,Peru,0.04,,,2006,12-64,ARQ,HHS,Ecstasy,,,PER
78,Americas,South America,Suriname,0.1,0.1,0.2,2013,12-65,ARQ,HHS,Ecstasy,,,SUR
79,Americas,South America,Suriname,0.1,,,2007,12-65,Government source,HHS,Ecstasy,0.01,0.21,SUR
80,Americas,South America,Suriname,0.1,,,2002,15-65,UNODC Estimate ,,Ecstasy,,,SUR
81,Americas,South America,Uruguay,0.9,1.1,0.6,2018,15-65,ARQ,HHS,Ecstasy,,,URY
82,Americas,South America,Uruguay,0.4,0.7,0.1,2014,15-65,ARQ,HHS,Ecstasy,,,URY
83,Americas,South America,Uruguay,0.2,0.2,0.1,2011,15-65,ARQ,HHS,Ecstasy,,,URY
84,Americas,South America,Uruguay,0.1,,,2006,15-64,ARQ ,HHS ,Ecstasy,,,URY
85,Americas,South America,Venezuela (Bolivarian Republic of),0.13,,,2011,15-64,Government source,HHS,Ecstasy,,,VEN
86,Americas,South America,Venezuela (Bolivarian Republic of),0.04,,,2005,15-64,Government source ,HHS ,Ecstasy,,,VEN
87,Asia,Central Asia and Transcaucasia,Armenia,0.1,,,2005,15-64,UNODC Estimate,HHS,Ecstasy,,,ARM
88,Asia,Central Asia and Transcaucasia,Georgia,0.1,0.1,0,2015,18-64,ARQ,HHS,Ecstasy,,,GEO
89,Asia,Central Asia and Transcaucasia,Georgia,0.54,,,2009,15-64,ARQ,SS,Ecstasy,0.17,0.91,GEO
90,Asia,Central Asia and Transcaucasia,Georgia,1.72,,,2007,15-64,ARQ ,SS ,Ecstasy,0.7,2.4,GEO
91,Asia,East and South-East Asia,Cambodia,0.14,,,2003,15-64,UNODC Estimate,,Ecstasy,,,KHM
92,Asia,East and South-East Asia,"China, Taiwan Province of China",0.52,,,2005,15-64,AMCEWG,,Ecstasy,,,TWN
93,Asia,East and South-East Asia,Indonesia,0.37,0.72,0.08,2019,15-64,ARQ,HHS,Ecstasy,,,IDN
94,Asia,East and South-East Asia,Indonesia,0.27,,,2015,10-59,Government source,HHS,Ecstasy,,,IDN
95,Asia,East and South-East Asia,Indonesia,0.03,0.05,0,2015,10-60,ARQ,HHS,Ecstasy,,,IDN
96,Asia,East and South-East Asia,Indonesia,0.19,,,2010,10-60,ARQ,HHS,Ecstasy,,,IDN
97,Asia,East and South-East Asia,Indonesia,0.2,,,2008,10-59,ARQ ,HHS ,Ecstasy,,,IDN
98,Asia,East and South-East Asia,Japan,0.03,,,2019,15-64,ARQ,HHS,Ecstasy,,,JPN
99,Asia,East and South-East Asia,Japan,0,,,2017,15-64,ARQ,HHS,Ecstasy,,,JPN
100,Asia,East and South-East Asia,Japan,0.1,,,2009,15-64,UNODC Estimate,HHS,Ecstasy,,,JPN
101,Asia,East and South-East Asia,Malaysia,0.44,,,2003,15-64,UNODC Estimate,,Ecstasy,,,MYS
102,Asia,East and South-East Asia,Philippines,0.02,,,2012,10-69,ARQ,HHS,Ecstasy,,,PHL
103,Asia,East and South-East Asia,Philippines,0.18,,,2004,15-64,Government source,HHS,Ecstasy,,,PHL
104,Asia,East and South-East Asia,Republic of Korea,0.08,,,2004,15-64,ARQ,HHS,Ecstasy,0.04,0.08,PRK
105,Asia,East and South-East Asia,Thailand,0.439,,,2019,12-65,Government source,HHS,Ecstasy,,,THA
106,Asia,East and South-East Asia,Thailand,0.3,,,2007,15-64,ARQ,HHS,Ecstasy,,,THA
107,Asia,East and South-East Asia,Viet Nam,0.22,,,2003,15-64,UNODC Estimate,,Ecstasy,,,VNM
108,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),0.08,,,2011,15-64,Government source,,Ecstasy,,,IRN
109,Asia,Near and Middle East/South-West Asia,Israel,0.6,0.5,0.7,2020,18-86,ARQ,HHS,Ecstasy,,,ISR
110,Asia,Near and Middle East/South-West Asia,Israel,0.6,0.9,0.3,2016,18-65,ARQ,HHS,Ecstasy,,,ISR
111,Asia,Near and Middle East/South-West Asia,Israel,1,1.27,0.58,2009,18-40,ARQ,HHS,Ecstasy,,,ISR
112,Asia,Near and Middle East/South-West Asia,Israel,0.7,,,2005,18-40,ARQ ,HHS ,Ecstasy,,,ISR
113,Asia,Near and Middle East/South-West Asia,Lebanon,1,,,2009,15-64,Government source/ NGO/Academic research,SS,Ecstasy,0.3,1.7,LBN
114,Asia,Near and Middle East/South-West Asia,Lebanon,0.5,,,2001,15-64,UNODC Estimate ,,Ecstasy,,,LBN
115,Europe,Eastern Europe,Belarus,0.31,,,2007,15-64,ESPAD,SS,Ecstasy,0.3,0.33,BLR
116,Europe,Eastern Europe,Republic of Moldova,0.1,,,2010,15-64,Government sources,HHS,Ecstasy,,,MDA
117,Europe,Eastern Europe,Republic of Moldova,0.32,,,2008,15-64,Government source,HHS ,Ecstasy,,,MDA
118,Europe,Eastern Europe,Russian Federation,0.68,,,2007,15-64,ESPAD/UNODC Estimate,SS,Ecstasy,,,RUS
119,Europe,Eastern Europe,Ukraine,0.57,,,2015,15-64,ESPAD/UNODC Estimate,SS,Ecstasy,0.01,1.12,UKR
120,Europe,Eastern Europe,Ukraine,0.93,,,2011,15-64,ESPAD,SS,Ecstasy,0.37,1.49,UKR
121,Europe,Eastern Europe,Ukraine,0.68,,,2007,15-64,ESPAD ,SS ,Ecstasy,0.68,0.69,UKR
122,Europe,South-Eastern Europe,Albania,0.2,,,2014,15-64,Public health research,HHS,Ecstasy,,,ALB
123,Europe,South-Eastern Europe,Albania,0.2,0.5,0.1,2014,15-64,ARQ,HHS,Ecstasy,,,ALB
124,Europe,South-Eastern Europe,Albania,1.19,,,2011,15-64,ESPAD,SS,Ecstasy,0.54,1.84,ALB
125,Europe,South-Eastern Europe,Albania,0.97,,,2006,15-64,Government source,SS ,Ecstasy,0.26,2.08,ALB
126,Europe,South-Eastern Europe,Bosnia and Herzegovina,0.5,,,2011,15-64,ARQ,SS,Ecstasy,0.11,0.88,BIH
127,Europe,South-Eastern Europe,Bosnia and Herzegovina,1.42,,,2008,15-64,ESPAD ,SS ,Ecstasy,0.37,2.67,BIH
128,Europe,South-Eastern Europe,Bulgaria,0.2,0.2,0.3,2020,15-64,ARQ,HHS,Ecstasy,,,BGR
129,Europe,South-Eastern Europe,Bulgaria,1.3,1.8,0.7,2016,15-64,ARQ,HHS,Ecstasy,,,BGR
130,Europe,South-Eastern Europe,Bulgaria,1.2,1.7,0.8,2012,15-64,ARQ,HHS,Ecstasy,,,BGR
131,Europe,South-Eastern Europe,Bulgaria,0.7,,,2008,15-64,ARQ,HHS,Ecstasy,,,BGR
132,Europe,South-Eastern Europe,Croatia,1.2,1.9,0.5,2019,15-64,ARQ,HHS,Ecstasy,,,HRV
133,Europe,South-Eastern Europe,Croatia,0.6,1,0.2,2015,15-64,ARQ,HHS,Ecstasy,,,HRV
134,Europe,South-Eastern Europe,Croatia,0.4,,,2011,15-64,ARQ,HHS,Ecstasy,,,HRV
135,Europe,South-Eastern Europe,Croatia,0.79,,,2007,15-64,ESPAD ,SS ,Ecstasy,0.78,0.8,HRV
136,Europe,South-Eastern Europe,Montenegro,0.9,1.2,0.5,2017,15-64,ARQ,HHS,Ecstasy,,,MNE
137,Europe,South-Eastern Europe,Montenegro,0.9,,,2015,15-64,ESPAD/UNODC Estimate,SS,Ecstasy,0.24,1.57,MNE
138,Europe,South-Eastern Europe,Montenegro,0.86,,,2011,15-64,ESPAD,SS,Ecstasy,0.31,1.4,MNE
139,Europe,South-Eastern Europe,Montenegro,0.45,,,2008,15-64,ESPAD ,SS ,Ecstasy,0.12,1.47,MNE
140,Europe,South-Eastern Europe,North Macedonia,0.8,1.2,0.4,2017,15-64,ARQ,HHS,Ecstasy,,,MKD
141,Europe,South-Eastern Europe,North Macedonia,0.63,,,2015,15-64,ESPAD/UNODC Estimate,SS,Ecstasy,0.12,1.14,MKD
142,Europe,South-Eastern Europe,North Macedonia,0.75,,,2008,15-64,ESPAD,SS,Ecstasy,0.2,1.82,MKD
143,Europe,South-Eastern Europe,North Macedonia,0.1,,,1999,15-64,UNODC Estimate ,,Ecstasy,,,MKD
144,Europe,South-Eastern Europe,Romania,0.5,0.7,0.2,2019,15-64,ARQ,HHS,Ecstasy,,,ROU
145,Europe,South-Eastern Europe,Romania,0.1,0.2,0.1,2016,15-64,ARQ,HHS,Ecstasy,,,ROU
146,Europe,South-Eastern Europe,Romania,0.2,0.1,0.2,2013,15-64,EMCDDA,HHS,Ecstasy,,,ROU
147,Europe,South-Eastern Europe,Romania,0.2,,,2010,15-64,ARQ,HHS,Ecstasy,,,ROU
148,Europe,South-Eastern Europe,Romania,0.1,,,2007,15-64,ARQ ,HHS ,Ecstasy,,,ROU
149,Europe,South-Eastern Europe,Serbia,0.4,0.3,0.4,2018,15-64,ARQ ,HHS ,Ecstasy,,,SRB
150,Europe,South-Eastern Europe,Serbia,0.1,0.1,0.1,2014,18-64,Government sources,HHS,Ecstasy,,,SRB
151,Europe,South-Eastern Europe,Serbia,0.63,,,2008,15-64,Government sources,HHS,Ecstasy,0.39,0.86,SRB
152,Europe,South-Eastern Europe,Türkiye,0.1,0.2,,2018,15-64,ARQ,HHS,Ecstasy,,,TUR
153,Europe,South-Eastern Europe,Türkiye,0.1,0.2,,2017,15-64,EMCDDA,HHS,Ecstasy,,,TUR
154,Europe,South-Eastern Europe,Türkiye,,0.1,,2011,15-64,ARQ,HHS,Ecstasy,,,TUR
155,Europe,South-Eastern Europe,Türkiye,0.26,,,2003,15-64,UNODC Estimate,,Ecstasy,,,TUR
156,Europe,Western and Central Europe,Austria,1.47,,,2020,15-64,Government source,HHS,Ecstasy,1.15,1.84,AUT
157,Europe,Western and Central Europe,Austria,0.4,0.5,0.4,2015,15-64,Government source,HHS,Ecstasy,0.2,0.7,AUT
158,Europe,Western and Central Europe,Austria,0.5,,,2008,15-64,ARQ,HHS,Ecstasy,,,AUT
159,Europe,Western and Central Europe,Austria,0.9,,,2004,15-64,EMCDDA ,HHS ,Ecstasy,,,AUT
160,Europe,Western and Central Europe,Belgium,1.2,1.9,0.5,2018,15-64,ARQ,HHS,Ecstasy,,,BEL
161,Europe,Western and Central Europe,Belgium,0.3,0.4,0.3,2013,15-64,EMCDDA,HHS,Ecstasy,,,BEL
162,Europe,Western and Central Europe,Belgium,0.9,,,2008,15-64,ARQ,HHS,Ecstasy,,,BEL
163,Europe,Western and Central Europe,Belgium,1.12,,,2007,15-64,ESPAD ,SS ,Ecstasy,,,BEL
164,Europe,Western and Central Europe,Cyprus,0.3,0.5,0.1,2019,15-64,ARQ,HHS,Ecstasy,,,CYP
165,Europe,Western and Central Europe,Cyprus,0.1,0.1,0.1,2016,15-64,ARQ,HHS,Ecstasy,,,CYP
166,Europe,Western and Central Europe,Cyprus,0.3,0.5,0.1,2012,15-64,ARQ,HHS,Ecstasy,,,CYP
167,Europe,Western and Central Europe,Cyprus,0.6,1,0.2,2009,15-64,ARQ,HHS,Ecstasy,,,CYP
168,Europe,Western and Central Europe,Cyprus,1,1.8,0.2,2006,15-64,ARQ ,,Ecstasy,,,CYP
169,Europe,Western and Central Europe,Czechia,1.5,1.7,1.2,2019,15-64,ARQ,HHS,Ecstasy,,,CZE
170,Europe,Western and Central Europe,Czechia,0.9,1.1,0.7,2018,15-64,ARQ,HHS,Ecstasy,,,CZE
171,Europe,Western and Central Europe,Czechia,0.8,1.3,0.3,2017,15-64,EMCDDA,HHS,Ecstasy,,,CZE
172,Europe,Western and Central Europe,Czechia,1.6,2.4,0.9,2016,15-64,ARQ,HHS,Ecstasy,,,CZE
173,Europe,Western and Central Europe,Czechia,1.3,1.6,1,2015,15-64,ARQ,HHS,Ecstasy,,,CZE
174,Europe,Western and Central Europe,Czechia,1.6,2.3,0.9,2014,15-64,ARQ,HHS,Ecstasy,,,CZE
175,Europe,Western and Central Europe,Czechia,1.1,1.2,0.9,2013,15-64,ARQ,HHS,Ecstasy,,,CZE
176,Europe,Western and Central Europe,Czechia,0.6,0.7,0.5,2012,15-64,ARQ,HHS,Ecstasy,,,CZE
177,Europe,Western and Central Europe,Czechia,2.2,,,2010,15-64,ARQ,HHS,Ecstasy,,,CZE
178,Europe,Western and Central Europe,Czechia,3.6,,,2008,15-64,Government source,HHS ,Ecstasy,,,CZE
179,Europe,Western and Central Europe,Denmark,0.5,0.8,0.3,2017,16-64,ARQ,HHS,Ecstasy,,,DNK
180,Europe,Western and Central Europe,Denmark,0.2,0.4,0.1,2013,16-64,ARQ,HHS,Ecstasy,,,DNK
181,Europe,Western and Central Europe,Denmark,0.3,,,2010,16-64,ARQ,HHS,Ecstasy,,,DNK
182,Europe,Western and Central Europe,Denmark,0.4,,,2008,16-64,ARQ ,HHS ,Ecstasy,,,DNK
183,Europe,Western and Central Europe,Estonia,0.98,1.54,0.6,2018,16-64,ARQ,HHS,Ecstasy,,,EST
184,Europe,Western and Central Europe,Estonia,1.2,1.6,0.8,2008,15-64,ARQ,HHS,Ecstasy,,,EST
185,Europe,Western and Central Europe,Estonia,1.7,,,2003,15-64,ARQ ,HHS ,Ecstasy,,,EST
186,Europe,Western and Central Europe,Finland,1.4,1.9,0.8,2018,15-64,ARQ,HHS,Ecstasy,,,FIN
187,Europe,Western and Central Europe,Finland,1.1,1.6,0.5,2014,15-64,ARQ,HHS,Ecstasy,,,FIN
188,Europe,Western and Central Europe,Finland,0.4,0.6,0.2,2010,15-64,ARQ,HHS,Ecstasy,,,FIN
189,Europe,Western and Central Europe,Finland,0.5,,,2006,15-64,ARQ ,,Ecstasy,,,FIN
190,Europe,Western and Central Europe,France,1,1.5,0.6,2017,15-64,ARQ,HHS,Ecstasy,,,FRA
191,Europe,Western and Central Europe,France,0.6,0.8,0.3,2017,18-64,EMCDDA,HHS,Ecstasy,,,FRA
192,Europe,Western and Central Europe,France,0.9,1.2,0.6,2014,15-64,ARQ,HHS,Ecstasy,,,FRA
193,Europe,Western and Central Europe,France,0.3,0.4,0.1,2010,15-64,ARQ,HHS,Ecstasy,,,FRA
194,Europe,Western and Central Europe,France,0.5,,,2005,15-64,ARQ ,,Ecstasy,,,FRA
195,Europe,Western and Central Europe,Germany,1.08,1.18,0.97,2018,18-64,ARQ,HHS,Ecstasy,,,DEU
196,Europe,Western and Central Europe,Germany,0.6,0.7,0.6,2015,18-64,ARQ/Academic,HHS,Ecstasy,0.5,0.9,DEU
197,Europe,Western and Central Europe,Germany,0.4,0.7,0.1,2012,18-64,ARQ,HHS,Ecstasy,,,DEU
198,Europe,Western and Central Europe,Germany,0.4,0.6,0.2,2009,18-64,ARQ,HHS,Ecstasy,,,DEU
199,Europe,Western and Central Europe,Germany,0.4,,,2006,18-64,Government source ,HHS ,Ecstasy,,,DEU
200,Europe,Western and Central Europe,Greece,0.2,0.3,0.1,2015,18-64,ARQ,HHS,Ecstasy,,,GRC
201,Europe,Western and Central Europe,Greece,0.2,0.2,0.1,2004,15-64,EMCDDA,,Ecstasy,,,GRC
202,Europe,Western and Central Europe,Hungary,0.6,1.2,0.3,2019,18-64,ARQ,HHS,Ecstasy,,,HUN
203,Europe,Western and Central Europe,Hungary,0.88,0.99,0.81,2015,18-64,ARQ,HHS,Ecstasy,,,HUN
204,Europe,Western and Central Europe,Hungary,0.5,,,2007,18-64,ARQ,HHS,Ecstasy,0.2,0.8,HUN
205,Europe,Western and Central Europe,Iceland,0.52,,,2015,15-64,ESPAD/UNODC Estimate,SS,Ecstasy,0.37,0.67,ISL
206,Europe,Western and Central Europe,Iceland,0.58,,,2011,15-64,ESPAD,SS,Ecstasy,0.16,1,ISL
207,Europe,Western and Central Europe,Iceland,0.5,,,2007,15-64,ESPAD ,SS ,Ecstasy,,,ISL
208,Europe,Western and Central Europe,Ireland,2.7,3.9,1.6,2019,15-64,ARQ,HHS,Ecstasy,,,IRL
209,Europe,Western and Central Europe,Ireland,2.1,3.1,1.1,2015,15-64,ARQ,HHS,Ecstasy,,,IRL
210,Europe,Western and Central Europe,Ireland,0.5,0.6,0.3,2011,15-64,ARQ,HHS,Ecstasy,,,IRL
211,Europe,Western and Central Europe,Ireland,1.2,,,2007,15-64,Government source ,,Ecstasy,,,IRL
212,Europe,Western and Central Europe,Italy,0.35,0.45,0.26,2017,15-64,ARQ,HHS,Ecstasy,,,ITA
213,Europe,Western and Central Europe,Italy,0.4,0.6,0.3,2013,15-64,ARQ,HHS,Ecstasy,,,ITA
214,Europe,Western and Central Europe,Italy,0.06,0.11,0.02,2012,15-64,ARQ,HHS,Ecstasy,,,ITA
215,Europe,Western and Central Europe,Italy,0.66,,,2008,15-64,ARQ,HHS,Ecstasy,0.7,0.7,ITA
216,Europe,Western and Central Europe,Italy,0.5,,,2005,15-64,EMCDDA ,HHS ,Ecstasy,,,ITA
217,Europe,Western and Central Europe,Latvia,0.7,0.9,0.5,2020,15-64,ARQ,HHS,Ecstasy,,,LVA
218,Europe,Western and Central Europe,Latvia,0.3,0.5,0.2,2015,15-64,ARQ,HHS,Ecstasy,,,LVA
219,Europe,Western and Central Europe,Latvia,0.4,0.6,0.1,2011,15-64,ARQ,HHS,Ecstasy,,,LVA
220,Europe,Western and Central Europe,Latvia,1.5,,,2007,15-64,ARQ ,,Ecstasy,,,LVA
221,Europe,Western and Central Europe,Lithuania,0.4,0.6,0.2,2016,15-64,ARQ,HHS,Ecstasy,,,LTU
222,Europe,Western and Central Europe,Lithuania,0.2,0.2,0.1,2012,15-64,ARQ,HHS,Ecstasy,,,LTU
223,Europe,Western and Central Europe,Lithuania,1,,,2008,15-64,ARQ,HHS,Ecstasy,,,LTU
224,Europe,Western and Central Europe,Lithuania,0.4,,,2004,15-64,ARQ ,HHS ,Ecstasy,,,LTU
225,Europe,Western and Central Europe,Luxembourg,0.3,0.4,0.2,2019,15-64,ARQ,HHS,Ecstasy,,,LUX
226,Europe,Western and Central Europe,Luxembourg,0.2,,,2014,15-64,Government source,HHS,Ecstasy,,,LUX
227,Europe,Western and Central Europe,Luxembourg,0.48,,,2010,15-64,ARQ,SS,Ecstasy,0.11,0.86,LUX
228,Europe,Western and Central Europe,Luxembourg,0.71,,,2006,15-64,ARQ,SS,Ecstasy,0.23,1.2,LUX
229,Europe,Western and Central Europe,Malta,0,,,2013,15-64,ARQ,HHS,Ecstasy,,,MLT
230,Europe,Western and Central Europe,Malta,0.86,,,2011,15-64,ESPAD,SS,Ecstasy,0.31,1.4,MLT
231,Europe,Western and Central Europe,Malta,0.88,,,2007,15-64,ESPAD ,SS ,Ecstasy,0.87,0.89,MLT
232,Europe,Western and Central Europe,Netherlands,4,4.5,3.5,2020,15-64,ARQ,HHS,Ecstasy,,,NLD
233,Europe,Western and Central Europe,Netherlands,4.2,5.6,2.9,2019,15-64,EMCDDA,HHS,Ecstasy,,,NLD
234,Europe,Western and Central Europe,Netherlands,3.5,4.2,2.9,2018,15-64,EMCDDA,HHS,Ecstasy,,,NLD
235,Europe,Western and Central Europe,Netherlands,3.3,4.1,2.6,2017,15-64,EMCDDA,HHS,Ecstasy,2.9,3.8,NLD
236,Europe,Western and Central Europe,Netherlands,3.6,4.6,2.5,2016,15-64,EMCDDA,HHS,Ecstasy,,,NLD
237,Europe,Western and Central Europe,Netherlands,3.4,4.4,2.4,2015,15-64,EMCDDA,HHS,Ecstasy,,,NLD
238,Europe,Western and Central Europe,Netherlands,2.5,,,2014,15-64,ARQ,HHS,Ecstasy,,,NLD
239,Europe,Western and Central Europe,Netherlands,1.4,,,2009,15-64,ARQ,HHS,Ecstasy,,,NLD
240,Europe,Western and Central Europe,Netherlands,1.2,,,2005,15-64,ARQ ,,Ecstasy,,,NLD
241,Europe,Western and Central Europe,Norway,0.9,1.4,0.5,2020,16-64,ARQ,HHS,Ecstasy,,,NOR
242,Europe,Western and Central Europe,Norway,0.6,0.7,0.5,2019,16-64,ARQ,HHS,Ecstasy,,,NOR
243,Europe,Western and Central Europe,Norway,0.7,1.3,0.1,2018,16-64,ARQ,HHS,Ecstasy,,,NOR
244,Europe,Western and Central Europe,Norway,1,1.3,0.7,2017,16-64,ARQ,HHS,Ecstasy,,,NOR
245,Europe,Western and Central Europe,Norway,0.6,0.6,0.6,2016,16-64,ARQ,HHS,Ecstasy,,,NOR
246,Europe,Western and Central Europe,Norway,0.6,1,0.2,2015,16-64,ARQ,HHS,Ecstasy,,,NOR
247,Europe,Western and Central Europe,Norway,0.1,0.2,0.1,2014,16-64,ARQ,HHS,Ecstasy,,,NOR
248,Europe,Western and Central Europe,Norway,0.4,0.8,0,2013,16-64,ARQ,HHS,Ecstasy,,,NOR
249,Europe,Western and Central Europe,Norway,0.3,,,2009,15-64,ARQ,HHS,Ecstasy,,,NOR
250,Europe,Western and Central Europe,Norway,0.5,,,2004,15-64,ARQ ,,Ecstasy,,,NOR
251,Europe,Western and Central Europe,Poland,0.3,0.3,0.3,2019,15-64,ARQ,HHS,Ecstasy,,,POL
252,Europe,Western and Central Europe,Poland,1.2,0.9,1.5,2016,15-64,ARQ,HHS,Ecstasy,,,POL
253,Europe,Western and Central Europe,Poland,0.3,0.7,,2014,15-64,ARQ,HHS,Ecstasy,,,POL
254,Europe,Western and Central Europe,Poland,0.1,,,2012,15-64,ARQ,HHS,Ecstasy,,,POL
255,Europe,Western and Central Europe,Poland,1.5,,,2010,15-64,ARQ,HHS,Ecstasy,,,POL
256,Europe,Western and Central Europe,Poland,0.3,,,2006,15-64,ARQ ,,Ecstasy,,,POL
257,Europe,Western and Central Europe,Portugal,0.1,0.2,0.04,2017,15-64,ARQ,HHS,Ecstasy,,,PRT
258,Europe,Western and Central Europe,Portugal,0.2,0.3,0.2,2012,15-64,ARQ,HHS,Ecstasy,,,PRT
259,Europe,Western and Central Europe,Portugal,0.4,0.6,0.2,2007,15-64,ARQ,HHS,Ecstasy,,,PRT
260,Europe,Western and Central Europe,Slovakia,0.5,0.8,0.1,2019,15-64,ARQ,HHS,Ecstasy,,,SVK
261,Europe,Western and Central Europe,Slovakia,0.6,1,0.1,2015,15-64,ARQ,HHS,Ecstasy,,,SVK
262,Europe,Western and Central Europe,Slovakia,0.46,,,2010,15-64,EMCDDA,HHS,Ecstasy,,,SVK
263,Europe,Western and Central Europe,Slovakia,1.6,,,2006,15-64,EMCDDA,HHS,Ecstasy,,,SVK
264,Europe,Western and Central Europe,Slovakia,1.2,,,2004,15-64,ARQ ,,Ecstasy,,,SVK
265,Europe,Western and Central Europe,Slovenia,0.5,0.6,0.4,2018,15-64,EMCDDA,HHS,Ecstasy,0.4,0.7,SVN
266,Europe,Western and Central Europe,Slovenia,0.3,0.4,0.2,2012,15-64,ARQ,HHS,Ecstasy,,,SVN
267,Europe,Western and Central Europe,Slovenia,0.46,,,2008,18-65,ARQ,HHS,Ecstasy,0.18,0.74,SVN
268,Europe,Western and Central Europe,Slovenia,0.68,,,2007,15-64,ESPAD ,SS ,Ecstasy,0.68,0.69,SVN
269,Europe,Western and Central Europe,Spain,0.9,1.4,0.4,2020,15-64,ARQ,HHS,Ecstasy,,,ESP
270,Europe,Western and Central Europe,Spain,0.6,1,0.3,2017,15-64,EMCDDA,HHS,Ecstasy,0.5,0.7,ESP
271,Europe,Western and Central Europe,Spain,0.6,0.9,0.3,2015,15-64,ARQ,HHS,Ecstasy,,,ESP
272,Europe,Western and Central Europe,Spain,0.7,1,0.3,2013,15-64,ARQ,HHS,Ecstasy,,,ESP
273,Europe,Western and Central Europe,Spain,0.8,1.4,0.3,2011,15-64,ARQ,HHS,Ecstasy,,,ESP
274,Europe,Western and Central Europe,Spain,1.4,,,2009,15-64,ARQ ,HHS ,Ecstasy,,,ESP
275,Europe,Western and Central Europe,Sweden,0.9,,,2017,17-64,ARQ,HHS,Ecstasy,,,SWE
276,Europe,Western and Central Europe,Sweden,0.5,0.6,0.3,2013,15-64,EMCDDA,HHS,Ecstasy,,,SWE
277,Europe,Western and Central Europe,Sweden,0.1,,,2008,15-64,ARQ,HHS,Ecstasy,,,SWE
278,Europe,Western and Central Europe,Sweden,0.25,,,2007,15-64,ESPAD ,SS ,Ecstasy,,,SWE
279,Europe,Western and Central Europe,Switzerland,0.18,,,2016,15-64,Government source,HHS,Ecstasy,,,CHE
280,Europe,Western and Central Europe,Switzerland,0.31,,,2015,15-64,ARQ,HHS,Ecstasy,,,CHE
281,Europe,Western and Central Europe,Switzerland,0.22,0.31,0.13,2013,15-64,ARQ,HHS,Ecstasy,,,CHE
282,Europe,Western and Central Europe,Switzerland,0.3,,,2012,15+,ARQ,HHS,Ecstasy,,,CHE
283,Europe,Western and Central Europe,Switzerland,0.29,,,2011,15-64,ARQ,HHS,Ecstasy,0.07,0.5,CHE
284,Europe,Western and Central Europe,Switzerland,0.33,,,2007,15-64,ARQ ,"HHS, SS",Ecstasy,0.13,0.51,CHE
285,Europe,Western and Central Europe,United Kingdom (England and Wales),1.27,1.56,1,2019,16-64,ARQ,HHS,Ecstasy,,,GBR
286,Europe,Western and Central Europe,United Kingdom (England and Wales),1.55,2.07,1.04,2018,16-59,Government source,HHS,Ecstasy,,,GBR
287,Europe,Western and Central Europe,United Kingdom (England and Wales),1.66,2.23,1.09,2017,16-59,Government source,HHS,Ecstasy,,,GBR
288,Europe,Western and Central Europe,United Kingdom (England and Wales),1.34,1.75,0.93,2016,16-59,Government source,HHS,Ecstasy,,,GBR
289,Europe,Western and Central Europe,United Kingdom (England and Wales),1.5,2.18,0.83,2015,16-59,Government source,HHS,Ecstasy,,,GBR
290,Europe,Western and Central Europe,United Kingdom (England and Wales),1.68,2.52,0.85,2014,16-59,Government source,HHS,Ecstasy,,,GBR
291,Europe,Western and Central Europe,United Kingdom (England and Wales),1.58,2.29,0.89,2013,16-59,Government source,HHS,Ecstasy,,,GBR
292,Europe,Western and Central Europe,United Kingdom (England and Wales),1.24,1.85,0.64,2012,16-59,Government source,HHS,Ecstasy,,,GBR
293,Europe,Western and Central Europe,United Kingdom (England and Wales),1.38,2.01,0.76,2011,16-59,Government source,HHS,Ecstasy,,,GBR
294,Europe,Western and Central Europe,United Kingdom (England and Wales),1.35,1.86,0.85,2010,16-59,Government source ,HHS ,Ecstasy,,,GBR
295,Europe,Western and Central Europe,United Kingdom (Northern Ireland),0.8,,,2014,15-64,Government source,HHS,Ecstasy,,,GBR
296,Europe,Western and Central Europe,United Kingdom (Northern Ireland),1.1,,,2011,15-64,Government source,HHS,Ecstasy,,,GBR
297,Europe,Western and Central Europe,United Kingdom (Northern Ireland),1.8,,,2006,15-64,Government source ,HHS ,Ecstasy,,,GBR
298,Europe,Western and Central Europe,United Kingdom (Scotland),1.7,2.66,0.78,2014,16-64,Government source,HHS,Ecstasy,,,GBR
299,Europe,Western and Central Europe,United Kingdom (Scotland),1.7,2.6,0.7,2012,16-64,Government source,HHS,Ecstasy,,,GBR
300,Europe,Western and Central Europe,United Kingdom (Scotland),1.7,,,2011,16-64,Government source,HHS,Ecstasy,,,GBR
301,Europe,Western and Central Europe,United Kingdom (Scotland),2.4,,,2010,16-64,Government source ,HHS ,Ecstasy,,,GBR
302,Oceania,Australia and New Zealand,Australia,3,3.9,2,2019,14+,ARQ,HHS,Ecstasy,,,AUS
303,Oceania,Australia and New Zealand,Australia,2.2,2.6,1.8,2016,14+,ARQ,HHS,Ecstasy,,,AUS
304,Oceania,Australia and New Zealand,Australia,2.5,3.2,1.8,2013,14+,ARQ,HHS,Ecstasy,,,AUS
305,Oceania,Australia and New Zealand,Australia,3,,,2010,14+,ARQ,HHS,Ecstasy,,,AUS
306,Oceania,Australia and New Zealand,Australia,4.2,,,2007,15-64,Government source/ NGO/Academic research ,HHS ,Ecstasy,,,AUS
307,Oceania,Australia and New Zealand,New Zealand,2,2.7,1.5,2013,15+,Government source,HHS,Ecstasy,1.7,2.4,NZL
308,Oceania,Australia and New Zealand,New Zealand,2.6,3.6,1.5,2008,16-64,Government source,HHS,Ecstasy,2,3.1,NZL
309,Oceania,Australia and New Zealand,New Zealand,2.6,,,2007,16-64,Government source,HHS,Ecstasy,,,NZL
310,Oceania,Australia and New Zealand,New Zealand,2.6,,,2006,15-64,ARQ ,HHS ,Ecstasy,,,NZL
0,Africa,West and Central Africa,Nigeria,0.156,,,2017,15-64,Government/UNODC,HHS/I,Prescription Stimulants,0,0.477,NGA
1,Americas,Central America,Costa Rica,1.71,1.8,1.62,2015,12-64,OAS,HHS,Prescription Stimulants,,,CRI
2,Americas,Central America,Costa Rica,1.1,1.3,0.9,2010,15-64,ARQ,HHS,Prescription Stimulants,,,CRI
3,Americas,Central America,Costa Rica,1.3,,,2006,12-70,ARQ,,Prescription Stimulants,,,CRI
4,Americas,Central America,El Salvador,0.36,0.54,0.23,2014,12-65,Government source,HHS,Prescription Stimulants,0.24,0.54,SLV
5,Americas,Central America,Panama,0.05,0.06,0.04,2015,12-65,ARQ,HHS,Prescription Stimulants,,,PAN
6,Americas,North America,Canada,0.35,0.6,0.1,2017,15+,ARQ,HHS,Prescription Stimulants,,,CAN
7,Americas,North America,Canada,0.28,0.33,,2015,15-64,ARQ,HHS,Prescription Stimulants,,,CAN
8,Americas,North America,Canada,0.2,,,2013,15-64,ARQ,HHS,Prescription Stimulants,,,CAN
9,Americas,North America,Canada,0.7,0.7,,2012,15-64,ARQ,,Prescription Stimulants,,,CAN
10,Americas,North America,United States of America,2.1,2.2,1.9,2020,15-64,ARQ,HHS,Prescription Stimulants,,,USA
11,Americas,North America,United States of America,2.4,2.6,2.1,2018,15-64,ARQ,HHS,Prescription Stimulants,,,USA
12,Americas,North America,United States of America,2.7,3.3,2.2,2017,15-64,ARQ,HHS,Prescription Stimulants,,,USA
13,Americas,North America,United States of America,2.6,2.8,2.4,2016,15-64,ARQ,HHS,Prescription Stimulants,,,USA
14,Americas,North America,United States of America,2.5,2.9,2.1,2015,15-64,ARQ,HHS,Prescription Stimulants,,,USA
15,Americas,North America,United States of America,1.6,1.8,1.5,2014,15-64,ARQ,HHS,Prescription Stimulants,,,USA
16,Americas,North America,United States of America,1.6,,,2012,15-64,ARQ,HHS,Prescription Stimulants,,,USA
17,Americas,North America,United States of America,1.3,,,2011,15-64,ARQ,HHS,Prescription Stimulants,,,USA
18,Americas,South America,Argentina,0.09,0.16,0.04,2017,15-64,ARQ,HHS,Prescription Stimulants,,,ARG
19,Americas,South America,Argentina,0.1,0.1,0.1,2011,16-65,Government source,,Prescription Stimulants,,,ARG
20,Americas,South America,Argentina,0.2,,,2008,12-65,Government source,HHS,Prescription Stimulants,,,ARG
21,Americas,South America,Bolivia (Plurinational State of),0.38,0.47,0.31,2018,12-65,ARQ,HHS,Prescription Stimulants,,,BOL
22,Americas,South America,Bolivia (Plurinational State of),0.26,0.42,0.12,2014,12-65,ARQ,HHS,Prescription Stimulants,,,BOL
23,Americas,South America,Bolivia (Plurinational State of),0.26,0.42,0.12,2013,12-65,ARQ,HHS,Prescription Stimulants,,,BOL
24,Americas,South America,Brazil,0.7,,,2005,15-64,ARQ,HHS,Prescription Stimulants,,,BRA
25,Americas,South America,Chile,0.18,0.1,0.25,2020,15-64,ARQ,HHS,Prescription Stimulants,,,CHL
26,Americas,South America,Chile,0.19,0.17,0.22,2018,15-64,ARQ,HHS,Prescription Stimulants,,,CHL
27,Americas,South America,Chile,0.25,0.35,0.15,2016,15-64,ARQ,HHS,Prescription Stimulants,,,CHL
28,Americas,South America,Chile,0.14,0.17,0.12,2014,15-64,ARQ,HHS,Prescription Stimulants,,,CHL
29,Americas,South America,Chile,0.25,0.1,0.4,2012,15-64,ARQ,HHS,Prescription Stimulants,,,CHL
30,Americas,South America,Chile,0.14,,,2010,15-64,ARQ,,Prescription Stimulants,,,CHL
31,Americas,South America,Colombia,0.11,0.16,0.07,2019,12-65,Government source,HHS,Prescription Stimulants,,,COL
32,Americas,South America,Colombia,0.04,0.07,0.01,2013,12-65,ARQ,HHS,Prescription Stimulants,,,COL
33,Americas,South America,Colombia,0.06,0.06,0.05,2008,12-65,ARQ/Government source,HHS,Prescription Stimulants,,,COL
34,Americas,South America,Ecuador,0.1,,,2007,12-65,ARQ,,Prescription Stimulants,,,ECU
35,Americas,South America,Peru,0.11,,,2010,12-65,ARQ,,Prescription Stimulants,,,PER
36,Americas,South America,Peru,0.2,,,2006,12-65,ARQ,HHS,Prescription Stimulants,,,PER
37,Americas,South America,Uruguay,0.2,0.2,0.1,2018,15-65,ARQ,HHS,Prescription Stimulants,,,URY
38,Americas,South America,Uruguay,0.03,0.04,0.02,2014,15-65,ARQ,HHS,Prescription Stimulants,,,URY
39,Americas,South America,Uruguay,0.3,,,2006,15-64,ARQ,,Prescription Stimulants,,,URY
40,Americas,South America,Venezuela (Bolivarian Republic of),0.37,,,2011,12-65,ARQ,,Prescription Stimulants,,,VEN
41,Asia,Near and Middle East/South-West Asia,Pakistan,0.1,0.1,0.13,2012,15-64,Government source/UNODC,HHS,Prescription Stimulants,,,PAK
42,Asia,South Asia,Sri Lanka,0.76,1.51,0.05,2019,15-64,ARQ,I,Prescription Stimulants,,,LKA
43,Oceania,Australia and New Zealand,New Zealand,0.5,0.7,0.4,2008,16-64,Government source,HHS,Prescription Stimulants,0.3,0.7,NZL
0,Africa,East Africa,Mauritius,1.29,,,2009,15-64,Government source,I,Opioids,,,MUS
1,Africa,Southern Africa,South Africa,0.5,,,2008,15-64,ARQ,HHS,Opioids,,,ZAF
2,Africa,West and Central Africa,Democratic Republic of the Congo,0.17,,,2004,15-64,Cure Research estimate,,Opioids,,,COD
3,Africa,West and Central Africa,Nigeria,4.66,,,2017,15-64,Government/UNODC,HHS/I,Opioids,4.27,5.05,NGA
4,Americas,Caribbean,Barbados,0.23,,,2006,15-64,UNODC Estimate,,Opioids,0.16,0.29,BRB
5,Americas,Caribbean,Dominican Republic,0.14,,,2001,15-64,UNODC Estimate ,,Opioids,,,DOM
6,Americas,Caribbean,Haiti,0.2,,,2006,15-64,ARQ,SS,Opioids,0.19,0.22,HTI
7,Americas,Caribbean,Jamaica,1,,,2006,15-64,UNODC Estimate,SS,Opioids,0.5,1.5,JAM
8,Americas,Central America,Belize,0.3,,,2005,12-65,CICAD/MEM,HHS,Opioids,,,BLZ
9,Americas,Central America,Costa Rica,0.75,0.78,0.71,2015,12-70,ARQ,HHS,Opioids,,,CRI
10,Americas,Central America,Costa Rica,0.79,0.83,0.75,2015,15-64,ARQ,HHS,Opioids,,,CRI
11,Americas,Central America,El Salvador,0.14,,,2005,15-64,UNODC Estimate,HHS,Opioids,,,SLV
12,Americas,North America,Mexico,0.38,,,2011,12-65,Government source,HHS,Opioids,0.19,0.56,MEX
13,Americas,North America,Mexico,0.1,,,2008,15-64,ARQ ,HHS,Opioids,,,MEX
14,Americas,North America,United States of America ,4.56,,,2020,15-64,UNODC Estimate,HHS/I,Opioids,4.38,4.74,USA
15,Americas,North America,United States of America ,4.92,,,2018,15-64,UNODC Estimate,HHS/I,Opioids,4.75,5.09,USA
16,Americas,North America,United States of America ,5.41,,,2017,15-64,UNODC Estimate,HHS/I,Opioids,5.22,5.59,USA
17,Americas,North America,United States of America ,5.75,,,2016,15-64,UNODC Estimate,HHS/I,Opioids,5.55,5.95,USA
18,Americas,North America,United States of America ,6.13,,,2015,15-64,UNODC Estimate,HHS/I,Opioids,5.95,6.31,USA
19,Americas,North America,United States of America ,5.4,,,2013,15-64,UNODC Estimate,HHS/I,Opioids,5.25,5.55,USA
20,Americas,North America,United States of America ,6.22,,,2010,15-64,UNODC Estimate,HHS/I,Opioids,6.08,6.37,USA
21,Americas,South America,Argentina,0.19,,,2007,15-64,UNODC Estimate ,,Opioids,0.13,0.26,ARG
22,Americas,South America,Brazil,0.64,0.45,0.82,2012,15-64,Government source,HHS,Opioids,,,BRA
23,Americas,South America,Chile,1.22,1.41,1.04,2020,15-64,ARQ,HHS,Opioids,,,CHL
24,Americas,South America,Chile,1.14,1.21,1.08,2018,15-64,ARQ,HHS,Opioids,,,CHL
25,Americas,South America,Chile,1.22,0.94,1.5,2016,15-64,ARQ,HHS,Opioids,,,CHL
26,Americas,South America,Chile,0.58,0.54,0.62,2014,15-64,ARQ,HHS,Opioids,,,CHL
27,Americas,South America,Colombia,0.28,0.2,0.35,2019,12-65,Government source,HHS,Opioids,,,COL
28,Americas,South America,Ecuador,0.08592116802574847,0.18161566613443947,0.03449748264873119,2020,15-64,ARQ/UNODC Estimates,I,Opioids,,,ECU
29,Americas,South America,Ecuador,0.04,0,0.02,2013,12-65,ARQ,HHS,Opioids,,,ECU
30,Americas,South America,Uruguay,4.9,,,2018,15-64,CICAD OAS/Governement sources,HHS,Opioids,,,URY
31,Americas,South America,Uruguay,0.18,,,2011,15-64,UNODC Estimate,HHS,Opioids,0.05,0.3,URY
32,Asia,Central Asia and Transcaucasia,Armenia,0.16,,,2009,15-64,Armenian Pubic Health Associations,I,Opioids,0.14,0.2,ARM
33,Asia,Central Asia and Transcaucasia,Armenia,0.28,,,2007,15-64,Government source,,Opioids,0.24,0.33,ARM
34,Asia,Central Asia and Transcaucasia,Armenia,0.3,,,2005,15-64,UNODC Estimate ,HHS ,Opioids,,,ARM
35,Asia,Central Asia and Transcaucasia,Georgia,1.36,,,2010,15-64,SCAD Report - Academic Research,I,Opioids,1.33,1.4,GEO
36,Asia,Central Asia and Transcaucasia,Georgia,0.58,,,2006,15-64,UNODC Estimate ,I,Opioids,,,GEO
37,Asia,Central Asia and Transcaucasia,Kazakhstan,1,,,2006,15-64,UNODC (GAP survey),I,Opioids,,,KAZ
38,Asia,Central Asia and Transcaucasia,Kyrgyzstan,0.8,,,2006,15-64,UNODC (GAP survey),I,Opioids,,,KGZ
39,Asia,Central Asia and Transcaucasia,Tajikistan,0.54,,,2006,15-64,UNODC (GAP survey),I,Opioids,,,TJK
40,Asia,Central Asia and Transcaucasia,Turkmenistan,0.32,,,2007,15-64,ARQ,R,Opioids,,,TKM
41,Asia,Central Asia and Transcaucasia,Uzbekistan,0.8,,,2006,15-64,UNODC (GAP survey),I,Opioids,,,UZB
42,Asia,East and South-East Asia,Philippines,0.05,,,2007,15-64,Reference Group to the UN on HIV and IDU,,Opioids,,,PHL
43,Asia,East and South-East Asia,Singapore,0.33,,,2010,15-64,UNODC Estimate,I,Opioids,0.28,0.38,SGP
44,Asia,Near and Middle East/South-West Asia,Afghanistan,8.5,10.3,6.7,2015,15+,INL,HHS,Opioids,,,AFG
45,Asia,Near and Middle East/South-West Asia,Afghanistan,2.92,4.3,1.45,2009,15-64,UNODC/ Government Source,HHS,Opioids,2.65,3.2,AFG
46,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),3.02,,,2011,15-64,Academic source,HHS,Opioids,2.56,3.47,IRN
47,Asia,Near and Middle East/South-West Asia,Israel,0.1,0,0.2,2020,18-86,ARQ,HHS,Opioids,,,ISR
48,Asia,Near and Middle East/South-West Asia,Pakistan,2.4,3.4,1.4,2012,15-64,Government/UNODC,HHS/I,Opioids,2,3.1,PAK
49,Asia,Near and Middle East/South-West Asia,Pakistan,0.7,,,2006,15-64,UNODC (GAP survey) ,I,Opioids,,,PAK
50,Asia,South Asia,Bangladesh,0.4,,,2003,15-64,ARQ,HHS,Opioids,,,BGD
51,Asia,South Asia,India,2.06,3.97,0.16,2018,10-75,Government source,HHS/I,Opioids,,,IND
52,Asia,South Asia,Maldives,1.46,,,2012,15-64,Government source,HHS,Opioids,,,MDV
53,Europe,Eastern Europe,Russian Federation,1.03,,,2016,15-64,Government/UNODC Estimate,I,Opioids,,,RUS
54,Europe,Eastern Europe,Russian Federation,2.29,,,2010,15-64,Government source,I,Opioids,,,RUS
55,Europe,South-Eastern Europe,Bulgaria,0.5,0.5,0.4,2020,15-64,ARQ,HHS,Opioids,,,BGR
56,Europe,South-Eastern Europe,Bulgaria,0.3,0.4,0.2,2016,15-64,ARQ,HHS,Opioids,,,BGR
57,Europe,South-Eastern Europe,Bulgaria,0.51,,,2011,15-64,ARQ,I,Opioids,,,BGR
58,Europe,South-Eastern Europe,Bulgaria,0.44,,,2008,15-64,ARQ ,I ,Opioids,,,BGR
59,Europe,South-Eastern Europe,Croatia,0.31,,,2015,15-64,ARQ,I,Opioids,0.251,0.402,HRV
60,Europe,South-Eastern Europe,North Macedonia,0.5,,,2005,15-64,ARQ,,Opioids,,,MKD
61,Europe,South-Eastern Europe,Romania,0.3,0.2,0.5,2019,15-64,ARQ,HHS,Opioids,,,ROU
62,Europe,South-Eastern Europe,Romania,0.2,0.2,0.1,2016,15-64,ARQ,HHS,Opioids,,,ROU
63,Europe,South-Eastern Europe,Serbia,5.15,4.15,6.1,2014,18-64,Government sources,HHS,Opioids,,,SRB
64,Europe,Western and Central Europe,Austria,0.539,1.16,0.19,2019,15-64,EMCDDA/ARQ/UNODC Estimates,I,Opioids,0.523,0.554,AUT
65,Europe,Western and Central Europe,Austria,0.53,,,2015,15-64,ARQ,I,Opioids,,,AUT
66,Europe,Western and Central Europe,Austria,0.5,,,2013,15-64,EMCDDA,I,Opioids,0.49,0.51,AUT
67,Europe,Western and Central Europe,Austria,0.53,,,2011,15-64,EMCDDA,I,Opioids,0.52,0.55,AUT
68,Europe,Western and Central Europe,Belgium,0.7,0.8,0.7,2018,15-64,ARQ/Government source,HHS,Opioids,0.4,1,BEL
69,Europe,Western and Central Europe,Belgium,0.2,0.3,0.1,2013,15-64,ARQ,HHS,Opioids,,,BEL
70,Europe,Western and Central Europe,Belgium,0.2,,,2008,15-64,ARQ,HHS,Opioids,,,BEL
71,Europe,Western and Central Europe,Cyprus,0.172,,,2019,15-64,EMCDDA,I,Opioids,0.131,0.232,CYP
72,Europe,Western and Central Europe,Cyprus,0.207,,,2018,15-64,EMCDDA,I,Opioids,0.164,0.269,CYP
73,Europe,Western and Central Europe,Cyprus,0.2,,,2017,15-64,EMCDDA,I,Opioids,0.157,0.264,CYP
74,Europe,Western and Central Europe,Czechia,0.153,,,2019,15-64,EMCDDA,I,Opioids,0.148,0.158,CZE
75,Europe,Western and Central Europe,Czechia,0.189,,,2017,15-64,EMCDDA,,Opioids,0.182,0.197,CZE
76,Europe,Western and Central Europe,Czechia,0.18,,,2016,15-64,ARQ,I,Opioids,0.17,0.186,CZE
77,Europe,Western and Central Europe,Czechia,0.18,,,2015,15-64,ARQ,HHS,Opioids,,,CZE
78,Europe,Western and Central Europe,Czechia,0.16,,,2014,15-64,EMCDDA,I,Opioids,0.14,0.18,CZE
79,Europe,Western and Central Europe,Czechia,0.15,,,2013,15-64,EMCDDA,I,Opioids,,,CZE
80,Europe,Western and Central Europe,Czechia,0.13,,,2012,15-64,EMCDDA,I,Opioids,,,CZE
81,Europe,Western and Central Europe,Estonia,0.17,0.33,0.08,2018,16-64,Government sources,HHS,Opioids,,,EST
82,Europe,Western and Central Europe,Estonia,1.53,,,2008,15-64,ARQ,I,Opioids,,,EST
83,Europe,Western and Central Europe,Finland,0.765,,,2017,15-64,EMCDDA,I,Opioids,0.686,0.861,FIN
84,Europe,Western and Central Europe,Finland,0.41,,,2012,15-64,ARQ,I,Opioids,0.38,0.45,FIN
85,Europe,Western and Central Europe,Finland,0.6,0.7,0.5,2010,15-64,ARQ,HHS,Opioids,,,FIN
86,Europe,Western and Central Europe,France,0.506,,,2019,15-64,EMCDDA,I,Opioids,0.494,0.517,FRA
87,Europe,Western and Central Europe,France,0.48,,,2018,15-64,ARQ,I,Opioids,,,FRA
88,Europe,Western and Central Europe,France,0.57,,,2015,15-64,EMCDDA,I,Opioids,0.444,0.69,FRA
89,Europe,Western and Central Europe,France,0.52,,,2013,15-64,EMCDDA,I,Opioids,0.44,0.74,FRA
90,Europe,Western and Central Europe,Germany,0.44,0.48,0.39,2018,18-64,ARQ,HHS,Opioids,,,DEU
91,Europe,Western and Central Europe,Germany,0.31,,,2016,15-64,Government sources/Academic sources,I,Opioids,,,DEU
92,Europe,Western and Central Europe,Germany,0.3,0.3,0.3,2015,18-64,ARQ,HHS,Opioids,,,DEU
93,Europe,Western and Central Europe,Germany,0.4,0.4,0.3,2012,18-64,ARQ,HHS,Opioids,,,DEU
94,Europe,Western and Central Europe,Germany,0.2,0.3,0.1,2009,18-64,ARQ,HHS,Opioids,,,DEU
95,Europe,Western and Central Europe,Italy,0.79,,,2017,15-64,UNODC Estimate,HHS/I,Opioids,0.57,1.02,ITA
96,Europe,Western and Central Europe,Italy,0.8,1.1,0.6,2013,15-64,ARQ,HHS,Opioids,,,ITA
97,Europe,Western and Central Europe,Latvia,0.5,0.9,0.2,2015,15-64,ARQ,HHS,Opioids,,,LVA
98,Europe,Western and Central Europe,Lithuania,0.4638634036877687,,,2018,15-64,ARQ,I,Opioids,,,LTU
99,Europe,Western and Central Europe,Lithuania,0.392,,,2016,15-64,EMCDDA,I,Opioids,0.267,0.649,LTU
100,Europe,Western and Central Europe,Luxembourg,0.351,,,2018,15-64,EMCDDA,I,Opioids,,,LUX
101,Europe,Western and Central Europe,Malta,0.318,,,2019,15-64,EMCDDA,I,Opioids,0.297,0.348,MLT
102,Europe,Western and Central Europe,Malta,0.451,,,2017,15-64,EMCDDA,I,Opioids,0.422,0.489,MLT
103,Europe,Western and Central Europe,Slovakia,0.13037154026525022,,,2018,15-64,ARQ,I,Opioids,,,SVK
104,Europe,Western and Central Europe,Slovakia,0.3,0.5,0,2015,15-64,ARQ,HHS,Opioids,,,SVK
105,Europe,Western and Central Europe,Slovakia,0.3,,,2006,15-64,ARQ ,HHS ,Opioids,,,SVK
106,Europe,Western and Central Europe,Slovenia,0.219,,,2019,15-64,EMCDDA,I,Opioids,0.203,0.237,SVN
107,Europe,Western and Central Europe,Slovenia,0.338,,,2018,15-64,ARQ,I,Opioids,,,SVN
108,Europe,Western and Central Europe,Slovenia,0.354,,,2016,15-64,ARQ,I,Opioids,,,SVN
109,Europe,Western and Central Europe,Slovenia,0.37,,,2015,15-64,ARQ,I,Opioids,,,SVN
110,Europe,Western and Central Europe,Slovenia,0.37,,,2013,15-64,EMCDDA,I,Opioids,0.34,0.41,SVN
111,Europe,Western and Central Europe,Spain,0.1,0.1,0,2017,15-64,ARQ/Government source,HHS,Opioids,0,0.1,ESP
112,Europe,Western and Central Europe,Spain,0.1,0.2,0,2015,15-64,ARQ,HHS,Opioids,,,ESP
113,Europe,Western and Central Europe,Sweden,0.2,,,2017,17-64,ARQ,HHS,Opioids,,,SWE
114,Europe,Western and Central Europe,Sweden,0.53,0.59,0.46,2013,17-64,ARQ,HHS,Opioids,,,SWE
115,Europe,Western and Central Europe,Sweden,0.23,,,2007,15-64,ARQ,I,Opioids,0.19,0.28,SWE
116,Oceania,Australia and New Zealand,Australia,3.7,3.8,3.6,2016,14+,Government source,HHS,Opioids,3.4,4,AUS
117,Oceania,Australia and New Zealand,Australia,3.3,3.3,3.2,2013,14+,UNODC Estimate,HHS,Opioids,,,AUS
118,Oceania,Australia and New Zealand,Australia,3.4,,,2010,15-64,Government source,HHS,Opioids,3.1,3.7,AUS
119,Oceania,Australia and New Zealand,New Zealand,1.1,1.5,1,2008,16-64,Government source,HHS,Opioids,0.8,1.4,NZL
120,Oceania,Australia and New Zealand,New Zealand,0.42,,,2006,15-45,ARQ ,,Opioids,,,NZL
0,Africa,East Africa,Kenya,0.22,,,2012,15-64,Government report,I,Opiates,,,KEN
1,Africa,East Africa,Kenya,0.73,,,2004,15-64,Reference Group to the UN on HIV and IDU ,I ,Opiates,,,KEN
2,Africa,East Africa,Mauritius,0.7785745190355908,,,2017,15-64,ARQ/UNODC Estimates,I,Opiates,,,MUS
3,Africa,East Africa,Mauritius,0.91,,,2007,15-54,ARQ ,I ,Opiates,,,MUS
4,Africa,East Africa,Rwanda,0.14,,,2004,15-64,Cure Research estimate,,Opiates,,,RWA
5,Africa,East Africa,Seychelles,2.3,,,2011,15-64,Government source,,Opiates,,,SYC
6,Africa,East Africa,Somalia,0.16,,,2004,15-64,Cure Research estimate,,Opiates,,,SOM
7,Africa,East Africa,Uganda,0.05,,,2004,15-64,Cure Research estimate,,Opiates,,,UGA
8,Africa,North Africa,Algeria,0.06,0.11,0.01,2010,12+,ARQ,HHS,Opiates,0.05,0.06,DZA
9,Africa,North Africa,Algeria,0.12,,,2004,15-64 ,UNODC Estimate ,,Opiates,,,DZA
10,Africa,North Africa,Egypt,1.76,,,2016,15-64,MedSPAD/UNODC Estimate,SS,Opiates,1.39,2.14,EGY
11,Africa,North Africa,Egypt,0.44,,,2006,15-64,Govt; Academic Research,"HHS, SS",Opiates,0.14,0.73,EGY
12,Africa,North Africa,Libya,0.14,,,2004,15-64,UNODC Estimate,,Opiates,,,LBY
13,Africa,North Africa,Morocco,0.71,,,2017,15-64,MedSPAD/UNODC Estimate,SS,Opiates,,,MAR
14,Africa,North Africa,Morocco,0.01,,,2014,15-64,UNAIDS/GARPR,I,Opiates,,,MAR
15,Africa,North Africa,Morocco,0.08,,,2011,15-64,Government report,I,Opiates,,,MAR
16,Africa,North Africa,Morocco,0.02,,,2004,15-64,ARQ ,,Opiates,,,MAR
17,Africa,North Africa,Tunisia,0.12,,,2011,15-64,Government report,I,Opiates,,,TUN
18,Africa,Southern Africa,Eswatini,0.17,,,2004,15-64,Cure Research estimate,,Opiates,,,SWZ
19,Africa,Southern Africa,South Africa,0.41,,,2008,15-64,ARQ,HHS,Opiates,,,ZAF
20,Africa,Southern Africa,Zambia,0.37,,,2003,15-64,UNODC Estimate,,Opiates,,,ZMB
21,Africa,Southern Africa,Zimbabwe,0.04,,,2004,15-64,Cure Research estimate,,Opiates,,,ZWE
22,Africa,West and Central Africa,Cabo Verde,0.18,,,2004,15-64,UNODC Estimate,,Opiates,,,CPV
23,Africa,West and Central Africa,Central African Republic,0.05,,,2004,15-64,Cure Research estimate,,Opiates,,,CAF
24,Africa,West and Central Africa,Chad,0.22,,,2004,15-64,Cure Research estimate,,Opiates,,,TCD
25,Africa,West and Central Africa,Côte d'Ivoire,0.9,,,2017,15-64,Government source/UNODC Estimate,SS,Opiates,0.86,0.94,CIV
26,Africa,West and Central Africa,Congo,0.13,,,2004,15-64,Cure Research estimate,,Opiates,,,COG
27,Africa,West and Central Africa,Democratic Republic of the Congo,0.13,,,2004,15-64,Cure Research estimate,,Opiates,,,COD
28,Africa,West and Central Africa,Ghana,0.14,,,2004,15-65,Cure Research estimate,,Opiates,,,GHA
29,Africa,West and Central Africa,Liberia,0.17,,,2004,15-64,Cure Research estimate,,Opiates,,,LBR
30,Africa,West and Central Africa,Niger,0.2,,,2004,15-64,Reference Group to the UN on HIV and IDU,I,Opiates,,,NER
31,Africa,West and Central Africa,Nigeria,0.09,,,2017,15-64,Government/UNODC,HHS/I,Opiates,0,0.21,NGA
32,Africa,West and Central Africa,Nigeria,0.7,,,2008,15-64,UNODC Estimate,,Opiates,0.3,1,NGA
33,Africa,West and Central Africa,Senegal,0.08,,,2006,15-64,UNODC Estimate,SS,Opiates,,,SEN
34,Africa,West and Central Africa,Sierra Leone,0.17,,,2004,15-64,Cure Research estimate,,Opiates,,,SLE
35,Americas,Caribbean,Bahamas,0.22,,,2003,15-64,UNODC Estimate,,Opiates,,,BHS
36,Americas,Caribbean,Barbados,0.11,,,2006,15-64,UNODC Estimate,,Opiates,0.1,0.13,BRB
37,Americas,Caribbean,Dominican Republic,0.07,,,2008,15-64,UNODC Estimate,SS,Opiates,0.05,0.09,DOM
38,Americas,Caribbean,Dominican Republic,0.11,,,2001,15-64,UNODC Estimate ,,Opiates,,,DOM
39,Americas,Caribbean,Haiti,0.07,,,2006,15-64,ARQ,SS,Opiates,,,HTI
40,Americas,Caribbean,Jamaica,0.7,,,2006,15-64,UNODC Estimate,SS,Opiates,0.3,1.1,JAM
41,Americas,Caribbean,Jamaica,0.1,,,2001,15-64,UNODC Estimate ,,Opiates,,,JAM
42,Americas,Central America,Belize,0.3,,,2005,12-65,CICAD/MEM,HHS,Opiates,,,BLZ
43,Americas,Central America,Costa Rica,0.03,0.06,0.01,2015,12-70,ARQ,,Opiates,,,CRI
44,Americas,Central America,Costa Rica,0.04,0.06,0.01,2015,15-64,ARQ,HHS,Opiates,,,CRI
45,Americas,Central America,Costa Rica,0,,,2010,12-70,ARQ,HHS,Opiates,,,CRI
46,Americas,Central America,Costa Rica,0.09,,,2006,12-70,ARQ ,HHS ,Opiates,,,CRI
47,Americas,Central America,El Salvador,0.11,,,2005,15-64,UNODC Estimate,HHS,Opiates,,,SLV
48,Americas,Central America,Guatemala,0.04,,,2005,15-65,ARQ,,Opiates,,,GTM
49,Americas,Central America,Honduras,0.15,,,2005,15-64,UNODC Estimate,HHS,Opiates,,,HND
50,Americas,Central America,Nicaragua,0.02,,,2006,12-65,CICAD/MEM,HHS,Opiates,,,NIC
51,Americas,North America,Bermuda,0.15,,,2009,16-65,Government source,HHS,Opiates,0.1,0.2,BMU
53,Americas,North America,Mexico,0.18,,,2011,12-65,Government source,HHS,Opiates,0.1,0.26,MEX
54,Americas,North America,Mexico,0.04,,,2008,12-65,ARQ ,HHS,Opiates,,,MEX
55,Americas,North America,United States of America ,0.937,,,2020,15-64,UNODC Estimate,HHS/I,Opiates,0.757,1.117,USA
56,Americas,North America,United States of America,0.91,,,2018,15-64,UNODC Estimate,HHS/I,Opiates,0.74,1.08,USA
57,Americas,North America,United States of America,0.974,,,2017,15-64,UNODC Estimate,HHS/I,Opiates,0.787,1.161,USA
58,Americas,North America,United States of America,1.04,,,2016,15-64,UNODC Estimate,HHS/I,Opiates,0.841,1.24,USA
59,Americas,North America,United States of America,0.931,,,2015,15-64,UNODC Estimate,HHS/I,Opiates,0.753,1.11,USA
60,Americas,North America,United States of America,0.756,,,2013,15-64,UNODC Estimate,HHS/I,Opiates,0.606,0.905,USA
61,Americas,North America,United States of America,0.73,,,2010,15-64,UNODC Estimate,HHS/I,Opiates,0.588,0.872,USA
62,Americas,South America,Argentina,0.07,,,2010,15-64,UNODC Estimate,,Opiates,0.05,0.09,ARG
63,Americas,South America,Argentina,0.13,,,2007,15-64,UNODC Estimate ,,Opiates,0.09,0.17,ARG
64,Americas,South America,Bolivia (Plurinational State of),0.07,,,2004,15-64,UNODC Estimate,,Opiates,,,BOL
65,Americas,South America,Brazil,0.2,0.1,0.3,2012,15-64,Government source,HHS,Opiates,,,BRA
66,Americas,South America,Chile,0,0,0,2018,15-64,ARQ,HHS,Opiates,,,CHL
67,Americas,South America,Chile,0,0,0,2016,15-64,ARQ,HHS,Opiates,,,CHL
68,Americas,South America,Chile,0.02,0.05,0,2014,15-64,ARQ,HHS,Opiates,,,CHL
69,Americas,South America,Chile,0.02,,,2010,15-64,ARQ,HHS,Opiates,,,CHL
70,Americas,South America,Chile,0.1,,,2008,15-64,HHS ,HHS ,Opiates,,,CHL
71,Americas,South America,Colombia,0.02,0.02,0.01,2019,12-65,Government source,HHS,Opiates,0.01,0.03,COL
72,Americas,South America,Colombia,0.03,,,2013,12-65,Government source,HHS,Opiates,,,COL
73,Americas,South America,Colombia,0.02,,,2008,12-64,ARQ,HHS,Opiates,,,COL
74,Americas,South America,Colombia,0.02,,,2004,15-64,UNODC Estimate ,,Opiates,,,COL
75,Americas,South America,Ecuador,0.01,,,2013,12-65,ARQ,HHS,Opiates,,,ECU
76,Americas,South America,Ecuador,0.03,0.01,,2013,12-65,ARQ,HHS,Opiates,,,ECU
77,Americas,South America,Ecuador,0.07,,,2007,12-65,ARQ,HHS,Opiates,0.06,0.08,ECU
78,Americas,South America,Ecuador,0.12,,,2005,15-64,UNODC Estimate ,,Opiates,,,ECU
79,Americas,South America,Paraguay,0.03,,,2003,12-65,ARQ,HHS,Opiates,,,PRY
80,Americas,South America,Peru,0.18,,,2005,12-64,UNODC Estimate,,Opiates,,,PER
81,Americas,South America,Uruguay,0.4,,,2018,18-65,CICAD OAS/Government sources,I,Opiates,,,URY
82,Americas,South America,Uruguay,0.06,,,2011,15-64,UNODC Estimate,HHS,Opiates,0.02,0.1,URY
83,Americas,South America,Uruguay,0.1,,,2006,15-64,UNODC Estimate,HHS ,Opiates,,,URY
84,Americas,South America,Venezuela (Bolivarian Republic of),0.03,,,2011,12-65,ARQ,HHS,Opiates,,,VEN
85,Americas,South America,Venezuela (Bolivarian Republic of),0.1,,,2003,15-64,ARQ ,SS ,Opiates,,,VEN
86,Asia,Central Asia and Transcaucasia,Armenia,0.2,,,2007,15-64,Government source,,Opiates,0.17,0.24,ARM
87,Asia,Central Asia and Transcaucasia,Azerbaijan,1.5,,,2010,15-64,Government report,I,Opiates,1.28,1.72,AZE
88,Asia,Central Asia and Transcaucasia,Azerbaijan,0.2,,,2008,15-64,ARQ ,I ,Opiates,,,AZE
89,Asia,Central Asia and Transcaucasia,Georgia,0.72,,,2010,15-64,Academic Research,I,Opiates,0.71,0.74,GEO
90,Asia,Central Asia and Transcaucasia,Georgia,0.31,,,2006,15-64,UNODC Estimate ,I,Opiates,,,GEO
91,Asia,Central Asia and Transcaucasia,Kazakhstan,1.03,,,2015,15-64,UNODC Estimate,I,Opiates,0.97,1.08,KAZ
92,Asia,Central Asia and Transcaucasia,Kazakhstan,0.89,,,2006,15-64,UNODC (GAP survey),I,Opiates,,,KAZ
93,Asia,Central Asia and Transcaucasia,Kyrgyzstan,0.89,,,2015,15-64,UNODC Estimate,I,Opiates,0.82,0.96,KGZ
94,Asia,Central Asia and Transcaucasia,Kyrgyzstan,0.74,,,2006,15-64,UNODC (GAP survey),I,Opiates,,,KGZ
95,Asia,Central Asia and Transcaucasia,Tajikistan,0.52,,,2015,15-64,UNODC Estimate,I,Opiates,0.51,0.52,TJK
96,Asia,Central Asia and Transcaucasia,Tajikistan,0.54,,,2006,15-64,UNODC (GAP survey),I,Opiates,,,TJK
97,Asia,Central Asia and Transcaucasia,Turkmenistan,0.32,,,2007,15-64,ARQ,,Opiates,,,TKM
98,Asia,Central Asia and Transcaucasia,Uzbekistan,0.93,,,2015,15-64,UNODC Estimate,I,Opiates,0.78,1.08,UZB
99,Asia,Central Asia and Transcaucasia,Uzbekistan,0.78,,,2006,15-64,UNODC (GAP survey),I,Opiates,,,UZB
100,Asia,East and South-East Asia,Cambodia,0.04,,,2007,15-64,Government source,I,Opiates,,,KHM
101,Asia,East and South-East Asia,Cambodia,0.03,,,2004,15-64,INCSR/ Reference Group to the UN on HIV and IDU ,I ,Opiates,,,KHM
102,Asia,East and South-East Asia,China,0.19,,,2012,15-64,UNAIDS,I,Opiates,0.13,0.25,CHN
103,Asia,East and South-East Asia,China,0.25,,,2005,15-64,Academic research/ Reference Group to the UN on HI,I,Opiates,0.19,0.31,CHN
104,Asia,East and South-East Asia,"China, Taiwan Province of China",0.2,,,2005,12-64,Government source,,Opiates,,,TWN
105,Asia,East and South-East Asia,Indonesia,0.07,,,2019,15-64,ARQ/UNODC Estimate,HHS,Opiates,0.07,0.07,IDN
106,Asia,East and South-East Asia,Indonesia,0.01,,,2014,15-64,ARQ,I,Opiates,,,IDN
107,Asia,East and South-East Asia,Indonesia,0.11,,,2010,15-64,ARQ,I,Opiates,,,IDN
108,Asia,East and South-East Asia,Indonesia,0.16,,,2005,15-64,ARQ ,,Opiates,,,IDN
109,Asia,East and South-East Asia,Japan,0.04,,,2019,15-64,ARQ ,HHS,Opiates,,,JPN
110,Asia,East and South-East Asia,Lao People's Democratic Republic,0.37,,,2008,15-64,UNODC (ICMP),HHS,Opiates,,,LAO
111,Asia,East and South-East Asia,Malaysia,0.94,,,2009,15-64,SMART,I,Opiates,,,MYS
112,Asia,East and South-East Asia,Myanmar,0.8,,,2010,15-64,UNODC (ICMP),HHS,Opiates,0.7,0.9,MMR
113,Asia,East and South-East Asia,Philippines,0.04,,,2011,15-64,Government report,I,Opiates,0.03,0.04,PHL
114,Asia,East and South-East Asia,Philippines,0.01,,,2008,10-64,ARQ,HHS,Opiates,,,PHL
115,Asia,East and South-East Asia,Republic of Korea,0,,,2004,15-64,ARQ,HHS,Opiates,,,PRK
116,Asia,East and South-East Asia,Singapore,0.32,,,2010,15-64,UNODC Estimate,I,Opiates,0.27,0.37,SGP
117,Asia,East and South-East Asia,Singapore,0.01,,,2006,15-64,ARQ ,R ,Opiates,,,SGP
118,Asia,East and South-East Asia,Thailand,0.2,,,2007,15-64,ARQ,HHS,Opiates,,,THA
119,Asia,East and South-East Asia,Viet Nam,0.53,,,2011,15-64,Government source,I,Opiates,,,VNM
120,Asia,East and South-East Asia,Viet Nam,0.27,,,2005,15-64,INCSR/ Reference Group to the UN on HIV and IDU,,Opiates,0.25,0.28,VNM
121,Asia,Near and Middle East/South-West Asia,Afghanistan,2.65,3.9,1.3,2009,15-64,UNODC/ Government source,HHS,Opiates,2.34,2.96,AFG
122,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),3.31,,,2015,15-64,Government source/UNODC Estimate,HHS,Opiates,,,IRN
123,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),2.69,,,2013,18+,Academic/UNODC Estimate,NSUM,Opiates,2.02,3.37,IRN
124,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),1.76,,,2011,15-64,Government source,,Opiates,1.38,2.14,IRN
125,Asia,Near and Middle East/South-West Asia,Iran (Islamic Republic of),2.26,,,2010,15-64,ARQ,,Opiates,,,IRN
126,Asia,Near and Middle East/South-West Asia,Israel,0.4,,,2016,18-65,UNODC Estimate,HHS,Opiates,0.3,0.5,ISR
127,Asia,Near and Middle East/South-West Asia,Israel,0.53,0.92,0.13,2009,18-40,ARQ,HHS,Opiates,0.46,0.59,ISR
128,Asia,Near and Middle East/South-West Asia,Kuwait,0.17,,,2004,15-64,UNODC Estimate,,Opiates,,,KWT
129,Asia,Near and Middle East/South-West Asia,Lebanon,0.2,,,2003,15-64,ARQ,,Opiates,,,LBN
130,Asia,Near and Middle East/South-West Asia,Pakistan,1,1.8,0.04,2012,15-64,Government/UNODC,,Opiates,0.7,1.5,PAK
131,Asia,Near and Middle East/South-West Asia,Pakistan,0.57,,,2006,15-64,UNODC (GAP survey) ,,Opiates,,,PAK
132,Asia,Near and Middle East/South-West Asia,Saudi Arabia,0.06,,,2006,15-64,UNODC Estimate,,Opiates,,,SAU
133,Asia,Near and Middle East/South-West Asia,Syrian Arab Republic,0.02,,,2005,,UNODC Estimate,,Opiates,,,SYR
134,Asia,Near and Middle East/South-West Asia,United Arab Emirates,0.02,,,2004,15-64,UNODC Estimate,,Opiates,,,ARE
135,Asia,South Asia,Bangladesh,0.37,,,2003,15-64,ARQ,HHS,Opiates,,,BGD
136,Asia,South Asia,India,1.42,,,2018,10-75,Government source,HHS/I,Opiates,,,IND
137,Asia,South Asia,Maldives,1.34,,,2012,15-64,Government source,HHS,Opiates,,,MDV
138,Asia,South Asia,Nepal,0.391,,,2019,15-50,Government source/UNODC Estimate,HHS,Opiates,,,NPL
139,Asia,South Asia,Nepal,0.24,,,2006,15-64,Government source,"I, b",Opiates,0.18,0.29,NPL
140,Asia,South Asia,Sri Lanka,0.61,1.24,0.02,2019,15-64,ARQ,HHS,Opiates,,,LKA
141,Asia,South Asia,Sri Lanka,0.6,1.2,0.017,2018,14+,Government source,,Opiates,,,LKA
142,Asia,South Asia,Sri Lanka,0.3,,,2016,15-64,Government source,I,Opiates,0.28,0.32,LKA
143,Asia,South Asia,Sri Lanka,0.33,,,2010,15-64,ARQ,I,Opiates,0.33,0.33,LKA
144,Asia,South Asia,Sri Lanka,0.11,,,2006,15-64,ARQ ,,Opiates,,,LKA
145,Europe,Eastern Europe,Belarus,0.765,,,2016,15-64,ARQ,I,Opiates,,,BLR
146,Europe,Eastern Europe,Belarus,0.59,,,2011,15-64,UNODC Estimate,I,Opiates,,,BLR
147,Europe,Eastern Europe,Belarus,0.39,,,2007,15-64,UNODC Estimate ,R ,Opiates,0.07,0.67,BLR
148,Europe,Eastern Europe,Republic of Moldova,0.12,,,2011,15-64,ARQ,I,Opiates,,,MDA
149,Europe,Eastern Europe,Republic of Moldova,0.15,,,2008,15-64,Government source,"R, HHS",Opiates,0.15,0.17,MDA
150,Europe,Eastern Europe,Russian Federation,1.4,,,2010,15-64,Government source,I,Opiates,1.4,1.4,RUS
151,Europe,Eastern Europe,Russian Federation,1.64,,,2007,15-64,UNODC Estimate ,I ,Opiates,,,RUS
152,Europe,Eastern Europe,Ukraine,1.05,,,2012,15-64,Government source,I,Opiates,0.88,1.23,UKR
153,Europe,Eastern Europe,Ukraine,0.91,,,2009,15-64,ARQ,I,Opiates,,,UKR
154,Europe,Eastern Europe,Ukraine,1.16,,,2006,15-64,Reference Group to the UN on HIV and IDU ,I ,Opiates,,,UKR
155,Europe,South-Eastern Europe,Albania,0.45,,,2007,15-64,ARQ,R,Opiates,,,ALB
156,Europe,South-Eastern Europe,Bosnia and Herzegovina,0.3,,,2009,15-64,ARQ,I,Opiates,,,BIH
157,Europe,South-Eastern Europe,Bosnia and Herzegovina,0.3,,,2005,15-64,Reference Group to the UN on HIV and IDU ,I ,Opiates,,,BIH
158,Europe,South-Eastern Europe,Bulgaria,0.37,,,2017,15-64,ARQ,I,Opiates,,,BGR
159,Europe,South-Eastern Europe,Bulgaria,0.5,,,2011,15-64,ARQ,I,Opiates,,,BGR
160,Europe,South-Eastern Europe,Bulgaria,0.29,,,2008,15-64,ARQ ,I ,Opiates,,,BGR
161,Europe,South-Eastern Europe,Croatia,0.35,,,2012,15-64,ARQ,I,Opiates,,,HRV
162,Europe,South-Eastern Europe,Croatia,0.36,,,2010,15-64,EMCDDA,I,Opiates,0.32,0.4,HRV
163,Europe,South-Eastern Europe,Croatia,0.36,,,2006,15-64,ARQ ,I ,Opiates,,,HRV
164,Europe,South-Eastern Europe,North Macedonia,0.4,,,2005,15-64,ARQ,,Opiates,0.4,0.5,MKD
165,Europe,South-Eastern Europe,Romania,0.3,0.2,0.5,2019,15-64,ARQ,HHS,Opiates,,,ROU
166,Europe,South-Eastern Europe,Romania,0.167,,,2016,15-64,ARQ,I,Opiates,,,ROU
167,Europe,South-Eastern Europe,Romania,0.11,,,2011,15-64,ARQ,I,Opiates,,,ROU
168,Europe,South-Eastern Europe,Serbia,0.1,0.1,0.1,2018,15-64,ARQ,HHS,Opiates,,,SRB
169,Europe,South-Eastern Europe,Serbia,0.1,0.1,0,2014,18-64,Government sources,HHS,Opiates,,,SRB
170,Europe,South-Eastern Europe,Serbia,0.28,,,2008,15-64,ARQ,I,Opiates,0.18,0.38,SRB
171,Europe,South-Eastern Europe,Türkiye,0.03,0.05,,2018,15-64,ARQ,HHS,Opiates,,,TUR
172,Europe,South-Eastern Europe,Türkiye,0.03,,,2011,15-64,EMCDDA,I,Opiates,0.02,0.05,TUR
173,Europe,South-Eastern Europe,Türkiye,0.03,,,2010,15-64,EMCDDA,I,Opiates,0.03,0.03,TUR
174,Europe,South-Eastern Europe,Türkiye,0.05,,,2008,15-64,EMCDDA ,I ,Opiates,,,TUR
175,Europe,Western and Central Europe,Austria,0.539,,,2019,15-64,EMCDDA,I,Opiates,0.52,0.55,AUT
176,Europe,Western and Central Europe,Austria,0.628,,,2017,15-64,EMCDDA,,Opiates,0.608,0.648,AUT
177,Europe,Western and Central Europe,Cyprus,0.179,,,2016,15-64,ARQ,I,Opiates,0.147,0.221,CYP
178,Europe,Western and Central Europe,Cyprus,0.246,,,2015,15-64,EMCDDA,I,Opiates,0.193,0.324,CYP
179,Europe,Western and Central Europe,Cyprus,0.18,,,2014,15-64,EMCDDA,I,Opiates,0.15,0.24,CYP
180,Europe,Western and Central Europe,Cyprus,0.15,,,2013,15-64,EMCDDA,I,Opiates,0.12,0.21,CYP
181,Europe,Western and Central Europe,Cyprus,0.12,,,2012,15-64,EMCDDA,I,Opiates,0.1,0.15,CYP
182,Europe,Western and Central Europe,Czechia,0.1,0.2,0,2019,15-64,ARQ,HHS,Opiates,,,CZE
183,Europe,Western and Central Europe,Czechia,0.2,0.1,0.2,2018,15-64,ARQ,HHS,Opiates,,,CZE
184,Europe,Western and Central Europe,Czechia,0.2,0.4,0.1,2016,15-64,ARQ,HHS,Opiates,,,CZE
185,Europe,Western and Central Europe,Denmark,0.1,0.1,0,2017,16-24,ARQ,HHS,Opiates,,,DNK
186,Europe,Western and Central Europe,Denmark,0.52,,,2009,15-64,Government source,I,Opiates,0.49,0.55,DNK
187,Europe,Western and Central Europe,Denmark,0.6,,,2005,15-64,ARQ,I,Opiates,,,DNK
188,Europe,Western and Central Europe,Estonia,0.04,0.11,0,2018,16-64,ARQ,HHS,Opiates,,,EST
189,Europe,Western and Central Europe,Finland,0.1,0.1,,2018,15-64,ARQ,HHS,Opiates,,,FIN
190,Europe,Western and Central Europe,Finland,0.1,0.1,0.1,2014,15-64,ARQ,HHS,Opiates,,,FIN
191,Europe,Western and Central Europe,France,0.317,,,2019,15-64,EMCDDA,I,Opiates,0.309,0.325,FRA
192,Europe,Western and Central Europe,France,0.2,0.3,0.1,2017,15-64,ARQ,HHS,Opiates,,,FRA
193,Europe,Western and Central Europe,France,0.52,,,2011,15-64,ARQ,I,Opiates,,,FRA
194,Europe,Western and Central Europe,France,0.36,,,2010,15-64,UNODC Estimate,I,Opiates,,,FRA
195,Europe,Western and Central Europe,Germany,0.22,,,2014,15-64,ARQ,I,Opiates,,,DEU
196,Europe,Western and Central Europe,Germany,0.21,,,2013,15-64,Government source,I,Opiates,,,DEU
197,Europe,Western and Central Europe,Germany,0.23,,,2012,18-64,ARQ,I,Opiates,,,DEU
198,Europe,Western and Central Europe,Greece,0.216,,,2019,15-64,EMCDDA,I,Opiates,0.179,0.266,GRC
199,Europe,Western and Central Europe,Greece,0.197,,,2018,15-64,EMCDDA,I,Opiates,0.163,0.243,GRC
200,Europe,Western and Central Europe,Greece,0.21,,,2017,15-64,EMCDDA,I,Opiates,0.18,0.247,GRC
201,Europe,Western and Central Europe,Greece,0.246,,,2016,15-64,ARQ,I,Opiates,0.211,0.29,GRC
202,Europe,Western and Central Europe,Greece,0.227,,,2015,15-64,ARQ,I,Opiates,,,GRC
203,Europe,Western and Central Europe,Greece,0.24,,,2014,15-64,EMCDDA,I,Opiates,0.21,0.28,GRC
204,Europe,Western and Central Europe,Greece,0.22,,,2013,15-64,EMCDDA,I,Opiates,0.2,0.26,GRC
205,Europe,Western and Central Europe,Greece,0.23,,,2012,15-64,EMCDDA,I,Opiates,0.26,0.32,GRC
206,Europe,Western and Central Europe,Hungary,0.2,0.3,0.1,2019,18-64,ARQ,HHS,Opiates,,,HUN
207,Europe,Western and Central Europe,Hungary,0.13,0.17,0,2015,18-64,ARQ,HHS,Opiates,,,HUN
208,Europe,Western and Central Europe,Hungary,0.05,,,2011,15-64,EMCDDA,I,Opiates,0.04,0.05,HUN
209,Europe,Western and Central Europe,Hungary,0.05,,,2009,15-64,ARQ,I,Opiates,,,HUN
210,Europe,Western and Central Europe,Ireland,0.618,,,2014,15-64,ARQ,I,Opiates,0.609,0.698,IRL
211,Europe,Western and Central Europe,Ireland,0.72,,,2006,15-64,EMCDDA,I,Opiates,0.62,0.81,IRL
212,Europe,Western and Central Europe,Ireland,0.5,,,2001,15-64,ARQ,I,Opiates,,,IRL
213,Europe,Western and Central Europe,Italy,0.756,,,2019,15-64,EMCDDA,I,Opiates,0.723,0.79,ITA
214,Europe,Western and Central Europe,Italy,0.685,,,2018,15-64,EMCDDA,I,Opiates,0.654,0.716,ITA
215,Europe,Western and Central Europe,Italy,0.57,,,2017,15-64,UNODC Estimate/ARQ,I,Opiates,,,ITA
216,Europe,Western and Central Europe,Italy,0.524,,,2015,15-64,EMCDDA,I,Opiates,0.459,0.587,ITA
217,Europe,Western and Central Europe,Italy,0.52,,,2014,15-64,EMCDDA,I,Opiates,0.46,0.58,ITA
218,Europe,Western and Central Europe,Italy,0.8,1.1,0.6,2013,15-64,Government source,HHS,Opiates,,,ITA
219,Europe,Western and Central Europe,Latvia,0.568,,,2017,15-64,ARQ/EMCDDA,I,Opiates,0.465,0.702,LVA
220,Europe,Western and Central Europe,Latvia,0.49,,,2016,15-64,Government source,I,Opiates,0.41,0.59,LVA
221,Europe,Western and Central Europe,Latvia,0.47,,,2014,15-64,EMCDDA,I,Opiates,0.34,0.75,LVA
222,Europe,Western and Central Europe,Latvia,0.62,,,2013,15-64,EMCDDA,I,Opiates,0.42,1,LVA
223,Europe,Western and Central Europe,Latvia,0.49,,,2012,15-64,EMCDDA,I,Opiates,0.5,0.36,LVA
224,Europe,Western and Central Europe,Liechtenstein,0.2,,,2005,15-64,ARQ,SS,Opiates,,,LIE
225,Europe,Western and Central Europe,Lithuania,0.24,,,2007,15-64,EMCDDA,I,Opiates,0.23,0.24,LTU
226,Europe,Western and Central Europe,Lithuania,0.1,,,2006,15-64,Government source,I,Opiates,,,LTU
227,Europe,Western and Central Europe,Luxembourg,0.446,,,2015,15-64,EMCDDA,I,Opiates,,,LUX
228,Europe,Western and Central Europe,Luxembourg,0.59,,,2007,15-64,ARQ/EMCDDA,I,Opiates,,,LUX
229,Europe,Western and Central Europe,Luxembourg,0.93,,,2000,15-64,EMCDDA,I,Opiates,,,LUX
230,Europe,Western and Central Europe,Malta,0.61,,,2016,15-64,ARQ,I,Opiates,,,MLT
231,Europe,Western and Central Europe,Malta,0.59,,,2015,15-64,ARQ,I,Opiates,,,MLT
232,Europe,Western and Central Europe,Malta,0.57,,,2014,15-64,EMCDDA,I,Opiates,0.53,0.62,MLT
233,Europe,Western and Central Europe,Malta,0.62,,,2012,15-64,EMCDDA,I,Opiates,0.58,0.66,MLT
234,Europe,Western and Central Europe,Netherlands,0.13,,,2012,15-64,EMCDDA,I,Opiates,0.11,0.15,NLD
235,Europe,Western and Central Europe,Netherlands,0.16,,,2008,15-64,EMCDDA,I,Opiates,,,NLD
236,Europe,Western and Central Europe,Norway,0.27,,,2013,15-64,ARQ,I,Opiates,,,NOR
237,Europe,Western and Central Europe,Norway,0.3,,,2008,15-64,EMCDDA,I,Opiates,0.21,0.39,NOR
238,Europe,Western and Central Europe,Poland,1.7,1.8,1.5,2016,15-64,ARQ,HHS,Opiates,,,POL
239,Europe,Western and Central Europe,Poland,0.06,,,2014,15-64,ARQ,I,Opiates,,,POL
240,Europe,Western and Central Europe,Poland,0.1,,,2013,15-64,ARQ,I,Opiates,,,POL
241,Europe,Western and Central Europe,Poland,0.1,0.1,0.1,2012,15-64,ARQ,HHS,Opiates,,,POL
242,Europe,Western and Central Europe,Poland,0.3,,,2010,15-64,ARQ,HHS,Opiates,,,POL
243,Europe,Western and Central Europe,Portugal,0.45,,,2018,15-64,EMCDDA,I,Opiates,0.3,0.7,PRT
244,Europe,Western and Central Europe,Portugal,0.52,,,2015,15-64,Government source,I,Opiates,0.38,0.76,PRT
245,Europe,Western and Central Europe,Portugal,0.49,,,2012,15-64,EMCDDA,I,Opiates,0.42,0.55,PRT
246,Europe,Western and Central Europe,Portugal,0.38,,,2007,15-64,ARQ,I,Opiates,,,PRT
247,Europe,Western and Central Europe,Slovakia,0.1,0.1,0,2019,15-64,ARQ,HHS,Opiates,,,SVK
248,Europe,Western and Central Europe,Slovakia,0.13,,,2008,15-64,EMCDDA,I,Opiates,0.1,0.25,SVK
249,Europe,Western and Central Europe,Slovakia,0.3,,,2006,15-64,ARQ,HHS,Opiates,,,SVK
250,Europe,Western and Central Europe,Slovenia,0.358,,,2017,15-64,EMCDDA,,Opiates,0.315,0.416,SVN
251,Europe,Western and Central Europe,Slovenia,0.49,,,2012,15-64,EMCDDA,I,Opiates,0.43,0.58,SVN
252,Europe,Western and Central Europe,Slovenia,0.44,,,2011,15-64,EMCDDA,I,Opiates,0.4,0.48,SVN
253,Europe,Western and Central Europe,Spain,0.21,,,2018,15-64,Government source,I,Opiates,0.14,0.28,ESP
254,Europe,Western and Central Europe,Spain,0.23,,,2017,15-64,ARQ/Government source,I,Opiates,0.15,0.29,ESP
255,Europe,Western and Central Europe,Spain,0.221,,,2016,15-64,ARQ,I,Opiates,0.149,0.293,ESP
256,Europe,Western and Central Europe,Spain,0.227,,,2015,15-64,ARQ,I,Opiates,0.155,0.299,ESP
257,Europe,Western and Central Europe,Spain,0.21,,,2014,15-64,ARQ,I,Opiates,0.158,0.263,ESP
258,Europe,Western and Central Europe,Spain,0.21,,,2013,15-64,ARQ/Government source,I,Opiates,0.16,0.25,ESP
259,Europe,Western and Central Europe,Spain,0.21,,,2012,15-64,Government source,I,Opiates,0.17,0.26,ESP
260,Europe,Western and Central Europe,Switzerland,0.43,,,2015,15-64,Government source,I,Opiates,0.39,0.47,CHE
261,Europe,Western and Central Europe,United Kingdom (England and Wales),0.74,,,2016,15-64,Government source,I,Opiates,0.73,0.77,GBR
262,Europe,Western and Central Europe,United Kingdom (England and Wales),0.76,,,2015,15-64,Government source,I,Opiates,0.75,0.79,GBR
263,Europe,Western and Central Europe,United Kingdom (England and Wales),0.73,,,2011,15-64,EMCDDA/UNODC Estimate,I,Opiates,0.72,0.76,GBR
264,Europe,Western and Central Europe,United Kingdom (England and Wales),0.75,,,2010,15-64,EMCDDA/UNODC Estimate,I,Opiates,0.73,0.78,GBR
265,Europe,Western and Central Europe,United Kingdom (Northern Ireland),0.12,,,2004,15-64,EMCDDA,I,Opiates,0.12,0.17,GBR
266,Europe,Western and Central Europe,United Kingdom (Scotland),1.51,2.19,0.86,2012,15-64,"Information Services Division, Scotland",I,Opiates,1.47,1.57,GBR
267,Europe,Western and Central Europe,United Kingdom (Scotland),1.52,,,2009,15-64,EMCDDA/UNODC Estimate,I,Opiates,1.49,1.56,GBR
268,Oceania,Australia and New Zealand,Australia,0.1,,,2019,14+,Govenment source,HHS,Opiates,,,AUS
269,Oceania,Australia and New Zealand,Australia,0.2,,,2016,14+,ARQ,HHS,Opiates,,,AUS
270,Oceania,Australia and New Zealand,Australia,0.1,0.2,0.1,2013,14+,ARQ,HHS,Opiates,,,AUS
271,Oceania,Australia and New Zealand,Australia,0.2,,,2010,15-64,ARQ,HHS,Opiates,,,AUS
272,Oceania,Australia and New Zealand,Australia,0.2,,,2007,15-64,ARQ ,HHS ,Opiates,,,AUS
273,Oceania,Australia and New Zealand,New Zealand,0.1,,,2008,16-64,Government source,HHS,Opiates,0.1,0.3,NZL
274,Oceania,Australia and New Zealand,New Zealand,0.42,,,2006,15-45,ARQ,,Opiates,,,NZL
0,Africa,East Africa,Mauritius,1.04,,,2007,15-54,ARQ ,I ,Prescription opioids,,,MUS
1,Africa,North Africa,Tunisia,0.13,,,2013,15-64,ARQ,HHS,Prescription opioids,,,TUN
2,Africa,Southern Africa,South Africa,0.09,,,2008,15-64,ARQ,HHS,Prescription opioids,,,ZAF
3,Africa,West and Central Africa,Nigeria,4.66,6,3.3,2017,15-64,Government/UNODC,HHS/I,Prescription opioids,4.21,5.11,NGA
4,Africa,West and Central Africa,Egypt,3,,,2016,15-64,Government source,HHS,Prescription opioids,,,EGY
5,Americas,Caribbean,Barbados,0.16,,,2006,15-64,UNODC Estimate,,Prescription opioids,0.12,0.21,BRB
6,Americas,Caribbean,Dominican Republic,0.03,,,2008,15-64,UNODC Estimate,SS,Prescription opioids,,,DOM
7,Americas,Caribbean,Haiti,0.13,,,2006,15-64,ARQ,SS,Prescription opioids,,,HTI
8,Americas,Central America,Costa Rica,0.75,0.77,0.74,2015,15-64,ARQ,HHS,Prescription opioids,,,CRI
9,Americas,Central America,Costa Rica,0.71,0.72,0.71,2015,12-70,ARQ,HHS,Prescription opioids,,,CRI
10,Americas,Central America,Costa Rica,0.63,1.37,0.59,2010,15-64,ARQ,HHS,Prescription opioids,,,CRI
11,Americas,Central America,Costa Rica,2.8,,,2006,12-70,ARQ ,HHS ,Prescription opioids,2.8,2.9,CRI
12,Americas,Central America,El Salvador,0.06,,,2005,15-64,UNODC Estimate,HHS,Prescription opioids,,,SLV
13,Americas,North America,Canada,,0.5,,2017,15+,ARQ,HHS,Prescription opioids,,,CAN
14,Americas,North America,Canada,0.36,0.46,,2015,15-64,ARQ,HHS,Prescription opioids,,,CAN
15,Americas,North America,Canada,0.4,0.4,,2013,15-64,ARQ/Government,HHS,Prescription opioids,,,CAN
16,Americas,North America,Canada,1,1.3,,2012,15-64,ARQ,HHS,Prescription opioids,,,CAN
17,Americas,North America,Canada,0.3,,,2010,15-64,ARQ,HHS,Prescription opioids,,,CAN
18,Americas,North America,Canada,0.5,,,2009,15-64,ARQ,"HHS, I x ",Prescription opioids,,,CAN
19,Americas,North America,Mexico,0.1,0.1,0.1,2016,12-65,ARQ,HHS,Prescription opioids,,,MEX
20,Americas,North America,Mexico,0.06,,,2008,12-65,ARQ ,HHS,Prescription opioids,,,MEX
21,Americas,North America,United States of America,3.9,3.5,4.2,2020,15-64,ARQ,HHS,Prescription opioids,,,USA
22,Americas,North America,United States of America,4.3,4.3,4.1,2018,15-64,ARQ,HHS,Prescription opioids,,,USA
23,Americas,North America,United States of America,4.8,5.4,4.2,2017,15-64,ARQ,HHS,Prescription opioids,,,USA
24,Americas,North America,United States of America,5.1,5.6,4.6,2016,15-64,ARQ,HHS,Prescription opioids,,,USA
25,Americas,North America,United States of America,5.5,6.3,4.8,2015,15-64,ARQ,HHS,Prescription opioids,,,USA
26,Americas,North America,United States of America,4.8,,,2014,15-64,UNODC Estimate,HHS,Prescription opioids,,,USA
27,Americas,North America,United States of America,5,,,2013,15-64,UNODC Estimate,,Prescription opioids,,,USA
28,Americas,North America,United States of America,5.7,,,2012,15-64,ARQ,HHS,Prescription opioids,,,USA
29,Americas,North America,United States of America,5.2,,,2011,15-64,ARQ/UNODC Estimate,HHS,Prescription opioids,,,USA
30,Americas,North America,United States of America,5.7,,,2010,15-64,ARQ/ UNODC Estimate,HHS,Prescription opioids,,,USA
31,Americas,South America,Argentina,0.06,0.08,0.04,2011,16-65,ARQ/Government,HHS,Prescription opioids,,,ARG
32,Americas,South America,Argentina,0.11,,,2007,15-64,UNODC Etimate,,Prescription opioids,0.1,0.13,ARG
33,Americas,South America,Brazil,0.57,0.45,0.69,2012,15-64,Government source,HHS,Prescription opioids,,,BRA
34,Americas,South America,Brazil,0.4,,,2005,12-65,ARQ,HHS,Prescription opioids,,,BRA
35,Americas,South America,Chile,1.22,1.41,1.04,2020,15-64,ARQ,HHS,Prescription opioids,,,CHL
36,Americas,South America,Chile,1.14,1.21,1.08,2018,15-64,ARQ,HHS,Prescription opioids,,,CHL
37,Americas,South America,Chile,1.22,0.94,1.5,2016,15-64,ARQ,HHS,Prescription opioids,,,CHL
38,Americas,South America,Chile,0.56,0.5,0.62,2014,15-64,ARQ,HHS,Prescription opioids,,,CHL
39,Americas,South America,Chile,0.28,0.24,0.32,2012,15-64,ARQ,HHS,Prescription opioids,,,CHL
40,Americas,South America,Chile,0.27,,,2010,15-64,ARQ,HHS,Prescription opioids,,,CHL
41,Americas,South America,Chile,0.4,,,2008,15-64,HHS ,HHS ,Prescription opioids,,,CHL
42,Americas,South America,Colombia,0.28,0.2,0.35,2019,12-65,Government source,HHS,Prescription opioids,,,COL
43,Americas,South America,Uruguay,0.12,,,2011,15-64,UNODC Estimate,HHS,Prescription opioids,0.03,0.2,URY
44,Asia,Central Asia and Transcaucasia,Armenia,0.08,,,2007,15-64,Government source,,Prescription opioids,,,ARM
45,Asia,Central Asia and Transcaucasia,Georgia,0.27,,,2010,15-64,SCAD/Report - Academic Research,I,Prescription opioids,,,GEO
46,Asia,Central Asia and Transcaucasia,Kazakhstan,0.11,,,2006,15-64,UNODC (GAP survey),I,Prescription opioids,,,KAZ
47,Asia,Central Asia and Transcaucasia,Kyrgyzstan,0.06,,,2006,15-64,UNODC (GAP survey),I,Prescription opioids,,,KGZ
48,Asia,Central Asia and Transcaucasia,Uzbekistan,0.02,,,2006,15-64,UNODC (GAP survey),I,Prescription opioids,,,UZB
49,Asia,East and South-East Asia,Indonesia,0.26,,,2017,10-59,Government,HHS,Prescription opioids,,,IDN
50,Asia,East and South-East Asia,Indonesia,0.05,0.1,0.01,2015,10-60,ARQ,HHS,Prescription opioids,,,IDN
51,Asia,East and South-East Asia,Republic of Korea,0.08,,,2004,15-64,ARQ,HHS,Prescription opioids,0.06,0.1,PRK
52,Asia,Near and Middle East/South-West Asia,Afghanistan,0.55,0.8,0.3,2009,15-64,UNODC/ Govt. source,HHS,Prescription opioids,0.46,0.63,AFG
53,Asia,Near and Middle East/South-West Asia,Israel,0.9,0.9,1,2016,18-65,ARQ,HHS,Prescription opioids,,,ISR
54,Asia,Near and Middle East/South-West Asia,Israel,0.21,0.39,0.04,2009,18-40,ARQ,HHS,Prescription opioids,,,ISR
55,Asia,Near and Middle East/South-West Asia,Pakistan,1.5,1.6,1.4,2012,15-64,Government/UNODC,HHS and indirect,Prescription opioids,1.3,1.6,PAK
56,Asia,Near and Middle East/South-West Asia,Pakistan,0.13,,,2006,15-64,UNODC (GAP survey) ,,Prescription opioids,,,PAK
57,Asia,South Asia,Bangladesh,0.03,,,2003,15-64,ARQ,HHS,Prescription opioids,,,BGD
58,Asia,South Asia,India,0.96,,,2018,10-75,Government source,HHS/I,Prescription opioids,,,IND
59,Europe,Eastern Europe,Belarus,0.04,,,2007,15-64,UNODC Estimate ,R ,Prescription opioids,0.01,0.07,BLR
60,Europe,South-Eastern Europe,Bulgaria,0.2,0.2,0.1,2020,15-64,ARQ,HHS,Prescription opioids,,,BGR
61,Europe,South-Eastern Europe,Bulgaria,0.2,0.2,0.2,2016,15-64,ARQ,HHS,Prescription opioids,,,BGR
62,Europe,South-Eastern Europe,Bulgaria,0.1,0.1,0.1,2012,15-64,ARQ,I,Prescription opioids,,,BGR
63,Europe,South-Eastern Europe,Serbia,5.1,4.1,6.1,2014,18-64,Government sources,HHS,Prescription opioids,,,SRB
64,Europe,Western and Central Europe,Czechia,0.7,1,0.5,2019,15-64,ARQ,HHS,Prescription opioids,,,CZE
65,Europe,Western and Central Europe,Czechia,0.1,0.2,0,2018,15-64,ARQ,HHS,Prescription opioids,,,CZE
66,Europe,Western and Central Europe,Czechia,2.6,2.2,2.9,2012,15-64,ARQ,HHS,Prescription opioids,,,CZE
67,Europe,Western and Central Europe,Estonia,0.13,0.22,0.08,2018,16-64,ARQ,HHS,Prescription opioids,,,EST
68,Europe,Western and Central Europe,Estonia,0.71,,,2008,15-64,ARQ,I,Prescription opioids,,,EST
69,Europe,Western and Central Europe,Finland,0.9,0.9,0.8,2018,15-64,ARQ,HHS,Prescription opioids,,,FIN
70,Europe,Western and Central Europe,Finland,0.7,1,0.3,2014,15-64,ARQ,HHS,Prescription opioids,,,FIN
71,Europe,Western and Central Europe,Germany,0.3,0.4,0.3,2012,18-64,HHS,,Prescription opioids,,,DEU
72,Europe,Western and Central Europe,Italy,0.45,0.6,0.31,2017,15-64,Government source,HHS,Prescription opioids,,,ITA
73,Europe,Western and Central Europe,Italy,0.7,0.9,0.4,2013,15-64,ARQ,HHS,Prescription opioids,,,ITA
74,Europe,Western and Central Europe,Poland,0.1,0.3,0,2019,15-64,ARQ,HHS,Prescription opioids,,,POL
75,Europe,Western and Central Europe,Poland,0.1,0.1,0,2012,15-64,ARQ,HHS,Prescription opioids,,,POL
76,Europe,Western and Central Europe,Spain,0.6,0.6,0.7,2020,15-64,ARQ,HHS,Prescription opioids,,,ESP
77,Europe,Western and Central Europe,United Kingdom (England and Wales),0.04,0.06,0.02,2019,16-64,ARQ,HHS,Prescription opioids,,,GBR
78,Europe,Western and Central Europe,United Kingdom (England and Wales),0.06,0.07,0.04,2018,16-59,Government source,HHS,Prescription opioids,,,GBR
79,Europe,Western and Central Europe,United Kingdom (England and Wales),0.06,,,2017,16-59,Government source,HHS,Prescription opioids,,,GBR
80,Europe,Western and Central Europe,United Kingdom (England and Wales),0.04,0.07,0.01,2016,16-59,Government source,HHS,Prescription opioids,,,GBR
81,Europe,Western and Central Europe,United Kingdom (England and Wales),0.08,0.12,0.03,2015,16-59,Government source,HHS,Prescription opioids,,,GBR
82,Europe,Western and Central Europe,United Kingdom (England and Wales),0.1,0.1,0,2014,16-59,ARQ,HHS,Prescription opioids,,,GBR
83,Europe,Western and Central Europe,United Kingdom (Scotland),0.19,0.28,0.1,2014,16-64,Government source,HHS,Prescription opioids,,,GBR
84,Oceania,Australia and New Zealand,Australia,4.2,,,2019,14+,ARQ,HHS,Prescription opioids,,,AUS
85,Oceania,Australia and New Zealand,Australia,3.6,,,2016,14+,ARQ,HHS,Prescription opioids,,,AUS
86,Oceania,Australia and New Zealand,Australia,3.28,3.33,3.23,2013,14+,Government source,HHS,Prescription opioids,,,AUS
87,Oceania,Australia and New Zealand,Australia,3.1,,,2010,15-64,Government source,HHS,Prescription opioids,,,AUS
88,Oceania,Australia and New Zealand,New Zealand,1,1.5,1,2008,15-64,Government source,HHS,Prescription opioids,0.7,1.3,NZL
0,Africa,East Africa,Kenya,0,0,0,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,KEN
1,Africa,North Africa,Algeria,0.59,0.54,0.63,2010,12+,ARQ,HHS,Tranquillizers and sedatives,,,DZA
2,Africa,North Africa,Morocco,0.18,,,2004,15+,ARQ/Government,HHS,Tranquillizers and sedatives,,,MAR
3,Africa,North Africa,Tunisia,0.52,,,2013,15-64,ARQ,HHS,Tranquillizers and sedatives,,,TUN
4,Africa,West and Central Africa,Nigeria,0.487,,,2017,15-64,Government/UNODC,HHS/I,Tranquillizers and sedatives,,,NGA
5,Americas,Caribbean,Haiti,11.7,11.6,11.8,2018,15-64,ARQ,HHS,Tranquillizers and sedatives,,,HTI
6,Americas,Caribbean,Jamaica,0.1,,0.2,2001,12-55,ARQ,HHS,Tranquillizers and sedatives,,,JAM
7,Americas,Central America,Costa Rica,2.01,1.92,2.1,2015,12-64,ARQ,HHS,Tranquillizers and sedatives,,,CRI
8,Americas,Central America,Costa Rica,0.74,0.73,0.74,2015,12-70,ARQ,HHS,Tranquillizers and sedatives,,,CRI
9,Americas,Central America,Costa Rica,1.15,1,1.31,2010,12-70,ARQ,HHS,Tranquillizers and sedatives,,,CRI
10,Americas,Central America,El Salvador,1.76,1.52,1.94,2014,12-65,ARQ,HHS,Tranquillizers and sedatives,,,SLV
11,Americas,Central America,El Salvador,1.42,,1.42,2006,12-70,ARQ,HHS,Tranquillizers and sedatives,,,SLV
12,Americas,Central America,Guatemala,2.9,,3.16,2005,15-64,ARQ,HHS,Tranquillizers and sedatives,,,GTM
13,Americas,Central America,Panama,0.75,0.67,0.82,2015,12-65,ARQ,HHS,Tranquillizers and sedatives,,,PAN
14,Americas,North America,Canada,0.2,0.2,,2017,15+,ARQ,HHS,Tranquillizers and sedatives,,,CAN
15,Americas,North America,Canada,0.35,,,2015,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CAN
16,Americas,North America,Canada,0.2,,0.2,2009,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CAN
17,Americas,North America,Mexico,0.3,0.3,0.3,2016,12-65,ARQ,HHS,Tranquillizers and sedatives,,,MEX
18,Americas,North America,Mexico,0.3,0.3,0.2,2011,12-65,ARQ,HHS,Tranquillizers and sedatives,,,MEX
19,Americas,North America,Mexico,6.8,,,2008,12-65,ARQ,HHS,Tranquillizers and sedatives,,,MEX
20,Americas,North America,United States of America,2.7,2.5,2.9,2020,15-64,ARQ,HHS,Tranquillizers and sedatives,,,USA
21,Americas,North America,United States of America,2.9,3,2.7,2018,15-64,ARQ,HHS,Tranquillizers and sedatives,,,USA
22,Americas,North America,United States of America,3,3.1,2.9,2017,15-64,ARQ,HHS,Tranquillizers and sedatives,,,USA
23,Americas,North America,United States of America,3.1,3,3.2,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,USA
24,Americas,North America,United States of America,3.1,3.2,3.1,2015,15-64,ARQ,HHS,Tranquillizers and sedatives,,,USA
25,Americas,North America,United States of America,2.6,2.7,2.5,2014,15-64,ARQ,HHS,Tranquillizers and sedatives,,,USA
26,Americas,South America,Argentina,0.75,0.6,0.89,2017,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ARG
27,Americas,South America,Argentina,1.3,1.2,1.4,2011,16-65,ARQ,HHS,Tranquillizers and sedatives,,,ARG
28,Americas,South America,Argentina,1.3,1,1.6,2010,12-65,ARQ,HHS,Tranquillizers and sedatives,,,ARG
29,Americas,South America,Bolivia (Plurinational State of),2.02,1.92,2.12,2018,15-64,ARQ,HHS,Tranquillizers and sedatives,,,BOL
30,Americas,South America,Bolivia (Plurinational State of),1.87,2.07,1.71,2014,12-65,ARQ,HHS,Tranquillizers and sedatives,,,BOL
31,Americas,South America,Bolivia (Plurinational State of),1.87,2.07,1.71,2013,12-65,ARQ,HHS,Tranquillizers and sedatives,,,BOL
32,Americas,South America,Bolivia (Plurinational State of),2.05,1.97,2.11,2018,12-65,ARQ,HHS,Tranquillizers and sedatives,,,BOL
33,Americas,South America,Bolivia (Plurinational State of),2.6,2,3.1,2007,12-65,ARQ,HHS,Tranquillizers and sedatives,,,BOL
34,Americas,South America,Brazil,5.68,3.18,8.03,2012,15-64,Government source,HHS,Tranquillizers and sedatives,,,BRA
35,Americas,South America,Brazil,2.1,,,2005,15-64,ARQ,HHS,Tranquillizers and sedatives,,,BRA
36,Americas,South America,Chile,2.06,2.36,1.77,2020,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CHL
37,Americas,South America,Chile,1.44,1.18,1.69,2018,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CHL
38,Americas,South America,Chile,1.77,1.54,2.01,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CHL
39,Americas,South America,Chile,1.2,0.97,1.43,2014,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CHL
40,Americas,South America,Chile,1.53,1.33,1.71,2012,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CHL
41,Americas,South America,Colombia,0.61,0.64,0.58,2019,12-65,Government source,HHS,Tranquillizers and sedatives,,,COL
42,Americas,South America,Colombia,0.53,0.55,0.51,2013,12-65,Government source,HHS,Tranquillizers and sedatives,,,COL
43,Americas,South America,Colombia,0.52,0.52,0.52,2008,12-65,ARQ/Government,HHS,Tranquillizers and sedatives,,,COL
44,Americas,South America,Colombia,1.2,1.7,0.9,2003,18-65,ARQ/UNODC,HHS,Tranquillizers and sedatives,,,COL
45,Americas,South America,Ecuador,1.5,,,2007,12-65,ARQ,HHS,Tranquillizers and sedatives,,,ECU
46,Americas,South America,Peru,1.29,1.08,1.46,2010,12-65,ARQ,HHS,Tranquillizers and sedatives,,,PER
47,Americas,South America,Peru,2.98,2.44,3.4,2006,15-74,ARQ,HHS,Tranquillizers and sedatives,,,PER
48,Americas,South America,Suriname,1.35,,,2013,12-65,UNODC Estimate/ARQ,HHS,Tranquillizers and sedatives,,,SUR
49,Americas,South America,Uruguay,2.7,2.3,3.1,2018,15-65,ARQ,HHS,Tranquillizers and sedatives,,,URY
50,Americas,South America,Uruguay,2.2,2,2.5,2014,15-65,ARQ,HHS,Tranquillizers and sedatives,,,URY
51,Americas,South America,Uruguay,1.3,1.2,1.03,2011,15-65,ARQ,HHS,Tranquillizers and sedatives,,,URY
52,Americas,South America,Venezuela (Bolivarian Republic of),2.13,1.76,2.5,2011,12-65,ARQ,HHS,Tranquillizers and sedatives,,,VEN
53,Asia,East and South-East Asia,Indonesia,0.305,,,2019,15-64,ARQ/UNODC Estimates,HHS,Tranquillizers and sedatives,,,IDN
54,Asia,East and South-East Asia,Indonesia,0.19,0.35,0.05,2015,10-60,ARQ,HHS,Tranquillizers and sedatives,,,IDN
55,Asia,East and South-East Asia,Indonesia,0.84,0.76,1.15,2012,15-60,ARQ,HHS,Tranquillizers and sedatives,,,IDN
56,Asia,East and South-East Asia,Japan,5.6,,,2017,15-64,ARQ,HHS,Tranquillizers and sedatives,,,JPN
57,Asia,East and South-East Asia,Japan,5.6,,,2015,15-64,ARQ,HHS,Tranquillizers and sedatives,,,JPN
58,Asia,East and South-East Asia,Myanmar,0.13,,,2002,15-64,ARQ,HHS,Tranquillizers and sedatives,,,MMR
59,Asia,Near and Middle East/South-West Asia,Afghanistan,1.4,1.4,1.4,2015,15+,INL,HHS,Tranquillizers and sedatives,,,AFG
60,Asia,Near and Middle East/South-West Asia,Afghanistan,0.8,,0.1,2003,15-64,UNODC/ Govt. Source,HHS,Tranquillizers and sedatives,,,AFG
61,Asia,Near and Middle East/South-West Asia,Israel,1,1,0.9,2016,18-65,ARQ,HHS,Tranquillizers and sedatives,,,ISR
62,Asia,Near and Middle East/South-West Asia,Israel,2.79,3.1,2.67,2009,18-40,ARQ,HHS,Tranquillizers and sedatives,,,ISR
63,Asia,Near and Middle East/South-West Asia,Israel,1.9,,,2005,18-40,ARQ,HHS,Tranquillizers and sedatives,,,ISR
64,Asia,Near and Middle East/South-West Asia,Pakistan,1.4,1.3,1.5,2012,15-64,Government/UNODC,HHS/I,Tranquillizers and sedatives,,,PAK
65,Asia,Near and Middle East/South-West Asia,Pakistan,2,,,2001,18-40,ARQ,HHS,Tranquillizers and sedatives,,,PAK
66,Asia,South Asia,India,1.08,2.07,0.09,2018,15-64,ARQ,HHS,Tranquillizers and sedatives,,,IND
67,Asia,South Asia,Nepal,0.629,,,2019,15-50,Government source/UNODC Estimate,HHS,Tranquillizers and sedatives,,,NPL
68,Europe,Eastern Europe,Republic of Moldova,0.5,0.49,0.01,2011,15-55,ARQ,HHS,Tranquillizers and sedatives,,,MDA
69,Europe,South-Eastern Europe,Albania,8.5,7.7,9.2,2014,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ALB
70,Europe,South-Eastern Europe,Bulgaria,7.7,10.6,5,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,BGR
71,Europe,South-Eastern Europe,Bulgaria,4.8,3,6.7,2012,15-64,ARQ,HHS,Tranquillizers and sedatives,,,BGR
72,Europe,South-Eastern Europe,Bulgaria,5.2,3.2,7.2,2008,15-64,ARQ,HHS,Tranquillizers and sedatives,,,BGR
73,Europe,South-Eastern Europe,Croatia,17.3,13.1,21.5,2015,15-64,ARQ,HHS,Tranquillizers and sedatives,,,HRV
74,Europe,South-Eastern Europe,Croatia,16.2,11.4,20.9,2011,15-64,ARQ,HHS,Tranquillizers and sedatives,,,HRV
75,Europe,South-Eastern Europe,Montenegro,11.6,12.5,10.6,2017,15-64,ARQ,HHS,Tranquillizers and sedatives,,,MNE
76,Europe,South-Eastern Europe,North Macedonia,10,,70,2008,15-64,ARQ,HHS,Tranquillizers and sedatives,,,MKD
77,Europe,South-Eastern Europe,Romania,0.7,0.8,0.6,2019,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ROU
78,Europe,South-Eastern Europe,Romania,1.9,1.6,2.2,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ROU
79,Europe,South-Eastern Europe,Romania,0.7,1.1,0.4,2013,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ROU
80,Europe,South-Eastern Europe,Romania,2.1,1.2,3,2010,,ARQ,HHS,Tranquillizers and sedatives,,,ROU
81,Europe,South-Eastern Europe,Türkiye,5.1,3,7.2,2011,15-64,ARQ,HHS,Tranquillizers and sedatives,,,TUR
82,Europe,Western and Central Europe,Austria,8.9,8.1,9.8,2015,15-64,Government source,HHS,Tranquillizers and sedatives,,,AUT
83,Europe,Western and Central Europe,Cyprus,3.9,2.8,5,2019,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CYP
84,Europe,Western and Central Europe,Cyprus,4,2.9,4.9,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CYP
85,Europe,Western and Central Europe,Cyprus,4.2,3,5.3,2012,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CYP
86,Europe,Western and Central Europe,Czechia,12.5,10.1,14.9,2019,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CZE
87,Europe,Western and Central Europe,Czechia,12.8,10.8,14.8,2018,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CZE
88,Europe,Western and Central Europe,Czechia,19.5,17.3,21.9,2015,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CZE
89,Europe,Western and Central Europe,Czechia,18.3,15.5,21.2,2014,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CZE
90,Europe,Western and Central Europe,Czechia,12.3,12.6,12.1,2013,15-64,ARQ,HHS,Tranquillizers and sedatives,,,CZE
91,Europe,Western and Central Europe,Estonia,0.49,0.88,0.23,2018,16-64,ARQ,HHS,Tranquillizers and sedatives,,,EST
92,Europe,Western and Central Europe,Finland,1.8,2.2,1.4,2014,15-64,ARQ,HHS,Tranquillizers and sedatives,,,FIN
93,Europe,Western and Central Europe,Finland,2.3,2.2,2.4,2010,15-64,ARQ,HHS,Tranquillizers and sedatives,,,FIN
94,Europe,Western and Central Europe,Germany,5.4,4.6,6.2,2012,18-64,ARQ,HHS,Tranquillizers and sedatives,,,DEU
95,Europe,Western and Central Europe,Germany,4.3,3.7,4.9,2009,18-64,ARQ,HHS,Tranquillizers and sedatives,,,DEU
96,Europe,Western and Central Europe,Greece,0.7,,1,2004,15-64,ARQ,HHS,Tranquillizers and sedatives,,,GRC
97,Europe,Western and Central Europe,Greece,0.3,,0.1,1998,15-64,ARQ,HHS,Tranquillizers and sedatives,,,GRC
98,Europe,Western and Central Europe,Hungary,7.5,4.8,9.8,2019,18-64,ARQ,HHS,Tranquillizers and sedatives,,,HUN
99,Europe,Western and Central Europe,Hungary,9.52,6.07,12.29,2015,18-64,Government source,HHS,Tranquillizers and sedatives,,,HUN
100,Europe,Western and Central Europe,Hungary,13.1,,19,2007,18-64,ARQ,HHS,Tranquillizers and sedatives,,,HUN
101,Europe,Western and Central Europe,Ireland,4.9,5,4.8,2019,15-64,ARQ,HHS,Tranquillizers and sedatives,,,IRL
102,Europe,Western and Central Europe,Ireland,6.1,4.4,7.7,2015,15-64,ARQ,HHS,Tranquillizers and sedatives,,,IRL
103,Europe,Western and Central Europe,Italy,13.8,10.4,17.1,2013,15-64,Government source,HHS,Tranquillizers and sedatives,,,ITA
104,Europe,Western and Central Europe,Italy,3.85,2.94,4.63,2012,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ITA
105,Europe,Western and Central Europe,Latvia,4.9,3.4,6.4,2020,15-64,ARQ,HHS,Tranquillizers and sedatives,,,LVA
106,Europe,Western and Central Europe,Latvia,7.2,4.3,10,2011,15-64,ARQ,HHS,Tranquillizers and sedatives,,,LVA
107,Europe,Western and Central Europe,Latvia,6.5,5.1,7.8,2007,15-64,ARQ,HHS,Tranquillizers and sedatives,,,LVA
108,Europe,Western and Central Europe,Lithuania,13.4,7.7,18.7,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,LTU
109,Europe,Western and Central Europe,Lithuania,11.1,6.5,15.5,2012,15-64,ARQ,HHS,Tranquillizers and sedatives,,,LTU
110,Europe,Western and Central Europe,Lithuania,11.85,7.5,15.6,2008,15-64,ARQ,HHS,Tranquillizers and sedatives,,,LTU
111,Europe,Western and Central Europe,Lithuania,11.2,7.3,14.8,2004,15-64,ARQ,HHS,Tranquillizers and sedatives,,,LTU
112,Europe,Western and Central Europe,Malta,0.9,,1,2008,15-64,ARQ,HHS,Tranquillizers and sedatives,,,MLT
113,Europe,Western and Central Europe,Netherlands,3.5,2.9,4.1,2020,15-64,ARQ,HHS,Tranquillizers and sedatives,,,NLD
114,Europe,Western and Central Europe,Netherlands,10.2,7,13.3,2018,18+,ARQ,HHS,Tranquillizers and sedatives,,,NLD
115,Europe,Western and Central Europe,Netherlands,10.5,7.5,13.4,2016,18+,ARQ,HHS,Tranquillizers and sedatives,,,NLD
116,Europe,Western and Central Europe,Netherlands,0.5,0.2,0.8,2015,18+,ARQ,HHS,Tranquillizers and sedatives,,,NLD
117,Europe,Western and Central Europe,Netherlands,0.5,0.2,0.8,2014,15-64,ARQ,HHS,Tranquillizers and sedatives,,,NLD
118,Europe,Western and Central Europe,Netherlands,10.1,7.2,13.1,2009,15-64,ARQ,HHS,Tranquillizers and sedatives,,,NLD
119,Europe,Western and Central Europe,Norway,4.3,3.1,5.5,2015,16-64,ARQ,HHS,Tranquillizers and sedatives,,,NOR
120,Europe,Western and Central Europe,Norway,4.5,3.9,5.2,2014,16-64,ARQ,HHS,Tranquillizers and sedatives,,,NOR
121,Europe,Western and Central Europe,Poland,3.4,2.5,4.3,2019,15-64,ARQ,HHS,Tranquillizers and sedatives,,,POL
122,Europe,Western and Central Europe,Poland,1.9,1.4,2.4,2016,15-64,ARQ,HHS,Tranquillizers and sedatives,,,POL
123,Europe,Western and Central Europe,Poland,2.2,1.4,3,2012,15-64,ARQ,HHS,Tranquillizers and sedatives,,,POL
124,Europe,Western and Central Europe,Poland,3.3,2.2,4.3,2010,15-64,ARQ,HHS,Tranquillizers and sedatives,,,POL
125,Europe,Western and Central Europe,Portugal,0.6,0.5,0.6,2017,15-64,ARQ,HHS,Tranquillizers and sedatives,,,PRT
126,Europe,Western and Central Europe,Portugal,0.6,0.6,0.6,2012,15-64,ARQ,HHS,Tranquillizers and sedatives,,,PRT
127,Europe,Western and Central Europe,Portugal,12,6.3,17.5,2007,15-64,ARQ,HHS,Tranquillizers and sedatives,,,PRT
128,Europe,Western and Central Europe,Slovakia,8.5,4.9,12.2,2019,15-64,ARQ,HHS,Tranquillizers and sedatives,,,SVK
129,Europe,Western and Central Europe,Slovakia,4,,4.2,2006,15-64,ARQ,HHS,Tranquillizers and sedatives,,,SVK
130,Europe,Western and Central Europe,Slovakia,6.1,,6.4,2004,15-64,ARQ,HHS,Tranquillizers and sedatives,,,SVK
131,Europe,Western and Central Europe,Spain,1.3,1.5,1.2,2020,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ESP
132,Europe,Western and Central Europe,Spain,1.3,1.2,1.4,2017,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ESP
133,Europe,Western and Central Europe,Spain,2.3,1.6,2.9,2015,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ESP
134,Europe,Western and Central Europe,Spain,1.2,1.1,1.3,2013,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ESP
135,Europe,Western and Central Europe,Spain,1.2,1.1,1.2,2011,15-64,ARQ,HHS,Tranquillizers and sedatives,,,ESP
136,Europe,Western and Central Europe,Sweden,2.78,2.7,2.86,2013,17-64,ARQ,HHS,Tranquillizers and sedatives,,,SWE
137,Europe,Western and Central Europe,Sweden,2,,2,2003,16-24,ARQ,HHS,Tranquillizers and sedatives,,,SWE
138,Europe,Western and Central Europe,United Kingdom (England and Wales),0.47,0.53,0.42,2019,16-64,ARQ,HHS,Tranquillizers and sedatives,,,GBR
139,Europe,Western and Central Europe,United Kingdom (England and Wales),0.4,0.57,0.23,2018,16-59,Government source,HHS,Tranquillizers and sedatives,,,GBR
140,Europe,Western and Central Europe,United Kingdom (England and Wales),0.6,0.75,0.46,2017,16-59,Government source,HHS,Tranquillizers and sedatives,,,GBR
141,Europe,Western and Central Europe,United Kingdom (England and Wales),0.4,0.5,0.4,2016,16-59,Government source,HHS,Tranquillizers and sedatives,,,GBR
142,Europe,Western and Central Europe,United Kingdom (England and Wales),0.4,0.5,0.3,2015,16-59,ARQ,HHS,Tranquillizers and sedatives,,,GBR
143,Europe,Western and Central Europe,United Kingdom (England and Wales),0.5,0.7,0.4,2014,16-59,ARQ,HHS,Tranquillizers and sedatives,,,GBR
144,Europe,Western and Central Europe,United Kingdom (Northern Ireland),10.3,9.6,10.9,2014,15-64,Government source,HHS,Tranquillizers and sedatives,,,GBR
145,Europe,Western and Central Europe,United Kingdom (Scotland),0.6,0.93,0.28,2014,16-64,Government source,HHS,Tranquillizers and sedatives,,,GBR
146,Europe,Western and Central Europe,United Kingdom (Scotland),0.8,1.4,0.2,2012,16-64,Government source,HHS,Tranquillizers and sedatives,,,GBR
147,Oceania,Australia and New Zealand,Australia,1.8,,,2019,14+,ARQ,HHS,Tranquillizers and sedatives,,,AUS
148,Oceania,Australia and New Zealand,Australia,1.6,,,2016,14+,ARQ,HHS,Tranquillizers and sedatives,,,AUS
149,Oceania,Australia and New Zealand,Australia,1.6,1.8,1.5,2014,14+,Government source,HHS,Tranquillizers and sedatives,,,AUS
150,Oceania,Australia and New Zealand,Australia,1.5,1.4,1.5,2010,14+,ARQ,HHS,Tranquillizers and sedatives,,,AUS
151,Oceania,Australia and New Zealand,New Zealand,1.7,2.4,1.1,2008,16-64,Government source,HHS,Tranquillizers and sedatives,,,NZL
